Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADCY1	"AC1, DFNB44"	ENSG00000164742	"Adenylate cyclase 1"	Q08828	7	45574140-45723116	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, cAMP biosynthesis"	"Calmodulin-binding, Lyase"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.7;liver: 19.2;retina: 53.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 521.3;Excitatory neurons: 147.2;Inhibitory neurons: 117.9;Rod photoreceptor cells: 174.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;SH-SY5Y: 25.5;SK-MEL-30: 30.1;WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018364, HPA068274"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"CAB018364: AB_2223098, HPA068274: "	"unprognostic (9.41e-3)"	"unprognostic (7.30e-4)"	"unprognostic (9.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.74e-6)"	"unprognostic (2.49e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.23e-1)"	1.9	1.8	13.7	0.3	22.4	0.0	4.7	15.4	33.7	5.3	0.0	0.4	0.2	1.8	0.5	0.6	2.0	0.6	2.9	31.9	0.0	1.9	19.2	0.6	0.4	1.2	0.9	0.9	3.3	1.9	2.6	0.4	1.1	2.8	0.4	53.0	0.3	1.2	7.7	0.4	0.3	0.9	0.0	1.7	1.1	2.8	4.0	0.3	2.4	8.5	0.3	0.8	1.3	24.5	0.8	5.9	2.1	3.2	4.1	0.1	4.0	0.2	0.0	0.8	0.3	0.6	0.0	0.0	0.2	0.2	5.8	1.9	3.8	0.3	0.1	10.7	2.7	0.0	0.0	0.6	0.0	0.2	0.1	4.9	2.8	0.5	22.2	0.0	0.1	8.6	0.3	7.0	0.3	7.1	0.0	0.0	8.3	5.1	0.0	0.0	0.0	11.7	0.0	5.7	13.4	25.5	2.1	0.0	30.1	3.1	2.0	3.5	0.0	0.6	4.2	0.5	3.6	0.0	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	22.4	15.4	33.7	31.9	0.0	1.2	0.9	1.1	0.0	4.0	24.5	3.5	0.0	0.0	30.7	0.3	0.3	0.6	0.0	0.0	43.8	10.6	5.7	11.4	2.8	0.0	0.0	521.3	0.1	0.3	0.5	1.9	0.0	2.9	1.0	23.1	10.8	31.2	0.0	147.2	0.9	0.2	4.2	0.0	0.7	0.0	0.2	15.7	52.3	0.3	42.1	117.9	1.0	2.0	3.2	0.4	0.7	1.8	0.2	3.6	17.8	0.0	13.8	0.0	63.3	4.0	0.5	0.1	7.5	0.1	2.6	0.0	0.4	0.0	174.4	0.0	2.3	8.8	0.5	6.8	0.1	0.1	0.0	0.6	0.6	0.6	0.3
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.8	2.8	2.6	4.1	2.3	0.4	5.2	1.6	1.9	3.0	1.9	6.2	17.5	1.1	1.3	11.6	5.2	8.3	4.0	1.8	1.7	7.2	71.9	15.2	1.7	2.4	2.9	1.4	3.2	1.3	0.3	47.4	2.2	3.2	6.4	0.1	9.0	6.5	0.5	14.5	10.2	2.2	2.5	7.5	12.3	2.1	4.6	4.6	1.6	1.2	4.0	15.1	5.6	1.9	17.0	88.6	1.9	9.4	0.5	0.0	0.2	23.1	4.3	17.2	10.7	71.3	51.0	0.0	20.3	13.4	4.9	41.3	2.6	22.1	28.3	0.0	6.8	3.6	14.5	84.8	16.7	14.6	0.0	0.1	34.9	0.4	81.5	10.0	161.4	0.4	0.6	0.1	6.9	155.6	0.3	0.0	0.7	6.2	20.0	0.0	7.7	17.7	9.0	37.9	0.1	0.1	6.8	30.8	14.5	14.1	16.7	0.3	5.6	0.1	7.6	7.7	11.5	0.0	0.1	0.0	0.1	0.1	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.3	1.6	1.9	1.8	1.7	2.4	2.9	2.2	2.5	4.6	1.9	5.1	6.4	5.9	0.0	0.3	0.0	21.9	0.0	18.8	0.0	5.3	2.7	1.9	24.3	8.1	9.2	0.0	5.3	0.0	0.6	0.0	13.2	0.1	0.1	0.5	41.7	0.0	17.0	1.6	5.4	33.5	14.5	32.1	0.5	0.0	0.0	27.1	143.8	2.2	0.0	12.7	3.5	0.0	40.5	0.0	0.6	0.6	8.1	0.0	15.0	0.9	0.0	0.0	0.5	0.3	37.9	8.8	0.4	0.1	18.7	9.5	11.8	2.9	0.0	6.6	0.4	1.3	2.6	5.3	30.2	0.0	13.5	1.6	0.0	1.7	25.0
AGAP1	"CENTG2, GGAP1, KIAA1099"	ENSG00000157985	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 1"	Q9UPQ3	2	235494043-236131800	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.9;retina: 54.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 304.0;Cone photoreceptor cells: 329.4;Excitatory neurons: 289.3;Oligodendrocyte precursor cells: 1438.1;Oligodendrocytes: 997.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (1.69e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.36e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (6.52e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.32e-2)"	5.3	4.7	30.7	3.4	34.4	1.9	8.3	7.6	29.6	5.7	0.0	12.5	7.0	5.2	8.9	6.6	6.7	5.6	5.9	34.0	33.0	7.7	2.6	5.6	1.7	44.6	24.1	5.5	6.5	8.9	7.1	6.9	48.2	4.8	11.2	54.7	4.2	5.0	8.4	3.7	8.6	10.5	10.9	1.9	6.7	6.6	30.5	1.5	9.1	9.2	1.9	6.2	3.4	53.9	17.3	13.6	20.9	9.8	15.1	9.7	13.1	8.6	9.1	9.9	7.5	14.0	31.3	0.1	3.6	14.9	37.2	4.3	15.8	20.4	12.3	0.3	8.1	26.4	12.5	10.5	6.0	0.1	17.5	14.1	19.3	20.4	15.9	7.1	6.8	6.1	13.8	1.0	12.6	22.2	0.5	3.0	9.1	14.9	6.2	3.6	10.6	16.8	10.8	20.4	78.9	19.9	7.3	17.1	9.5	11.4	9.8	4.1	6.8	11.8	12.0	9.8	11.7	5.4	0.1	0.8	18.4	0.2	12.7	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	30.7	34.4	7.6	29.6	34.0	33.0	44.6	24.1	48.2	10.9	30.5	53.9	16.0	6.4	15.5	100.6	0.2	4.1	3.7	6.2	5.2	304.0	19.4	11.7	22.9	2.8	8.7	11.0	329.4	9.7	5.5	23.3	3.9	21.4	9.4	24.0	12.0	13.3	16.3	0.4	289.3	15.0	1.5	19.5	4.6	15.8	20.8	12.7	7.9	6.3	1.4	119.5	219.0	17.8	12.2	0.6	3.8	2.9	5.0	2.1	1.8	139.6	1.6	33.3	9.2	1438.1	997.9	19.1	20.7	13.5	0.8	4.9	21.1	14.0	14.4	142.0	26.3	20.4	22.5	4.8	20.7	7.1	4.3	6.6	3.0	7.0	21.8	4.9
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
ANKRD27	"DKFZp434L0718, FLJ00040, VARP"	ENSG00000105186	"Ankyrin repeat domain 27"	Q96NW4	19	32597006-32676597	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 137.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042769	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Vesicles	Cytosol	"HPA042769: AB_10796584"	"unprognostic (2.16e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (9.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-2)"	8.9	7.4	10.8	8.9	12.9	10.4	8.7	12.1	12.6	10.3	21.5	17.2	7.6	10.0	8.8	14.3	8.0	7.7	9.6	11.8	9.8	9.7	4.4	10.3	11.1	12.0	12.9	8.3	7.2	9.3	6.8	13.6	12.4	12.3	11.9	11.7	9.7	13.5	20.7	12.4	10.7	11.6	8.9	9.0	11.0	17.3	12.1	16.7	13.3	10.8	11.5	16.9	11.1	11.8	32.0	36.0	11.5	20.8	23.5	18.0	28.1	18.0	18.0	19.4	25.4	28.8	19.0	34.7	16.5	23.0	20.4	19.4	29.6	22.3	32.0	47.3	15.1	137.9	13.7	23.9	29.4	53.5	47.6	13.1	28.8	20.9	33.8	13.5	19.7	25.3	37.5	76.3	15.1	31.5	20.8	46.2	6.0	40.2	13.8	30.6	15.6	12.7	15.6	30.5	21.3	8.6	17.6	29.6	21.0	15.2	12.4	25.7	18.5	21.1	22.4	19.6	28.0	19.7	12.7	23.8	21.0	51.8	13.8	36.5	11.1	28.5	13.9	15.7	17.5	7.5	14.3	15.6	12.6	6.9	10.9	11.7	9.0	30.6	13.3	6.2	13.2	13.3	10.8	12.9	12.1	12.6	11.8	9.8	12.0	12.9	12.4	8.9	12.1	11.8	6.8	16.0	9.4	18.3	10.0	15.6	5.5	5.6	14.2	9.4	9.0	5.1	9.2	7.2	5.7	9.2	20.9	14.9	9.7	9.3	0.0	3.3	5.1	7.5	9.4	7.1	9.1	26.5	35.5	5.9	10.6	7.6	5.6	11.6	12.0	10.1	4.6	4.8	8.4	11.8	16.3	9.6	8.2	12.0	12.1	16.2	10.8	8.7	16.0	12.2	6.0	5.8	9.2	11.1	18.7	7.1	10.3	9.4	8.0	10.0	10.8	7.7	7.1	14.7	0.0	6.8	9.3	4.1	17.1	14.7	15.5	15.2	14.0	7.2	8.9	8.4
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.0	1.6	4.3	0.7	4.4	0.7	0.9	8.7	8.4	2.9	0.0	1.3	0.4	1.2	0.4	1.7	1.6	0.3	0.4	8.0	2.5	0.9	0.9	3.3	0.6	3.3	2.4	1.1	5.9	0.0	7.6	0.1	2.4	2.5	0.2	1.1	0.4	0.1	0.1	1.0	4.9	0.0	2.2	10.7	1.4	5.7	3.0	1.4	2.7	0.0	0.7	1.3	1.5	4.9	0.0	1.6	0.7	3.7	0.0	0.0	0.0	0.9	1.4	0.1	0.5	0.0	0.0	0.0	3.5	0.0	2.3	0.0	0.5	0.0	0.0	0.0	3.1	8.4	0.0	0.1	3.1	0.0	0.2	0.4	2.5	0.4	0.0	0.4	4.4	1.8	5.0	0.2	0.0	0.5	0.2	2.4	1.1	0.0	3.3	0.0	0.4	0.2	0.0	0.0	5.4	20.0	0.0	0.0	0.2	0.1	0.0	1.0	4.4	0.0	4.4	0.0	0.9	0.0	0.1	0.0	0.1	14.9	1.7	0.0	0.0	0.0	0.9	0.0	0.2	0.0	1.5	3.3	0.0	0.0	5.4	5.6	0.1	1.3	0.0	0.0	0.0	2.0	4.3	4.4	8.7	8.4	8.0	2.5	3.3	2.4	2.4	2.2	3.0	4.9	0.5	0.0	0.6	53.2	1.8	0.4	0.2	0.0	0.0	21.5	1.9	2.3	1.4	0.0	0.1	0.0	0.0	0.1	36.5	0.1	1.9	1.8	18.9	2.9	6.4	1.2	0.0	2.1	142.7	5.8	0.2	2.2	0.0	2.1	0.0	1.9	3.6	0.5	1.2	89.2	106.1	0.3	0.0	1.6	0.4	10.4	1.8	0.8	3.6	33.7	1.9	1.3	63.8	97.0	74.1	3.3	0.0	3.8	12.3	0.1	0.0	0.3	0.2	4.5	0.0	0.4	2.1	1.6	14.5	0.4	0.3	0.1	30.7	10.6	0.0	0.1
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058346-131089885	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"adrenal gland: 105.4;brain: 144.3;pituitary gland: 176.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast glandular cells: 2.7;Oligodendrocyte precursor cells: 1.0;Skeletal myocytes: 1.5"	"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	161	"SH-SY5Y: 176.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 89.4"	"Low region specificity"	"Detected in many"			"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		0.2	105.4	20.1	0.0	3.7	0.0	1.4	0.8	3.2	1.6	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	13.5	132.5	0.0	0.0	0.0	0.0	35.0	46.1	0.0	0.0	0.0	176.9	0.1	144.3	0.2	0.1	0.0	0.2	0.0	6.6	0.1	0.0	0.0	4.7	0.0	0.1	0.8	52.1	0.4	0.1	1.1	0.0	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	176.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	3.7	0.8	3.2	13.5	132.5	35.0	46.1	144.3	4.7	52.1	10.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 339.7;Astrocytes: 248.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: AB_2680671"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	8.0	2.1	5.8	1.8	5.7	0.3	6.0	4.1	5.3	5.0	7.7	18.3	7.3	4.3	1.2	7.4	6.2	5.5	3.2	4.6	5.0	1.7	15.5	16.3	0.3	5.9	7.3	3.9	6.0	9.9	1.7	3.4	5.8	3.4	2.6	7.1	3.1	4.8	0.4	6.2	6.6	7.1	5.4	0.8	8.7	5.1	6.1	0.8	3.1	1.4	0.9	5.1	6.4	4.8	8.5	3.7	10.6	6.8	5.1	1.4	0.3	0.3	0.0	3.1	4.3	6.5	0.8	5.0	0.5	0.6	4.9	8.9	6.7	4.4	3.9	0.0	8.8	0.1	2.6	1.5	4.7	1.6	0.2	1.3	0.4	4.0	0.5	1.8	0.6	5.4	0.0	0.0	2.0	8.1	2.0	0.1	6.7	2.4	3.0	0.0	12.9	0.0	0.7	4.1	3.2	1.1	1.7	14.4	1.5	4.6	10.1	0.5	0.0	1.1	5.3	0.1	26.6	4.5	0.7	0.0	2.5	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.7	4.1	5.3	4.6	5.0	5.9	7.3	5.8	5.4	6.1	4.8	5.0	339.7	26.8	248.8	1.7	19.5	9.0	2.7	17.6	11.6	54.2	6.6	1.8	20.0	10.8	3.7	4.2	1.8	4.3	1.5	0.0	2.2	11.9	4.7	4.5	4.3	0.0	2.7	4.2	2.5	1.1	12.0	14.3	2.1	5.1	3.6	8.6	60.8	0.6	5.0	10.1	7.9	6.1	2.5	3.4	3.4	10.5	1.3	3.6	7.5	2.7	58.1	12.3	41.7	5.1	2.0	6.9	18.8	0.7	7.5	21.4	0.1	14.9	47.8	0.0	14.1	3.7	4.7	37.0	11.7	23.7	6.2	4.7	2.5	8.1	5.7
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA012577: AB_1845155, HPA063900: AB_2685146"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.6	7.8	7.0	3.8	7.5	14.3	8.8	7.9	8.4	8.1	12.8	11.1	5.0	9.6	5.5	11.6	7.1	3.3	10.7	7.3	6.6	9.2	15.1	7.6	5.8	6.5	6.3	8.5	8.6	5.3	5.5	4.0	6.9	12.1	5.2	5.6	11.5	4.3	19.9	17.2	11.1	5.2	6.3	11.5	11.1	13.5	6.5	5.9	11.2	6.1	5.2	11.5	8.2	7.7	13.3	12.2	4.9	8.5	12.4	8.0	14.0	11.4	9.3	9.6	8.9	8.9	9.7	3.1	3.7	8.9	14.3	7.7	9.8	6.4	9.8	6.2	7.7	7.1	9.1	14.6	9.1	5.6	9.0	5.3	9.1	11.5	8.7	7.2	9.0	4.7	7.6	2.9	10.2	9.3	6.7	11.2	19.1	14.1	17.6	4.8	10.3	2.6	9.9	8.4	8.8	6.5	7.8	8.5	8.5	7.4	5.3	7.1	10.7	6.2	5.4	9.6	10.3	6.5	3.9	6.1	10.5	5.7	10.2	0.0	1.7	2.9	4.8	1.4	3.7	2.0	3.1	4.4	1.4	2.2	3.5	3.5	1.2	4.1	4.7	0.7	3.8	2.1	7.0	7.5	7.9	8.4	7.3	6.6	6.5	6.3	6.9	6.3	6.5	7.7	6.1	6.4	8.2	5.2	7.4	9.1	4.6	5.2	3.4	8.4	12.0	6.6	5.6	7.2	11.6	5.5	4.2	4.6	20.9	13.9	5.9	8.3	1.2	16.4	10.9	6.4	9.0	3.8	31.0	6.7	6.2	5.2	8.2	31.8	9.5	6.4	6.1	10.2	5.6	1.7	25.6	5.1	6.1	6.3	5.7	1.7	4.1	5.1	10.6	8.4	6.6	7.1	4.1	11.6	21.4	16.8	8.0	3.8	8.1	7.1	9.2	5.6	11.5	19.5	6.6	5.8	6.9	11.0	17.6	7.3	13.2	3.7	19.2	5.1	8.4	6.0
AXIN2	"DKFZp781B0869, MGC126582"	ENSG00000168646	"Axin 2"	Q9Y2T1	17	65528563-65561648	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.7;Extravillous trophoblasts: 102.6"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 33.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.2;CACO-2: 52.3;Hep G2: 78.8;OE19: 86.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012283, CAB017783"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB012283: AB_2290204, CAB017783: "	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.48e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.84e-3)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.25e-1)"	8.7	10.9	6.8	5.4	6.9	0.9	5.3	7.9	7.9	17.2	5.5	12.3	7.1	23.9	5.9	5.9	19.8	6.6	8.0	9.4	6.2	3.7	2.7	17.0	3.5	8.5	7.9	15.0	4.2	4.2	6.2	18.4	5.3	14.0	14.6	3.4	5.2	8.9	14.6	14.9	7.4	17.3	7.3	7.4	13.6	6.7	11.0	17.3	12.3	7.8	2.7	11.4	8.0	5.6	0.0	13.9	27.2	0.5	9.6	4.1	12.0	0.4	1.3	0.9	1.7	52.3	5.0	1.0	1.7	8.0	1.0	0.4	5.7	0.1	1.9	2.4	3.1	0.0	2.4	78.8	1.0	0.1	0.1	2.4	2.1	2.2	0.6	1.6	2.4	5.1	0.2	1.2	1.4	0.3	13.9	0.1	5.3	86.9	0.6	9.9	1.6	0.1	2.6	0.3	8.4	5.5	0.5	0.3	4.8	20.0	1.0	0.3	6.3	5.3	9.6	7.6	1.7	0.1	3.0	3.8	2.5	0.6	2.6	3.2	0.0	0.0	0.1	0.0	0.4	0.5	1.1	0.2	0.0	1.8	2.3	0.4	0.0	1.0	0.0	0.0	0.0	0.3	6.8	6.9	7.9	7.9	9.4	6.2	8.5	7.9	5.3	7.3	11.0	5.6	2.4	0.0	9.0	9.8	1.0	11.2	2.2	1.0	11.4	3.7	5.2	8.1	8.7	1.5	8.1	0.0	4.2	18.1	0.7	15.2	0.0	1.4	33.7	7.8	15.1	5.3	5.4	0.0	8.4	0.9	102.6	10.3	5.6	16.5	0.0	3.1	1.1	2.0	3.8	1.7	8.7	17.4	0.0	0.0	7.5	17.5	6.5	0.6	17.8	9.4	1.0	3.3	0.0	8.0	2.0	0.8	18.9	10.9	0.9	2.9	1.9	0.9	1.3	2.5	13.1	1.6	10.6	6.2	12.9	3.3	5.5	14.2	4.6	3.6	19.8	1.3
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 196.4;Intestinal goblet cells: 47.4;Paneth cells: 72.5;Proximal enterocytes: 94.1;Undifferentiated cells: 57.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 23.5;RPTEC TERT1: 27.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.6"	"HPA054092, HPA054684"	Approved				"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.0	0.3	2.5	0.9	8.6	0.0	2.6	0.7	3.7	2.2	1.9	22.4	27.3	0.7	1.3	1.6	1.3	5.5	0.0	2.4	4.6	0.2	0.1	0.1	0.0	2.0	2.1	0.3	3.3	0.0	1.8	0.0	1.3	0.4	37.4	0.8	4.5	0.1	0.0	0.8	33.7	0.8	1.3	0.0	5.0	0.4	6.9	1.0	1.2	0.3	2.0	1.3	2.3	0.7	0.0	0.9	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	23.5	0.0	0.2	0.2	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.3	0.2	0.6	0.0	2.7	0.1	27.1	1.7	4.6	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.7	0.2	1.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	8.6	0.7	3.7	2.4	4.6	2.0	2.1	1.3	1.3	6.9	0.7	0.1	0.0	0.0	6.5	0.3	0.0	0.5	0.1	0.0	7.4	8.0	8.1	2.2	10.0	5.3	5.5	0.0	0.0	0.2	196.4	0.0	7.5	0.4	0.2	5.9	0.4	28.9	0.0	3.6	4.7	0.0	0.2	13.3	0.2	4.5	0.8	0.0	0.0	0.0	0.0	4.8	47.4	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	1.4	0.0	11.1	1.0	9.2	72.5	0.0	0.0	0.6	94.1	0.1	1.5	0.2	0.0	0.1	0.4	0.1	1.7	0.5	0.0	0.0	0.5	0.0	57.7	9.7
BARHL2		ENSG00000143032	"BarH like homeobox 2"	Q9NY43	1	90711539-90717302	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 27.4"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 23.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	14	"cerebellum: 27.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;HEK 293: 3.7;HMC-1: 1.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 12.9"	"Region enriched"	"Detected in some"	20	"cerebellum: 24.6"							NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"								"unprognostic (1.83e-1)"				"unprognostic (1.73e-1)"	"unprognostic (6.80e-2)"				"unprognostic (3.10e-1)"	"unprognostic (1.60e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	27.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.7	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	27.4	0.7	0.0	1.2	0.1	1.9	1.9	0.3	2.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"JURKAT: 38.3;MOLT-4: 47.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.4	0.3	8.0	5.1	21.2	4.9	1.1	0.0	17.2	0.9	0.0	1.2	2.0	0.2	0.5	4.3	0.3	0.9	0.1	18.9	1.1	0.3	0.4	1.1	10.2	0.3	0.8	0.2	0.1	0.0	0.2	0.1	0.0	0.5	1.4	0.0	1.7	0.3	0.2	15.0	3.5	0.2	1.5	4.4	1.9	0.5	2.0	36.6	0.8	0.0	7.5	1.3	2.9	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.0	0.0	38.3	0.0	4.1	0.0	2.8	47.3	0.8	0.5	3.6	0.0	7.0	0.0	0.0	0.0	2.6	3.7	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.2	0.0	2.6	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.1	2.0	0.0	1.8	0.0	2.8	2.4	0.0	0.0	4.6	3.1	0.0	0.3	0.0	0.0	2.0	0.8	8.0	21.2	0.0	17.2	18.9	1.1	0.3	0.8	0.0	1.5	2.0	3.9	1.3	3.2	0.0	1.3	6.4	62.8	1.6	6.3	73.4	0.4	4.3	4.4	3.8	4.3	1.3	0.0	0.0	0.1	44.2	3.8	1.9	0.2	0.2	0.2	0.2	1.2	1.2	5.3	57.5	0.5	0.0	3.3	2.0	0.3	5.1	0.2	3.3	0.3	0.3	0.0	105.7	4.9	2.0	1.0	11.4	0.4	0.6	4.0	5.4	1.0	4.9	0.0	51.5	32.2	2.0	1.1	5.4	0.0	24.4	0.6	10.1	0.5	0.3	0.1	0.0	0.5	1.9	1.6	5.8	42.7	71.3	0.0	133.4	0.1	9.7	0.6
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110853-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;prostate: 3.3;testis: 9.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 8.1;Inhibitory neurons: 6.2;Muller glia cells: 10.7;Spermatogonia: 38.3"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 33.2;HEK 293: 7.9;HEL: 21.1;MOLT-4: 13.1;SuSa: 15.4;U-698: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.0	0.0	0.7	1.1	0.7	0.8	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.3	1.1	0.0	0.1	0.2	2.1	1.2	3.6	0.1	0.0	0.0	1.0	0.3	2.8	3.3	0.2	1.1	0.0	0.0	0.0	0.0	1.2	0.1	0.1	1.2	0.2	9.4	0.7	1.1	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	33.2	0.0	0.0	0.0	7.9	21.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	7.0	0.0	0.1	0.0	0.0	13.1	0.0	6.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.7	0.8	0.0	0.0	0.0	15.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	1.3	1.3	1.1	1.2	3.6	2.8	0.1	0.7	0.4	0.4	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	3.4	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4.8	2.5	0.0	0.0	3.3	6.2	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	10.7	0.0	3.5	0.2	0.0	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.6	38.3	0.0	0.0	0.0	1.5	2.2	0.0	0.0
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757955-95158448	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1;cervix: 24.7;prostate: 22.4"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 480.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 32.4;prostate cancer: 24.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.0;MCF7: 11.1;SH-SY5Y: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-3)"	"prognostic favorable (2.84e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-3)"	"unprognostic (7.89e-4)"	"unprognostic (6.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.63e-2)"	0.7	4.6	13.4	0.3	15.4	0.1	1.0	13.5	15.0	24.7	2.1	0.9	0.1	4.4	2.4	0.2	12.5	2.6	0.8	12.5	16.0	7.8	0.8	1.7	0.0	19.3	20.1	6.2	1.1	0.1	1.9	0.7	17.5	22.4	0.2	8.1	1.0	14.2	3.0	0.8	0.1	0.6	15.3	0.9	2.4	3.7	15.6	6.4	0.5	1.1	0.0	0.2	0.5	12.1	0.0	22.0	5.6	0.0	2.3	4.8	0.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	1.0	0.0	1.3	3.6	8.4	0.1	0.0	4.9	0.0	1.4	0.0	0.6	0.5	0.1	2.7	9.0	2.8	6.2	0.4	0.1	0.0	0.0	0.0	7.1	11.1	0.6	0.1	2.1	0.1	3.2	0.2	3.4	0.1	4.3	0.1	0.2	18.8	0.3	3.2	3.2	0.8	1.7	0.0	0.0	4.0	3.8	0.2	4.3	0.0	0.0	0.0	1.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	13.4	15.4	13.5	15.0	12.5	16.0	19.3	20.1	17.5	15.3	15.6	12.1	0.0	6.4	0.0	480.6	0.0	2.7	1.3	13.1	1.2	0.4	3.8	1.0	3.4	2.8	33.4	60.7	0.0	0.0	0.0	0.0	1.9	3.0	1.4	28.5	1.4	1.1	18.4	0.0	51.0	0.4	0.3	1.5	0.0	20.8	0.0	38.6	2.9	0.0	0.1	0.0	2.5	0.0	8.2	0.0	1.2	1.4	3.1	0.4	28.4	22.5	0.0	38.5	0.0	10.1	2.8	0.7	0.0	3.8	0.0	28.5	0.0	0.2	15.7	1.6	0.0	1.7	2.9	1.2	10.6	0.4	2.3	0.0	0.5	4.4	0.0	1.6
C19orf84		ENSG00000262874	"Chromosome 19 open reading frame 84"	I3L1E1	19	51388289-51390591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 22.1"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 31.9"	"Group enriched"	"Detected in some"	5	"ovarian cancer: 1.3;testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA068082	Uncertain		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles		"HPA068082: AB_2685949"	"unprognostic (5.94e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.13e-3)"	"unprognostic (9.28e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.99e-3)"	0.0	0.0	0.4	0.2	0.4	0.6	0.0	0.4	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.1	0.3	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	22.1	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.4	0.7	0.4	0.4	0.4	0.5	0.5	0.3	0.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.3	0.3	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	31.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
C3orf56	FLJ40141	ENSG00000214324	"Chromosome 3 open reading frame 56"	Q8N813	3	127193131-127198185	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA055395			Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Centrosome, Cytosol"	"HPA055395: "															"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 37.0"	HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	4.5	1.4	5.9	19.4	23.9	31.2	6.9	3.2	7.1	4.0	2.5	9.4	13.3	3.1	1.6	12.5	12.2	6.2	4.0	3.6	3.9	6.8	3.6	9.7	33.9	5.6	6.7	1.0	8.3	5.3	5.2	2.4	4.6	9.4	7.0	1.0	10.1	3.9	2.3	7.0	11.7	2.3	4.3	21.7	12.4	8.0	7.8	20.4	2.5	2.7	20.4	8.1	7.6	3.2	8.5	6.9	7.5	9.5	0.0	0.0	34.9	0.0	0.0	0.0	0.0	6.8	13.4	45.1	6.1	0.0	0.4	0.4	11.3	6.4	0.0	28.8	4.7	10.0	4.8	9.9	0.7	23.0	8.4	0.0	11.4	0.0	0.0	0.7	8.6	55.6	11.2	50.1	0.1	24.9	24.2	29.6	7.1	6.2	11.5	19.5	0.2	14.2	2.6	10.2	53.6	11.6	4.6	16.9	4.6	5.6	10.2	20.7	2.6	0.0	0.2	0.1	0.1	58.5	76.2	22.8	0.0	20.1	0.1	7.8	3.3	1.3	9.4	1.9	8.8	2.5	6.0	9.2	1.8	2.1	3.8	5.8	2.3	4.0	3.0	2.0	10.7	4.1	5.9	23.9	3.2	7.1	3.6	3.9	5.6	6.7	4.6	4.3	7.8	3.2	26.6	3.2	28.8	7.8	54.1	9.3	15.9	19.0	27.9	0.0	15.3	7.6	19.8	10.0	22.1	14.7	0.0	3.6	80.1	29.6	0.0	4.4	9.6	62.6	1.4	17.3	23.9	20.6	7.1	5.9	2.2	4.2	20.4	12.1	2.5	1.3	20.3	1.6	6.3	0.0	2.5	15.3	22.4	21.0	12.4	18.7	4.1	18.9	1.8	9.4	20.1	8.0	142.2	8.0	5.2	7.8	18.2	3.0	93.2	16.8	13.1	13.2	112.5	0.1	0.0	2.9	4.4	4.7	17.4	31.2	9.5	1.8	89.2	3.3	19.4	19.8
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 51.0;Spermatogonia: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	5.9	1.4	3.9	15.0	9.1	51.7	15.7	5.7	5.2	8.7	17.8	17.0	10.7	13.8	5.5	11.2	11.5	8.1	25.3	3.9	3.5	2.8	4.8	14.0	37.1	6.9	4.8	21.8	13.0	1.8	1.1	4.7	3.8	7.3	19.0	5.1	9.0	7.6	6.2	18.5	13.6	11.9	5.0	13.3	17.8	18.5	7.8	49.0	29.8	3.4	31.8	6.3	8.1	9.8	84.5	27.6	26.0	0.6	14.5	17.9	0.0	65.9	58.2	51.8	73.5	11.3	75.4	173.6	21.8	59.3	102.4	51.1	41.4	69.4	103.6	0.3	28.6	42.3	83.8	7.4	21.1	111.1	0.4	35.2	12.7	40.0	116.9	54.9	104.8	133.5	58.3	0.1	41.4	34.5	146.1	46.1	153.2	17.4	36.2	141.0	94.0	119.8	15.4	14.8	96.9	79.7	30.3	19.9	29.9	34.4	45.6	54.6	43.0	57.1	68.5	101.3	83.8	90.6	63.6	223.0	55.7	154.6	54.5	1.1	2.3	43.2	2.2	3.8	0.3	101.0	6.4	3.2	14.9	124.5	30.9	12.8	3.8	3.4	4.9	75.9	9.9	12.2	3.9	9.1	5.7	5.2	3.9	3.5	6.9	4.8	3.8	5.0	7.8	9.8	1.0	19.2	31.5	7.5	51.0	27.1	23.7	6.9	17.1	1.5	12.5	20.7	38.7	11.5	19.0	0.0	2.1	0.5	30.7	8.4	3.9	8.9	7.3	5.4	2.7	4.8	10.7	21.9	0.5	6.2	0.3	13.4	18.3	5.3	8.8	14.9	1.4	4.0	10.8	13.5	1.0	26.1	8.2	15.2	3.5	5.2	4.1	7.0	8.8	1.9	1.6	2.4	1.0	15.1	8.7	3.9	7.4	2.6	20.2	14.2	1.5	0.1	4.2	2.7	13.1	6.8	12.4	4.6	63.5	9.6	7.7	0.3	5.4	8.3	23.0	6.2
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.5;Oligodendrocytes: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 134.8;TIME: 160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	21.4	11.2	26.3	18.9	45.9	48.1	18.4	23.0	34.7	13.2	8.3	17.0	11.9	26.2	9.1	14.6	13.9	16.2	11.4	36.7	28.6	11.6	16.3	20.6	21.7	23.2	23.0	15.7	10.5	10.6	8.0	31.8	23.0	14.0	12.2	19.3	8.7	11.1	8.8	11.0	11.5	29.5	27.4	21.8	10.5	26.6	28.5	24.8	11.6	12.3	22.2	17.1	12.8	54.0	15.4	12.5	32.5	8.9	15.9	41.2	24.1	34.8	46.9	29.1	27.2	7.7	8.8	22.7	23.0	24.5	15.6	13.8	19.8	20.9	39.5	24.9	15.5	32.7	8.5	10.9	34.4	17.9	18.4	30.0	21.3	43.0	77.1	51.8	134.8	18.9	24.7	18.1	66.8	9.5	17.0	28.1	14.4	7.6	22.8	29.2	18.0	19.8	35.1	12.7	17.1	11.7	19.9	18.4	25.9	24.7	14.0	15.7	160.5	25.6	10.0	13.8	18.7	26.0	21.1	24.1	9.6	7.6	19.2	66.7	6.4	17.1	22.2	9.3	24.0	17.5	17.9	25.1	10.0	16.6	25.0	21.7	23.2	31.4	9.0	7.3	15.8	16.6	26.3	45.9	23.0	34.7	36.7	28.6	23.2	23.0	23.0	27.4	28.5	54.0	58.1	16.0	6.5	54.5	37.3	26.8	10.7	8.6	19.4	11.8	13.8	9.8	11.9	7.2	10.3	9.2	16.7	12.0	64.4	7.2	0.0	4.9	3.3	17.6	10.0	51.7	15.0	17.9	101.5	3.6	27.9	24.0	21.4	17.2	18.3	8.9	34.2	10.8	12.1	5.0	59.2	7.9	4.1	14.5	20.7	4.1	9.9	16.7	17.8	64.6	8.6	22.6	32.0	52.3	259.2	7.4	3.4	9.4	64.7	12.5	6.5	8.6	15.4	9.6	6.6	22.7	22.0	8.8	21.6	24.2	25.9	13.7	63.2	10.7	6.0	15.1
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836573	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 215.9;Erythroid cells: 213.5;Late spermatids: 237.0;Oligodendrocytes: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 378.4;REH: 173.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	3.7	7.3	6.7	4.7	7.1	18.1	4.9	5.4	5.1	4.8	2.6	5.9	6.1	3.1	2.1	4.2	2.9	3.6	4.7	4.0	5.0	4.4	5.9	4.1	6.6	6.3	6.7	2.7	6.2	9.9	1.7	17.3	6.3	3.0	7.5	0.5	5.7	4.2	1.0	6.8	7.2	3.2	5.8	4.9	9.1	3.3	9.6	41.1	2.4	2.3	6.2	3.8	4.6	8.8	27.1	11.3	34.9	23.9	10.6	11.5	5.8	27.2	18.4	14.3	13.5	34.7	20.9	21.7	14.4	19.9	8.4	15.8	20.8	42.6	34.4	43.0	10.6	50.8	23.3	34.7	6.3	33.0	2.7	11.5	23.1	17.9	90.8	13.4	5.6	75.1	49.3	55.5	26.7	5.9	378.4	3.8	9.8	37.4	9.1	173.7	112.0	36.4	20.3	0.7	18.1	113.8	3.7	9.8	17.1	26.0	0.6	54.9	19.3	44.1	63.7	18.0	54.2	27.4	0.5	27.6	6.9	112.1	60.8	0.9	0.2	0.6	0.6	0.4	0.9	0.2	0.6	0.8	0.5	0.3	0.7	0.7	0.1	0.7	0.4	0.9	0.3	0.3	6.7	7.1	5.4	5.1	4.0	5.0	6.3	6.7	6.3	5.8	9.6	8.8	38.6	25.6	3.7	2.9	17.7	60.3	23.5	55.0	62.6	0.4	20.7	21.2	18.1	22.8	32.8	22.0	0.0	53.8	30.5	12.1	9.8	37.0	215.9	3.1	29.0	30.7	16.8	213.5	114.7	23.3	5.3	28.5	42.3	6.9	25.3	39.2	11.4	27.0	16.0	0.0	60.3	63.7	28.5	23.0	48.6	237.0	5.0	27.6	19.6	108.7	22.4	0.8	39.1	119.6	235.3	94.7	22.8	3.4	85.3	47.1	20.1	8.2	11.9	0.0	6.6	100.8	32.2	2.7	33.6	36.7	50.4	17.6	42.5	62.8	92.7	27.3
CNTNAP2	"Caspr2, KIAA0868, NRXN4"	ENSG00000174469	"Contactin associated protein 2"	Q9UHC6	7	146116002-148420998	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Autism, Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;retina: 14.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 3383.0;Inhibitory neurons: 6845.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 8.0;CACO-2: 6.7;NTERA-2: 12.0;SCLC-21H: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002739	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002739: AB_1078545"	"unprognostic (2.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.05e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.00e-3)"	0.2	0.8	10.0	0.2	13.8	0.0	0.6	1.4	20.7	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.6	0.0	0.2	5.6	5.7	0.1	1.9	0.0	0.4	5.7	0.5	1.1	0.2	0.3	3.8	0.5	3.8	4.1	0.4	14.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.4	0.2	0.5	1.8	3.7	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	8.0	3.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.0	0.2	0.0	2.0	1.7	0.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.0	1.4	0.0	0.0	0.0	2.2	0.0	0.0	21.5	1.4	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.0	13.8	1.4	20.7	5.6	5.7	5.7	0.5	3.8	0.0	1.8	0.0	0.1	0.0	0.0	65.6	9.3	0.1	0.3	15.5	1.8	33.9	0.3	0.0	1.2	7.2	4.1	0.0	2.1	40.8	0.0	1.8	0.0	1.4	7.2	0.6	0.0	0.6	2.4	0.0	3383.0	0.7	6.8	1.1	0.5	0.7	0.0	0.2	0.0	8.9	3.3	1031.4	6845.7	3.9	0.0	0.6	2.0	2.7	1.2	0.4	0.0	180.8	0.2	8.2	1.0	429.3	914.7	4.1	2.1	0.0	0.3	7.4	4.7	0.5	0.9	16.7	0.0	0.0	0.9	2.4	12.0	9.1	0.0	6.3	0.0	1.2	6.8	0.2
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.2;skeletal muscle: 131.6;tongue: 107.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	3.0	1.0	83.8	1.4	96.7	0.0	14.8	62.0	91.1	4.8	41.6	13.3	18.9	2.2	2.1	13.6	19.1	5.8	54.8	81.8	67.9	12.9	19.6	13.8	0.2	76.6	88.3	2.8	18.4	31.5	12.8	4.7	69.2	14.4	10.9	23.3	47.3	4.2	131.6	27.5	21.5	2.7	66.6	0.3	17.6	3.0	89.8	1.3	8.3	107.9	1.0	1.8	5.8	118.2	12.4	8.8	0.2	0.3	0.0	0.0	33.7	0.0	0.0	0.0	0.0	24.1	18.2	0.0	0.9	0.0	1.4	21.1	12.0	0.0	0.0	0.0	9.6	0.0	57.0	4.7	0.0	0.0	0.1	1.5	2.3	0.0	0.0	0.0	0.0	1.6	6.5	0.2	0.2	7.9	0.1	0.1	9.0	53.4	8.0	0.1	0.5	45.5	17.4	0.0	11.0	0.2	3.2	26.2	3.9	32.6	16.6	0.1	0.0	0.0	9.8	0.3	0.9	0.0	34.1	0.1	0.1	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	83.8	96.7	62.0	91.1	81.8	67.9	76.6	88.3	69.2	66.6	89.8	118.2	1.4	38.5	19.6	48.0	1.0	17.8	3.4	1.2	4.0	2.3	38.0	34.7	76.2	28.6	13.2	9.2	58.4	23.3	4.6	59.4	0.0	21.5	3.8	65.9	3.3	2.2	18.6	0.0	198.7	9.7	9.2	7.7	35.7	74.6	10.1	4.6	0.4	29.7	2.2	0.0	96.6	35.2	4.1	0.8	1.7	3.1	0.6	0.9	16.0	10.3	1.1	94.4	0.0	353.9	548.8	23.2	35.0	0.4	0.2	25.3	76.8	18.6	31.4	73.6	0.0	10.5	1.5	0.7	8.8	6.8	35.7	40.2	1.7	11.2	14.4	7.3
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6;testis: 32.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.0;Inhibitory neurons: 44.3;Oligodendrocytes: 196.5;Spermatocytes: 34.1;Spermatogonia: 62.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 37.9;U-2197: 106.0;U-87 MG: 39.1"									HPA040396			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040396: AB_2676960"	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.8	5.0	10.4	1.3	18.6	0.2	2.5	20.3	18.6	9.3	4.5	6.8	1.2	4.2	7.9	3.6	8.3	4.0	2.9	12.7	17.0	1.2	0.2	1.6	0.5	21.3	21.7	14.3	1.3	0.8	21.8	0.3	24.0	2.3	2.4	4.5	1.5	3.7	2.4	1.9	2.5	3.4	15.0	0.6	2.5	32.4	20.4	0.4	2.3	10.5	0.5	7.7	6.1	33.6	0.1	3.6	0.3	0.4	2.6	0.2	0.1	2.8	0.3	1.8	1.4	0.2	0.1	0.0	6.3	1.1	19.5	0.1	5.1	0.0	0.4	0.0	4.2	0.1	0.1	0.1	1.8	0.1	2.3	1.4	0.0	3.5	0.0	0.2	0.0	7.6	8.9	0.2	1.3	0.2	0.6	0.1	8.2	0.1	1.0	0.0	0.2	0.1	0.0	0.1	10.5	2.4	9.2	0.5	37.9	11.2	0.1	1.1	0.1	18.9	7.5	106.0	6.0	5.3	14.3	1.4	39.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	18.6	20.3	18.6	12.7	17.0	21.3	21.7	24.0	15.0	20.4	33.6	0.3	0.0	0.0	19.6	0.1	0.8	0.3	0.0	0.0	11.5	0.6	0.3	1.9	0.0	0.0	0.0	10.4	0.0	0.1	0.1	0.0	0.1	12.6	0.5	1.4	0.2	0.0	0.0	70.0	0.0	0.0	5.9	0.5	0.1	1.3	0.3	0.4	0.0	0.3	11.8	44.3	0.0	0.0	0.0	0.8	20.0	4.1	0.4	5.4	10.3	0.1	5.2	0.0	10.1	196.5	0.1	0.0	2.2	0.2	0.5	0.0	0.4	2.2	4.3	6.6	1.9	1.8	34.1	62.3	0.0	0.6	0.1	0.4	0.0	0.0	0.1
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 128.8;granulocytes: 139.9;Inhibitory neurons: 194.9;Oligodendrocyte precursor cells: 428.8;Oligodendrocytes: 444.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"non-classical monocyte: 7.7"	"Lineage enriched"	"Detected in single"	26	"monocytes: 7.7"	"Group enriched"	"Detected in some"	6	"HEL: 57.6;HMC-1: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: AB_2679037"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	6.9	1.8	11.4	0.7	16.7	0.0	3.8	13.0	14.7	5.7	6.8	2.4	1.6	10.6	4.8	12.1	6.0	3.5	1.8	12.7	14.8	6.4	1.8	1.8	0.2	15.7	14.7	3.1	7.8	9.3	2.9	1.7	16.3	3.4	2.4	7.9	3.4	1.8	0.5	1.8	2.4	5.2	11.9	2.2	1.3	1.0	15.1	0.7	5.5	0.9	0.9	4.2	4.2	26.1	0.0	0.9	1.6	0.0	0.0	0.0	1.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.1	8.3	0.0	0.0	0.0	2.5	57.6	0.5	0.0	0.2	0.0	74.1	0.3	0.4	0.0	0.0	1.0	1.6	0.0	0.0	0.1	1.1	0.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	0.2	10.6	0.0	6.1	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	2.6	1.0	0.1	0.0	0.7	0.0	0.2	5.0	0.0	1.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	11.4	16.7	13.0	14.7	12.7	14.8	15.7	14.7	16.3	11.9	15.1	26.1	15.6	3.2	4.8	10.1	0.0	1.9	3.4	3.7	15.9	33.6	1.9	6.7	3.6	10.0	5.6	7.3	56.3	2.8	0.3	1.8	1.9	6.3	1.8	5.1	32.5	10.2	1.8	0.0	128.8	4.2	2.1	9.1	1.1	7.4	139.9	3.8	20.0	1.1	9.2	74.0	194.9	1.1	24.4	10.1	12.3	3.3	0.9	8.0	7.2	75.9	1.3	97.2	0.0	428.8	444.2	0.6	2.1	1.2	0.3	2.1	0.3	24.3	1.4	6.6	0.0	3.3	9.6	0.6	2.1	38.8	0.3	1.1	2.7	0.2	6.8	1.4
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007509	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 309.9"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 5.0;Hofbauer cells: 6.2;Kupffer cells: 10.3;Macrophages: 12.6;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	902000		"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic favorable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	5.5	2.0	0.1	65.1	0.2	0.2	17.5	0.1	0.6	4.9	0.3	10.2	3.0	4.8	0.7	5.3	2.8	8.5	5.9	0.1	0.1	8.7	19.1	31.8	309.9	1.8	0.2	3.8	1.4	1.5	1.0	1.7	1.6	3.7	25.3	0.0	19.0	0.7	1.5	2.9	6.0	3.2	0.3	31.2	17.5	6.0	0.2	32.8	7.1	2.5	30.6	11.1	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.1	0.1	1.8	0.2	1.6	0.3	0.2	0.3	3.4	0.0	1.7	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.4	0.0	0.2	1.3	0.1	1.1	2.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	5.0	1.8	6.2	0.0	0.0	0.0	0.0	10.3	3.6	1.3	0.6	12.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	3.5	1.7	8.0	0.0	0.3	0.1	0.5	0.0	0.1	0.4
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.2;kidney: 139.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Collecting duct cells: 158.2;Distal tubular cells: 174.1;Excitatory neurons: 117.7;Inhibitory neurons: 147.5;Oligodendrocyte precursor cells: 120.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 202.4;JURKAT: 145.2;MOLT-4: 204.8;U-266/70: 153.6;U-698: 142.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favorable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	3.2	12.3	61.0	30.8	54.4	55.5	2.8	23.6	103.8	3.1	16.3	8.9	6.3	6.6	25.1	3.8	9.2	8.8	10.4	112.2	25.6	139.9	18.3	12.2	57.1	8.4	33.4	4.8	7.1	64.9	40.1	9.3	6.6	5.8	9.8	35.4	4.0	5.0	7.0	2.8	17.5	5.6	0.0	35.0	20.9	5.3	67.7	85.9	9.9	1.7	55.3	8.3	2.3	37.7	0.3	31.8	47.3	28.8	1.1	1.3	81.5	6.1	9.6	2.5	6.8	6.2	0.6	202.4	14.5	3.4	7.4	0.4	38.0	27.1	5.8	48.8	60.8	28.4	42.3	24.9	4.1	29.1	71.8	5.4	10.9	8.1	0.5	18.8	8.8	145.2	0.4	81.1	7.0	7.7	204.8	5.5	22.3	0.5	8.5	50.6	1.4	102.3	24.5	30.2	70.5	27.4	0.6	28.3	4.6	46.8	19.9	0.8	11.3	2.0	21.4	7.1	5.4	153.6	40.2	142.8	21.4	33.5	11.8	64.8	12.6	90.1	85.9	57.4	61.0	35.8	60.6	75.7	17.8	35.9	63.2	73.2	41.0	53.9	133.7	43.9	53.5	78.0	61.0	54.4	23.6	103.8	112.2	25.6	8.4	33.4	6.6	0.0	67.7	37.7	1.8	3.2	26.9	133.5	76.6	1.1	2.2	2.8	3.4	62.0	3.5	3.4	17.9	8.6	7.4	158.2	16.7	37.2	78.8	6.0	174.1	9.7	15.3	2.8	1.8	2.6	14.4	11.6	117.7	1.6	43.0	3.6	6.1	6.2	2.5	23.1	5.7	30.8	5.3	90.9	147.5	5.6	4.1	6.5	11.4	24.2	1.8	15.7	7.2	23.4	20.3	14.0	101.0	120.6	33.8	1.9	9.9	6.8	41.1	1.3	5.4	55.0	4.7	35.2	0.0	12.2	11.0	3.2	13.1	0.8	1.4	21.1	88.8	2.1	9.1	1.7
DBX2	FLJ16139	ENSG00000185610	"Developing brain homeobox 2"	Q6ZNG2	12	45014672-45051099	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"brain: 9.3"	"Group enriched"	"Detected in some"	9	"Astrocytes: 11.4;Oligodendrocyte precursor cells: 14.1;Spermatogonia: 5.1"	"Cancer enriched"	"Detected in single"	32	"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065045, HPA066053"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065045: , HPA066053: AB_2685605"	"unprognostic (1.13e-4)"			"unprognostic (9.99e-2)"	"unprognostic (7.82e-3)"	"unprognostic (5.24e-2)"				"unprognostic (5.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.22e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.19e-1)"		0.4	0.0	3.6	0.0	4.0	0.0	0.2	3.7	3.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	3.6	0.1	0.0	0.0	0.0	8.2	4.6	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	9.3	0.0	0.0	0.6	5.2	0.0	0.2	0.2	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.0	3.7	3.7	3.4	3.6	8.2	4.6	5.6	9.3	5.2	7.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0
DNAH5	"CILD3, Dnahc5, HL1, KTGNR, PCD"	ENSG00000039139	"Dynein axonemal heavy chain 5"	Q8TE73	5	13690328-14011818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7;choroid plexus: 14.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 61.7;Endometrial ciliated cells: 190.3;Respiratory ciliated cells: 258.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;LHCN-M2: 1.1;PC-3: 2.7;RPTEC TERT1: 1.3;TIME: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA037469, HPA037470"	Enhanced					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA037469: AB_10672791, HPA037470: AB_10672348"	"unprognostic (3.85e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.94e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-3)"	"unprognostic (8.87e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	0.0	0.1	0.9	0.0	1.1	0.0	1.5	0.5	0.3	0.3	14.0	0.1	0.0	0.1	0.1	0.0	3.8	0.1	0.0	1.0	1.7	0.8	1.0	1.7	0.0	4.2	6.7	0.0	0.9	0.0	2.0	0.0	4.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.4	0.3	1.8	0.0	1.1	0.0	0.0	0.8	0.0	1.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.1	0.0	0.5	0.0	0.5	0.2	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	1.3	0.4	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.5	0.3	1.0	1.7	4.2	6.7	4.0	2.1	1.8	1.4	0.3	3.2	24.4	7.2	0.2	0.0	1.7	5.6	0.0	0.0	11.7	7.0	1.5	14.3	61.7	5.5	0.0	0.0	0.1	0.0	0.0	6.7	7.3	190.3	1.9	1.2	1.8	0.0	12.9	3.6	0.2	1.8	0.0	12.4	2.5	0.0	0.0	10.9	0.0	0.0	7.8	0.0	6.1	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	4.0	0.4	2.6	0.0	0.0	0.1	14.8	0.0	4.3	258.7	0.0	0.0	1.6	2.6	2.6	3.6	0.0	0.0	0.0	0.4	0.1	0.0	3.8
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.2;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 7.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.3"	"Group enriched"	"Detected in some"	4	"HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome, Cytosol"	"CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536"	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	12.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	89.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	327.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.5	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	22.3	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.4	0.1	0.0	17.2	0.5	0.0	0.0	1.3	0.0	0.4	1.6	1.7	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.7	0.0	0.0	0.9	0.3	0.3	11.7	0.0	0.0	6.2	0.5	0.2	0.0	0.3
DSCC1	"DCC1, hDCC1, MGC5528"	ENSG00000136982	"DNA replication and sister chromatid cohesion 1"	Q9BVC3	8	119833976-119855894	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.6;Extravillous trophoblasts: 17.6;Spermatogonia: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023780, HPA024401"	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023780: AB_2671311, HPA024401: AB_2671557"	"unprognostic (7.36e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.91e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.92e-6)"	"prognostic unfavorable (3.93e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.12e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.32e-9)"	"unprognostic (2.75e-2)"	"unprognostic (5.01e-1)"	"unprognostic (4.40e-2)"	"unprognostic (8.18e-2)"	1.8	1.8	1.3	3.7	1.6	6.1	2.4	2.1	2.0	2.6	1.1	2.7	2.4	2.4	1.3	2.4	1.5	1.0	1.5	1.4	1.4	0.9	1.1	1.4	7.1	1.5	1.5	1.5	2.8	0.5	0.5	2.3	1.6	1.9	3.5	0.3	3.7	1.2	2.1	2.6	2.3	2.7	1.5	1.3	1.7	2.6	1.4	9.9	1.0	3.4	5.7	1.5	2.1	1.8	34.3	16.6	32.1	29.4	4.6	8.3	13.8	23.1	4.7	16.3	16.9	15.2	20.4	61.7	19.7	6.9	10.1	24.8	36.7	14.4	17.5	42.2	33.3	78.7	16.2	17.9	1.5	31.2	26.4	3.8	2.2	20.1	9.7	3.8	4.7	40.5	27.2	26.9	19.9	33.8	82.4	19.2	47.2	90.4	41.2	29.1	30.4	29.9	12.7	21.3	28.7	17.6	12.4	96.7	15.8	25.0	18.1	17.0	3.2	17.7	48.0	17.2	33.9	36.5	58.2	65.4	9.0	49.2	26.2	0.0	0.0	0.0	0.9	0.0	0.7	0.3	0.2	0.4	0.0	0.1	0.1	0.3	0.0	0.8	0.0	0.2	0.3	0.2	1.3	1.6	2.1	2.0	1.4	1.4	1.5	1.5	1.6	1.5	1.4	1.8	4.7	0.0	0.5	2.6	1.2	3.4	2.2	2.1	4.6	0.7	2.2	3.2	0.8	1.5	0.2	0.0	0.0	7.9	1.6	1.0	0.0	1.6	0.1	0.8	2.8	3.0	0.0	24.6	6.4	2.4	17.6	4.3	1.5	1.3	4.5	3.7	4.6	0.9	4.7	0.0	5.2	1.2	2.0	1.0	1.2	0.2	1.2	0.9	3.6	1.0	0.0	1.5	1.0	7.5	5.3	0.5	0.3	2.6	5.2	1.7	0.2	1.5	1.7	0.3	0.0	2.3	3.3	1.1	18.8	6.0	3.3	1.4	3.0	2.0	3.8	1.5
DTNB		ENSG00000138101	"Dystrobrevin beta"	O60941	2	25377198-25673647	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 36.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.8;Inhibitory neurons: 214.1;Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA061357	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA061357: AB_2684489"	"unprognostic (1.14e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.78e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.98e-2)"	"unprognostic (9.45e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.49e-2)"	2.1	2.1	7.8	1.6	6.7	2.9	9.7	3.4	12.1	4.2	0.0	1.7	1.2	2.8	10.1	4.5	4.6	3.3	2.0	12.4	3.6	4.2	3.4	4.3	2.5	4.9	1.7	4.4	7.7	9.9	5.8	1.9	4.5	8.4	1.0	5.0	36.0	5.1	2.7	4.5	1.6	1.2	0.1	2.7	5.6	6.7	2.9	4.0	11.1	1.5	1.9	3.5	4.0	5.6	10.7	9.1	6.6	7.5	4.0	5.2	0.2	3.2	4.2	4.0	5.3	3.5	2.6	5.5	1.3	2.5	5.0	3.7	4.6	13.1	2.2	8.2	11.1	4.5	2.9	10.0	2.9	5.4	4.1	3.6	10.9	4.2	7.2	4.9	5.5	10.5	0.4	8.0	3.0	10.9	8.5	4.6	7.3	2.9	5.4	7.0	11.5	9.7	4.9	9.7	8.9	13.7	10.3	16.2	12.9	3.6	8.7	3.3	2.3	1.6	7.3	2.4	5.7	14.6	6.8	10.0	4.6	9.5	5.7	0.4	1.6	5.7	4.1	0.9	4.4	4.4	5.0	3.7	0.5	5.8	5.0	3.3	3.2	4.1	0.4	0.9	5.2	2.0	7.8	6.7	3.4	12.1	12.4	3.6	4.9	1.7	4.5	0.1	2.9	5.6	3.9	9.6	12.8	53.2	12.6	8.0	26.6	16.4	44.3	9.4	20.3	18.9	2.3	7.2	9.3	14.7	6.2	3.7	4.2	0.9	11.7	4.0	3.1	7.2	4.2	4.7	3.0	4.4	176.8	11.6	1.5	3.2	15.8	12.1	1.3	4.6	5.0	5.6	33.6	21.9	214.1	2.8	14.2	7.8	1.7	6.9	1.5	4.9	12.4	83.4	3.2	18.5	7.2	137.7	343.3	9.5	1.4	2.6	8.7	17.9	0.3	9.3	2.2	9.9	6.6	1.9	3.2	12.6	27.9	15.7	2.0	2.1	10.8	2.3	1.3	17.7
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 270.6;U-266/70: 130.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	36.9	16.4	25.6	27.7	29.1	23.7	33.0	27.4	28.8	31.6	21.2	47.8	22.5	28.9	12.2	45.7	25.9	21.3	42.1	25.1	27.1	32.4	32.7	38.5	32.4	32.3	28.5	19.6	40.8	13.2	21.2	27.3	30.3	23.2	16.1	7.8	30.4	15.1	52.3	41.4	33.7	22.0	28.0	43.9	32.7	44.9	29.3	15.0	28.1	37.7	30.5	30.3	36.8	42.7	13.7	8.3	17.3	25.9	19.5	21.5	22.8	9.9	8.0	8.6	10.3	8.8	15.1	28.4	23.3	10.3	18.3	9.4	21.9	18.3	6.1	68.6	25.1	19.3	7.1	24.7	9.9	7.0	24.4	16.2	54.1	6.2	11.3	14.1	24.8	24.0	18.3	92.2	7.2	8.2	10.3	25.1	10.4	10.0	18.7	20.2	11.7	270.6	16.2	5.8	29.7	11.6	8.5	3.4	29.6	37.4	17.6	8.9	34.2	7.7	10.1	7.8	6.0	130.0	98.6	40.0	3.0	19.0	17.7	36.4	32.5	13.6	8.6	26.5	6.2	40.4	6.7	9.1	33.5	33.3	6.1	8.8	21.8	5.9	25.1	28.8	15.9	19.6	25.6	29.1	27.4	28.8	25.1	27.1	32.3	28.5	30.3	28.0	29.3	42.7	45.5	16.0	21.3	5.5	53.7	26.5	22.0	33.3	14.2	5.7	19.4	17.5	40.8	10.0	30.7	5.5	0.0	10.8	51.1	11.7	21.5	24.2	13.4	18.6	8.2	33.4	9.5	8.2	8.5	51.4	7.7	21.9	15.3	12.9	33.0	8.8	21.8	25.0	30.1	0.0	6.1	14.7	32.6	38.6	43.0	20.5	15.5	47.1	46.2	21.5	78.4	14.9	36.0	7.1	25.9	29.2	12.4	9.4	59.7	16.5	23.2	18.2	39.7	3.2	26.3	11.6	22.8	34.5	73.8	42.5	37.1	6.6	21.3	6.8	15.4	27.9
DUSP5	HVH3	ENSG00000138166	"Dual specificity phosphatase 5"	Q16690	10	110497907-110511533	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 175.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 409.1;Langerhans cells: 298.4;Plasma cells: 412.2;Urothelial cells: 1063.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 10.3;plasmacytoid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 408.0;Karpas-707: 161.2;U-266/70: 227.8"	"Region enhanced"	"Detected in all"		"cerebellum: 60.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 45.4"							NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.25e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (8.30e-6)"	"unprognostic (1.70e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	38.8	37.6	8.5	26.8	8.6	38.5	26.6	26.1	17.3	39.4	13.3	22.3	12.2	19.7	2.0	115.5	12.7	51.4	34.1	17.9	12.4	26.4	25.6	23.2	12.8	7.7	9.3	7.6	8.0	6.7	20.0	48.3	7.4	17.7	26.3	9.8	23.4	12.5	2.7	16.9	19.5	21.1	8.3	28.4	26.5	20.1	10.7	14.9	18.8	3.7	32.5	175.7	37.9	7.9	22.0	14.6	3.0	7.3	11.1	46.5	10.6	50.9	114.6	26.8	32.2	9.4	28.9	2.6	9.4	12.4	56.9	7.0	2.8	26.7	43.2	62.8	1.8	12.1	2.6	5.8	41.8	3.2	15.1	17.9	35.9	85.7	408.0	11.8	17.1	1.2	2.1	161.2	81.4	5.9	0.9	9.2	9.6	2.1	22.2	0.2	6.3	38.8	92.0	42.3	1.6	4.0	3.3	8.0	17.4	25.6	4.5	3.8	26.5	9.0	6.2	21.7	24.7	227.8	44.7	6.2	34.9	16.4	6.4	0.5	0.2	0.0	3.5	2.2	1.3	0.2	1.8	1.0	0.9	0.0	0.1	1.0	0.2	0.0	10.3	14.5	0.1	0.6	8.5	8.6	26.1	17.3	17.9	12.4	7.7	9.3	7.4	8.3	10.7	7.9	150.7	3.2	7.8	0.3	71.2	66.0	409.1	91.4	30.7	9.0	72.7	77.0	33.5	11.5	78.3	35.0	6.2	44.0	97.7	63.5	5.9	29.1	1.5	50.6	32.2	90.8	48.9	0.4	4.4	4.8	11.2	42.7	39.3	196.6	3.8	5.5	158.5	4.1	10.7	0.0	2.2	12.8	22.4	16.6	298.4	3.3	1.5	91.5	158.3	1.0	46.9	2.3	4.1	1.0	0.0	49.1	93.2	0.7	412.2	127.0	44.4	0.6	27.3	12.6	0.0	25.8	37.3	1.2	19.8	61.8	101.9	137.4	122.0	3.3	9.2	1063.2
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 56.9;placenta: 72.6"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Hep G2: 372.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.0	4.1	0.0	3.3	0.0	0.2	1.7	3.8	0.1	1.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	4.0	1.9	56.9	1.1	0.0	0.0	2.1	2.5	0.8	0.5	0.7	0.0	72.6	2.2	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	1.9	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.7	0.1	2.6	1.6	0.8	0.1	32.6	0.0	0.0	10.3	0.1	0.0	0.0	0.0	6.5	2.0	0.0	15.8	0.0	1.2	7.5	39.9	1.0	0.0	1.1	7.3	0.0	3.0	372.7	0.0	0.0	5.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	2.1	0.1	0.8	1.1	1.8	14.8	0.0	0.0	0.0	0.1	9.4	0.4	1.2	2.3	2.8	1.6	0.9	0.6	3.9	0.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.3	1.7	3.8	4.0	1.9	2.1	2.5	2.2	1.9	2.8	2.6	0.0	0.0	0.0	3.6	0.5	0.6	1.0	0.6	2.8	0.0	0.2	3.4	2.3	1.5	0.0	11.0	0.0	1171.5	0.0	0.0	727.8	0.1	0.0	0.1	0.1	3.1	0.0	0.0	0.7	0.0	84.0	6.1	0.0	0.0	0.0	3.8	0.0	0.9	84.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	3.2	0.4	0.0	0.0	0.0	0.4	0.8	8.9	0.2	0.0	1735.1	0.2	10.8	0.1	1.1
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"EBF transcription factor 3"	Q9H4W6	10	129835233-129973053	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.9;brain: 16.9"	"Group enriched"	"Detected in some"	5	"Adipocytes: 29.6;Endothelial cells: 13.1;Fibroblasts: 14.9;Skeletal myocytes: 33.5;Smooth muscle cells: 11.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 16.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;HAP1: 13.6;LHCN-M2: 25.4;NB-4: 35.7;RH-30: 13.2;SCLC-21H: 28.7;THP-1: 14.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	23.9	0.6	0.3	1.0	0.1	0.1	13.7	1.4	0.2	4.1	0.4	2.7	0.2	2.3	0.8	1.4	4.8	2.4	9.4	0.1	2.7	0.5	0.5	0.2	6.9	6.5	8.5	1.0	1.3	2.1	0.9	2.5	3.8	2.4	0.5	1.9	3.0	1.1	7.9	3.3	1.0	1.5	16.9	0.2	1.6	1.6	3.2	1.3	7.3	7.7	1.0	3.3	5.5	1.1	0.0	0.0	0.6	0.1	12.5	10.3	0.1	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.5	0.0	0.0	13.6	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	2.4	0.0	0.0	0.0	0.7	0.0	0.0	25.4	0.0	0.0	35.7	0.0	0.0	0.0	0.3	13.2	0.0	0.0	0.1	28.7	0.4	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	1.3	8.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.4	0.2	0.1	2.7	6.5	8.5	3.8	16.9	3.2	1.1	29.6	0.0	0.0	0.3	0.0	1.9	0.0	0.0	0.0	1.8	0.3	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	13.1	0.0	0.0	0.9	0.0	0.0	14.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.5	0.4	0.3	0.4	0.0	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.7	0.0	33.5	11.7	0.0	3.4	0.1	0.9	0.0	0.2	0.1	0.0	0.1
EGR4	"NGFI-C, PAT133"	ENSG00000135625	"Early growth response 4"	Q05215	2	73290929-73293701	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 54.0"	"Cell type enriched"	"Detected in many"	6	"Enteroendocrine cells: 99.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"cerebellum: 31.4;cerebral cortex: 54.0;hippocampal formation: 22.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"HMC-1: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028983	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA028983: AB_10603665"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.07e-3)"	0.2	0.1	2.6	0.1	5.5	0.1	0.0	31.4	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	22.1	1.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.5	31.4	54.0	22.1	1.6	0.0	2.4	2.4	0.0	1.5	2.6	1.3	0.0	0.0	0.0	2.6	2.7	13.2	0.6	0.6	3.0	6.8	7.2	1.2	0.0	0.2	0.0	0.0	0.1	5.0	0.4	0.0	0.2	0.0	2.9	7.0	1.0	99.5	0.0	3.8	1.0	0.3	0.7	5.1	15.9	8.9	16.1	0.0	0.0	0.2	0.0	0.5	0.6	2.0	0.6	5.3	0.6	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	1.1	0.0	1.0	10.8	0.0	0.0	0.1	0.8	0.0	0.2	5.7	0.2	13.2	1.7	2.3	0.8	1.5	3.4	0.8	0.2
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2;liver: 14.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Endothelial cells: 5.7;Hepatic stellate cells: 7.1;Hepatocytes: 13.5;Inhibitory neurons: 19.2;Rod photoreceptor cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 31.2;U-138 MG: 18.5;U-2 OS: 27.0;U-2197: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"		NA	NA		43000		"Cluster 15: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"		"HPA066382: AB_2732744"	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	3.1	0.4	1.5	0.3	2.5	0.0	1.5	1.0	3.4	4.2	0.0	0.6	0.1	2.9	0.1	0.5	1.5	0.4	4.6	1.0	4.4	3.9	14.5	0.6	0.1	3.2	4.6	0.4	0.6	0.1	0.8	0.4	3.2	1.0	0.0	3.0	0.4	0.1	0.7	1.0	0.8	0.2	7.2	1.1	0.6	0.8	2.6	0.7	0.8	0.4	0.0	0.6	1.7	0.8	0.3	0.0	4.6	9.7	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.1	0.5	0.0	4.6	2.1	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	5.7	0.0	4.7	1.9	0.0	1.1	31.2	0.0	3.1	0.0	0.0	4.3	2.0	0.3	0.2	0.0	0.5	0.1	0.3	0.1	18.5	27.0	32.1	0.0	0.0	0.4	8.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.5	1.0	3.4	1.0	4.4	3.2	4.6	3.2	7.2	2.6	0.8	4.8	0.0	0.6	0.0	0.0	0.1	0.3	0.3	2.8	1.3	0.1	0.3	1.8	0.0	0.0	0.0	6.2	0.0	0.0	0.0	3.9	0.1	0.1	0.3	2.0	5.7	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	7.1	13.5	0.1	0.0	19.2	0.0	0.0	0.6	0.7	0.1	0.9	0.1	1.8	1.0	0.0	0.9	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
EPB41L4B	"EHM2, LULU2"	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171974-109321059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.9;pancreas: 149.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 134.8;Excitatory neurons: 79.7;Hepatocytes: 125.2;Proximal enterocytes: 79.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.7;hTCEpi: 49.8;OE19: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavorable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	21.0	9.7	6.0	4.5	8.7	0.0	15.3	2.0	12.2	4.1	11.8	57.6	47.6	1.2	17.9	1.5	10.8	4.2	8.8	10.7	6.4	6.4	88.9	6.3	0.2	2.7	5.3	13.8	149.1	11.1	1.6	2.5	3.7	7.6	56.7	3.0	26.9	9.1	6.1	15.5	51.9	1.9	7.2	0.1	30.6	7.5	10.9	0.6	44.7	0.7	1.6	2.2	3.4	4.3	8.7	10.8	0.7	0.8	0.8	0.0	31.7	1.1	0.4	3.7	1.9	18.5	8.5	0.0	2.3	1.0	8.9	13.9	21.5	11.5	3.9	9.2	5.1	0.0	3.4	26.5	2.2	0.4	0.0	0.3	49.8	1.5	17.0	1.1	0.2	8.0	0.3	0.0	5.2	22.3	0.4	0.2	13.8	62.8	15.7	0.0	0.0	0.6	12.9	13.1	13.1	1.4	3.4	22.2	0.0	6.3	5.2	0.1	0.5	7.5	7.6	2.5	3.1	0.1	0.1	0.0	5.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	8.7	2.0	12.2	10.7	6.4	2.7	5.3	3.7	7.2	10.9	4.3	0.2	6.4	5.1	2.6	0.4	11.5	5.4	6.0	1.2	7.5	22.7	10.4	18.5	20.0	9.6	7.3	0.0	4.1	0.0	134.8	0.0	3.5	11.7	23.8	2.3	0.8	51.6	0.0	79.7	20.8	2.1	2.5	26.0	20.7	0.0	6.2	5.0	125.2	0.6	38.7	58.9	51.4	12.2	1.6	1.5	1.9	13.4	0.4	1.8	3.7	0.0	1.9	0.0	12.1	3.8	10.2	54.4	2.6	0.0	7.2	79.2	0.8	39.2	1.1	0.0	0.8	1.0	1.4	17.2	0.9	24.0	1.9	0.5	6.8	46.5	6.5
ESX1	"ESX1L, ESXR1"	ENSG00000123576	"ESX homeobox 1"	Q8N693	X	104250038-104254933	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 8.9"	"Cell type enriched"	"Detected in some"	25	"Spermatogonia: 98.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"TIME: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051992, HPA073330"	Enhanced		Supported	"Nuclear speckles"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA051992: AB_2681684, HPA073330: "															"unprognostic (1.87e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	98.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	9.1	3.9	8.1	10.5	9.7	21.2	10.7	5.1	9.2	7.4	0.1	13.3	11.0	6.5	4.2	6.0	5.1	14.7	6.6	9.4	8.6	3.2	4.9	7.8	9.0	4.1	6.8	5.3	3.8	7.5	3.8	5.9	8.1	6.3	14.6	3.6	13.7	7.8	1.3	3.7	11.2	8.8	3.0	8.8	7.6	8.6	5.6	8.7	3.5	6.0	8.2	16.4	4.4	5.0	6.9	4.9	9.7	5.2	17.0	10.2	6.4	4.0	5.4	6.1	10.3	1.8	6.8	7.6	3.6	10.4	6.3	13.1	33.2	1.4	7.8	5.1	4.8	10.6	35.8	0.8	4.3	14.0	19.8	5.5	1.4	9.0	0.5	12.3	4.0	12.5	26.3	41.2	14.4	28.4	9.0	10.0	7.6	16.2	24.6	20.8	24.5	1.6	1.7	7.9	31.4	9.3	15.9	27.4	8.3	6.8	5.8	22.5	0.7	9.8	18.4	8.6	15.5	7.6	1.9	7.1	14.4	10.8	5.3	2.9	0.4	0.4	0.3	0.9	0.2	0.3	0.3	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.1	8.1	9.7	5.1	9.2	9.4	8.6	4.1	6.8	8.1	3.0	5.6	5.0	5.9	0.0	2.2	12.1	6.1	6.1	2.3	1.0	4.6	3.9	10.1	7.2	1.9	10.0	2.2	1.8	0.0	2.4	17.2	15.6	1.9	2.7	15.3	2.1	7.8	5.5	7.2	3.8	54.9	6.1	2.7	16.3	6.6	5.2	7.6	3.6	8.2	1.2	9.7	0.0	27.9	8.1	0.0	25.1	43.2	6.9	14.3	27.5	5.4	52.5	15.2	1.2	11.3	25.1	7.2	4.5	10.5	20.7	11.9	1.9	4.5	1.0	1.8	1.1	0.0	3.2	6.5	4.4	6.4	6.5	3.7	3.4	16.4	36.2	13.8	4.6
FAM155B	"CXorf63, TED, TMEM28"	ENSG00000130054	"Family with sequence similarity 155 member B"	O75949	X	69504326-69532508	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"heart muscle: 43.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 23.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;HAP1: 16.2;Hep G2: 6.1;NTERA-2: 24.3;OE19: 6.5;SCLC-21H: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036093	Uncertain					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA036093: AB_10673613"	"prognostic unfavorable (4.61e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.09e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (1.83e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.21e-2)"	0.1	0.8	2.2	0.0	2.1	0.0	0.2	3.0	2.6	0.2	0.5	0.3	0.1	0.3	0.4	0.1	0.7	0.2	43.5	2.1	2.7	0.9	0.2	0.1	0.1	2.4	3.1	0.1	1.8	3.1	2.4	0.0	3.4	0.9	0.2	0.4	1.1	4.9	0.1	0.0	0.2	0.1	2.0	0.7	1.1	1.5	3.5	0.1	8.0	0.0	0.1	0.2	0.1	2.3	0.0	2.7	0.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.7	0.0	5.2	0.0	0.0	0.0	16.2	0.6	0.0	0.0	5.0	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.2	0.0	0.0	24.3	6.5	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.8	0.1	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.1	3.0	2.6	2.1	2.7	2.4	3.1	3.4	2.0	3.5	2.3	0.2	0.0	0.0	1.3	0.0	0.0	0.3	1.6	0.0	0.4	0.6	0.1	23.7	0.0	0.8	1.8	0.0	0.0	0.0	0.5	0.0	0.5	0.0	2.0	0.5	0.7	1.2	0.0	0.8	1.2	0.0	0.4	0.0	4.4	0.0	0.0	0.4	0.3	0.1	0.0	0.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.8	0.2	0.0	0.0	1.2	0.0	0.5	0.3	0.8	0.0	0.1	0.2	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3
FAM83G	"FLJ41564, PAWS1"	ENSG00000188522	"Family with sequence similarity 83 member G"	A6ND36	17	18968789-19004764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.3;skin 1: 67.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 77.8;Basal squamous epithelial cells: 39.3;Distal enterocytes: 46.5;Squamous epithelial cells: 55.3;Suprabasal keratinocytes: 68.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023369, HPA023940"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA023369: AB_1848415, HPA023940: AB_1848416"	"unprognostic (2.12e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (1.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (7.58e-6)"	"unprognostic (9.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.74e-2)"	2.3	2.2	0.8	2.9	0.8	1.4	2.8	0.8	1.2	10.8	2.1	8.2	10.8	2.5	0.9	51.3	1.6	6.4	17.2	0.8	1.9	7.1	21.7	3.2	3.0	1.6	1.4	1.4	9.5	6.4	4.3	0.7	2.7	3.5	5.3	0.2	10.9	2.2	6.9	67.3	11.3	1.5	0.9	2.0	9.8	1.0	1.4	3.7	5.6	0.8	5.7	2.5	17.0	0.7	24.7	22.4	0.2	0.0	0.7	2.0	35.9	25.2	11.0	21.0	15.7	28.7	8.8	16.1	15.1	16.7	17.1	28.6	3.6	21.1	9.6	13.2	8.1	0.4	11.2	15.9	15.3	2.9	7.9	2.8	38.9	13.6	22.3	7.9	7.6	2.5	7.7	0.5	6.0	15.0	0.7	6.0	11.0	34.1	0.1	0.1	0.0	7.8	10.1	6.2	11.2	0.0	8.7	5.3	1.5	29.1	9.2	3.6	14.2	12.9	21.6	6.1	29.8	2.2	4.0	4.1	10.1	0.1	8.6	1.1	0.0	0.0	0.7	0.0	0.3	0.3	0.4	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.8	0.8	0.8	1.2	0.8	1.9	1.6	1.4	2.7	0.9	1.4	0.7	0.6	3.2	2.2	0.0	2.5	77.8	12.2	9.9	39.3	0.2	7.1	2.9	5.1	11.5	6.3	7.3	0.0	0.4	0.7	46.5	0.0	15.8	0.1	2.4	1.0	1.9	7.1	2.7	0.1	10.0	9.7	2.6	17.3	5.0	8.9	3.5	1.1	20.9	1.2	0.0	0.1	17.7	8.2	0.3	7.8	1.9	0.0	1.0	5.4	0.0	1.0	0.2	3.1	0.5	0.0	24.3	22.8	0.0	3.0	13.2	15.3	4.4	2.5	0.4	0.0	1.3	2.0	0.1	1.0	55.3	68.5	1.9	2.6	0.0	17.1	9.1
FAM89A	"C1orf153, MGC15887"	ENSG00000182118	"Family with sequence similarity 89 member A"	Q96GI7	1	231018958-231040254	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.0;placenta: 68.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 186.3;Extravillous trophoblasts: 267.5;Rod photoreceptor cells: 102.5;Syncytiotrophoblasts: 278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 145.4;SK-MEL-30: 81.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059052, HPA059578"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA059052: AB_2683890, HPA059578: AB_2684070"	"unprognostic (7.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.05e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.26e-2)"	60.0	18.0	16.0	4.8	15.3	5.9	36.5	20.7	16.4	11.0	21.3	4.4	1.7	7.5	1.6	6.5	7.1	5.9	10.6	14.2	23.4	22.2	9.2	19.2	5.9	22.6	21.4	6.0	10.6	6.0	5.8	68.2	20.9	7.1	2.7	17.3	5.3	4.6	5.9	30.6	4.6	4.1	21.2	17.5	7.6	3.0	25.1	2.9	5.5	6.7	4.7	8.9	9.2	19.5	0.9	13.7	6.3	13.4	15.0	3.0	145.4	7.8	5.8	2.8	5.1	21.1	12.1	0.0	1.8	5.1	16.7	8.4	12.0	1.9	2.3	42.4	28.9	6.7	0.3	0.9	57.6	5.0	35.2	50.1	26.6	0.0	13.2	0.1	7.4	15.0	53.4	8.6	2.7	5.0	3.2	8.8	9.4	12.6	4.3	16.6	20.3	16.0	10.1	14.8	5.8	16.1	2.6	1.2	81.6	13.9	0.8	29.2	1.1	22.5	0.1	0.4	14.7	18.3	23.7	11.6	6.7	9.8	45.7	1.4	0.2	0.0	0.2	0.0	0.3	0.3	0.2	0.5	0.0	0.1	0.4	0.9	0.0	0.1	0.0	0.0	0.0	0.2	16.0	15.3	20.7	16.4	14.2	23.4	22.6	21.4	20.9	21.2	25.1	19.5	82.3	0.0	2.6	3.6	4.2	30.1	22.0	0.3	8.0	48.1	3.8	5.2	3.3	7.2	0.7	0.0	77.2	186.3	4.9	0.3	3.9	2.8	1.3	1.3	39.3	44.5	0.0	14.9	1.1	3.3	267.5	11.6	0.5	2.6	4.5	0.5	10.8	11.1	51.0	8.4	10.8	0.6	0.0	19.6	2.1	3.6	2.8	8.5	21.4	22.5	0.5	26.2	1.0	10.1	2.0	4.4	0.5	1.5	1.4	30.2	0.0	5.1	0.1	102.5	0.0	9.9	8.5	4.2	11.6	1.7	32.8	278.3	5.5	0.4	1.3	15.4
FAXC	"C6orf168, dJ273F20, MGC2817"	ENSG00000146267	"Failed axon connections homolog, metaxin like GST domain containing"	Q5TGI0	6	99271168-99350062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Excitatory neurons: 57.1;Inhibitory neurons: 60.1;Oligodendrocyte precursor cells: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.0;HAP1: 23.8;SCLC-21H: 34.2;SH-SY5Y: 23.7;SK-MEL-30: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039106	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039106: AB_10697546"	"unprognostic (8.03e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (2.47e-3)"	"unprognostic (6.70e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.49e-3)"	0.7	2.2	11.0	1.5	12.7	0.0	3.2	9.3	19.0	2.5	2.0	22.7	1.5	6.5	11.0	6.2	3.7	2.4	0.8	14.1	7.6	2.7	0.0	1.7	0.1	7.2	5.6	2.2	2.5	6.5	15.9	0.8	6.3	8.2	2.9	10.4	7.4	10.6	0.5	0.9	3.3	7.8	4.4	0.4	7.1	2.1	8.5	2.2	1.7	0.6	0.1	14.3	2.9	11.4	4.0	3.2	10.3	14.3	0.0	0.0	3.8	5.0	3.2	8.1	7.0	1.9	1.3	0.0	0.6	1.0	26.0	0.1	23.8	4.7	7.0	0.0	11.8	0.1	1.9	0.7	0.6	0.0	0.0	0.5	7.5	0.2	3.8	5.9	0.0	2.0	0.5	0.0	2.7	7.0	0.0	0.0	12.2	0.0	4.8	0.0	1.0	0.0	4.3	0.3	34.2	23.7	4.5	3.2	22.6	4.2	10.0	0.0	1.0	2.5	4.7	0.0	15.5	0.0	0.0	0.0	0.1	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	12.7	9.3	19.0	14.1	7.6	7.2	5.6	6.3	4.4	8.5	11.4	0.2	25.6	15.2	5.5	0.5	0.4	4.2	4.2	5.7	14.4	5.3	9.0	1.1	0.0	8.1	1.8	10.4	1.2	0.4	0.2	9.8	2.3	2.6	0.6	1.0	1.7	0.0	0.0	57.1	0.7	0.2	1.4	0.0	0.4	3.8	0.4	1.4	0.1	0.2	3.3	60.1	0.2	4.1	0.6	1.1	5.0	0.0	1.2	1.8	2.8	0.1	3.6	2.1	43.7	4.4	1.0	0.1	1.9	0.1	4.8	0.0	1.0	2.1	13.6	0.0	0.2	1.3	1.3	8.9	1.2	0.3	0.3	1.2	0.2	0.4	1.2
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 273.8;choroid plexus: 198.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 13.2;eosinophil: 3.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		1200000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	5.7	21.3	103.9	8.2	186.8	0.3	22.9	178.9	198.9	19.7	198.1	44.8	10.4	54.6	15.3	25.2	29.6	31.3	5.6	109.9	124.7	26.3	41.0	30.9	2.9	250.9	185.9	18.0	31.0	61.0	6.8	15.7	220.5	27.4	21.2	1.2	59.1	54.6	0.5	109.3	12.2	43.6	165.5	0.8	22.5	7.6	148.0	10.1	54.6	0.2	9.1	16.6	27.4	273.8	7.2	0.4	30.2	189.0	0.1	0.0	60.9	0.4	0.0	0.0	0.0	49.6	1.1	0.1	12.5	2.8	0.1	55.6	63.7	13.0	0.0	0.1	12.7	0.0	0.2	1.2	1.5	0.2	11.7	0.1	26.2	0.0	0.6	0.0	0.0	0.3	0.2	0.2	0.0	11.7	0.2	0.1	57.8	8.7	0.0	0.1	0.0	7.5	18.0	15.8	0.5	0.5	0.4	33.4	0.0	36.6	49.3	0.0	0.1	0.3	8.5	0.2	0.7	0.1	0.1	0.0	0.3	0.0	0.5	13.2	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	103.9	186.8	178.9	198.9	109.9	124.7	250.9	185.9	220.5	165.5	148.0	273.8	1.4	19.2	36.0	228.2	0.6	40.1	34.3	18.4	58.6	0.2	8.7	25.4	9.1	213.1	38.4	36.8	0.0	16.5	0.3	7.3	0.0	7.4	4.1	28.1	4.4	1.0	2.4	2.7	14.8	0.2	3.0	9.0	13.3	53.1	0.0	0.1	1.8	5.0	2.3	0.0	31.2	40.8	10.2	0.6	4.4	9.6	1.2	1.1	5.4	10.3	0.6	2.0	1.0	6.0	562.5	0.7	3.0	6.0	0.1	15.0	1.8	13.6	15.3	0.2	0.0	1.6	2.6	0.7	9.9	18.7	27.7	4.0	1.5	0.4	3.8	31.4
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 148.3;esophagus: 139.7;skin 1: 271.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.4;Basal keratinocytes: 103.8;Cholangiocytes: 91.5;Suprabasal keratinocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 48.2;HaCaT: 34.9;Hep G2: 80.6;NTERA-2: 36.1;RT4: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA		2500000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.97e-1)"	1.6	1.6	118.0	1.5	140.6	1.4	5.5	115.6	104.0	23.7	37.4	12.2	19.5	1.5	2.8	139.7	2.2	7.9	4.8	100.8	107.6	39.3	40.7	7.4	0.4	144.7	129.2	0.5	76.4	0.2	16.1	9.3	109.8	13.8	5.2	0.2	20.2	15.0	1.3	271.5	14.7	0.4	108.9	4.0	7.8	17.6	148.3	1.7	1.5	0.9	11.1	23.1	60.9	81.2	0.0	3.8	19.5	5.6	0.0	0.3	22.1	2.4	0.3	0.8	0.4	48.2	1.0	0.0	17.8	0.7	0.7	34.9	5.5	0.3	0.3	0.2	19.3	14.2	3.9	80.6	0.1	0.0	0.6	0.0	10.9	0.2	0.1	0.1	0.1	2.3	16.7	0.1	0.0	23.9	0.8	0.5	36.1	19.5	0.1	1.2	1.0	0.3	2.8	64.1	5.7	1.6	1.9	4.0	0.0	22.2	20.4	2.5	1.0	0.0	2.1	0.5	1.6	0.1	0.0	0.0	0.2	1.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.0	140.6	115.6	104.0	100.8	107.6	144.7	129.2	109.8	108.9	148.3	81.2	2.2	0.0	32.5	410.4	1.1	103.8	4.1	29.8	23.9	0.0	4.8	1.5	3.1	91.5	37.6	14.7	0.0	0.5	1.6	36.1	0.0	5.0	7.9	3.0	1.7	3.4	4.2	0.0	0.5	0.7	12.0	3.2	3.6	4.0	0.0	0.1	16.1	30.4	0.6	0.0	1.3	20.7	4.1	1.2	6.5	1.3	0.6	0.6	12.4	14.0	0.6	0.1	0.0	34.2	2.2	0.4	18.0	0.4	0.0	4.2	21.2	9.9	9.8	0.6	0.0	0.7	2.9	0.4	25.9	55.0	88.7	0.8	0.7	0.1	17.0	12.8
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026898	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Granulosa cells: 30.9;Hepatocytes: 37.5;Muller glia cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	38.1	56.0	40.8	5.0	43.3	7.6	24.1	40.6	49.5	15.7	29.8	10.2	7.3	9.9	3.4	5.5	36.0	9.3	19.8	39.2	33.5	25.4	52.8	15.1	3.1	49.9	45.8	25.4	71.6	16.1	21.6	3.0	46.5	12.4	4.9	10.5	37.6	2.7	20.6	10.7	13.5	4.0	42.2	9.1	27.2	5.5	47.9	1.4	67.1	9.6	2.2	11.2	8.0	42.1	23.2	31.6	11.3	34.3	11.9	12.3	2.9	40.4	6.2	12.9	8.4	23.1	47.9	2.6	49.3	63.3	58.3	5.8	21.8	14.1	11.8	8.3	21.0	0.3	41.2	61.5	24.0	13.7	5.6	25.7	11.7	22.4	9.5	48.4	12.5	9.3	25.3	8.9	7.9	30.8	16.0	37.7	14.2	39.7	83.8	24.7	16.3	16.7	22.6	3.6	1.2	2.2	38.1	0.8	15.2	13.4	22.5	11.9	26.1	68.8	27.2	35.2	99.8	8.9	12.9	3.8	18.1	15.6	22.8	0.6	0.0	0.0	0.2	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	40.8	43.3	40.6	49.5	39.2	33.5	49.9	45.8	46.5	42.2	47.9	42.1	3.8	3.2	4.1	34.0	2.8	6.5	3.7	5.4	2.2	5.4	13.2	6.1	8.5	11.5	6.9	7.3	0.0	1.6	4.1	4.4	0.0	9.6	0.2	6.0	4.2	2.6	1.8	4.8	3.2	10.2	26.6	5.1	6.6	13.5	1.3	30.9	5.3	37.5	3.2	0.0	2.8	11.0	0.0	1.6	2.5	1.2	4.4	3.4	7.2	1.9	1.3	94.0	1.0	5.0	5.4	19.9	2.7	3.4	2.2	11.4	2.9	7.6	7.0	5.6	0.0	3.3	5.1	0.4	4.2	1.2	4.7	1.5	4.2	17.5	3.6	8.8
FOXI3		ENSG00000214336	"Forkhead box I3"	A8MTJ6	2	88446787-88452693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"placenta: 5.2;retina: 2.0"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 3.3;Muller glia cells: 6.4;Syncytiotrophoblasts: 2.7"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 10.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 43.2;SuSa: 55.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (2.72e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.72e-4)"		"unprognostic (8.11e-3)"		"unprognostic (1.36e-1)"		"unprognostic (6.58e-2)"				"unprognostic (5.29e-2)"	"unprognostic (1.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	5.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	0.0	0.0	0.0	55.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0
FREM2	DKFZp686J0811	ENSG00000150893	"FRAS1 related extracellular matrix 2"	Q5SZK8	13	38687077-38887131	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 7.7;thyroid gland: 4.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.2;Astrocytes: 46.0;Cholangiocytes: 15.7;Endometrial ciliated cells: 18.6;Glandular and luminal cells: 48.6;Oligodendrocyte precursor cells: 15.6;Proximal tubular cells: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 15.5;HAP1: 10.6;MCF7: 7.8;RT4: 7.2;SK-BR-3: 6.3;SuSa: 29.7;WM-115: 5.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA028831	Uncertain		Approved	Cytosol		NA	NA		1500000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA028831: AB_10603668"	"unprognostic (1.71e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.23e-7)"	"unprognostic (7.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.14e-1)"	0.2	0.1	0.3	0.0	1.1	0.0	0.2	0.2	0.9	0.3	0.1	0.5	0.1	0.5	0.2	0.0	0.4	0.8	0.0	0.6	0.0	7.7	2.0	2.2	0.0	0.0	0.4	0.7	2.7	0.0	0.3	1.4	0.0	1.8	0.1	0.3	0.0	0.7	2.8	0.1	0.2	0.3	0.0	0.1	0.9	0.3	0.0	0.2	4.9	3.6	0.0	0.2	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	10.6	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	2.3	0.0	0.2	0.0	1.4	0.1	2.3	7.2	0.2	0.1	0.0	6.3	0.3	29.7	1.1	0.0	0.0	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.2	0.9	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	27.2	46.0	0.0	0.6	0.1	0.7	0.0	0.2	0.4	0.5	2.7	15.7	1.4	1.8	0.0	5.9	0.0	0.3	5.9	3.2	0.5	18.6	4.5	0.6	0.0	0.0	0.5	0.2	0.4	0.4	0.0	48.6	0.0	0.5	0.0	1.3	0.8	0.0	9.1	0.1	2.0	0.3	0.0	0.1	0.0	0.2	0.0	3.7	0.0	3.3	0.0	15.6	9.7	1.0	0.1	0.0	0.0	0.0	0.0	24.8	2.9	0.3	0.0	3.1	0.7	0.2	0.9	0.0	0.1	1.9	0.5	2.9	0.1	0.1
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor subunit alpha3"	P34903	X	152166234-152451315	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.5;choroid plexus: 16.3;retina: 9.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 70.3;Hofbauer cells: 16.2;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;HMC-1: 8.4;Karpas-707: 14.4;PC-3: 8.4;U-266/70: 7.7;U-266/84: 13.6;U-87 MG: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.0	0.0	10.0	0.0	13.7	0.0	0.0	0.0	13.2	0.9	16.3	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	9.6	15.5	0.0	0.0	0.0	0.0	0.9	4.0	0.0	0.0	0.0	0.6	2.9	3.0	0.1	0.0	9.0	0.1	0.6	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.7	11.2	0.0	0.0	0.0	0.1	0.4	0.2	2.7	0.0	0.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	14.4	0.0	0.0	0.0	0.0	2.6	6.4	8.4	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	5.3	0.4	0.3	0.1	1.3	0.1	5.3	7.0	0.3	1.6	7.7	13.6	0.0	8.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.7	0.0	13.2	9.6	15.5	0.9	4.0	3.0	0.6	11.2	2.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	2.1	3.2	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.0	0.0	70.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	1.7	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	3.0	0.0	58.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.9	0.0	1.9	0.0	0.0	0.0	0.5
GAN	"GAN1, GIG, KLHL16"	ENSG00000261609	Gigaxonin	Q9H2C0	16	81314944-81390809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 24.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 130.4;Urothelial cells: 188.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011825, HPA049473"	Approved		Supported	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Microtubules		"CAB011825: AB_732515, HPA049473: AB_2680782"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.91e-3)"	"unprognostic (3.12e-3)"	"unprognostic (5.93e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.86e-2)"	1.3	0.9	7.3	0.7	5.7	0.7	2.4	6.6	4.7	2.6	1.0	2.3	0.8	1.3	1.1	5.4	1.3	0.6	1.5	6.9	8.8	1.0	1.1	1.7	0.7	9.3	8.6	1.4	1.2	0.8	1.4	0.8	5.5	2.0	1.2	3.2	2.3	0.7	1.5	24.8	1.4	0.9	8.7	0.9	1.8	0.9	8.7	0.9	1.1	1.4	1.3	1.5	4.3	9.2	1.6	2.0	1.5	2.1	1.9	1.0	10.4	1.2	0.7	0.8	0.3	5.1	1.8	2.5	1.4	1.6	0.4	3.1	2.7	1.3	1.8	0.6	1.4	2.2	1.8	4.1	2.0	2.1	2.4	1.1	3.8	1.3	3.5	1.1	1.7	2.1	2.8	1.1	1.1	9.1	1.9	2.9	4.0	2.2	0.6	3.7	1.4	1.0	1.6	5.0	1.5	1.0	4.3	4.2	1.4	3.6	2.9	2.0	2.5	2.3	2.1	0.8	1.9	2.2	2.7	5.8	1.2	2.4	1.7	0.7	0.4	0.2	0.8	0.4	0.7	0.4	0.8	0.6	0.2	0.5	0.7	0.9	0.3	0.9	0.3	0.9	0.6	0.2	7.3	5.7	6.6	4.7	6.9	8.8	9.3	8.6	5.5	8.7	8.7	9.2	12.2	12.8	8.2	69.5	9.9	91.3	66.8	15.0	34.1	28.4	15.4	18.5	12.5	7.2	29.5	5.5	89.6	19.3	17.4	27.5	0.0	9.4	2.3	11.6	19.3	14.7	5.4	12.6	21.2	6.7	15.4	14.1	17.3	14.0	1.3	7.2	12.1	6.7	5.6	23.5	29.5	15.1	10.2	6.8	30.9	4.6	9.6	8.6	37.4	14.0	7.5	14.0	9.2	22.1	18.3	18.6	16.8	12.8	11.0	75.0	14.8	3.8	30.1	43.8	6.6	20.2	17.6	11.9	16.4	67.1	130.4	21.3	16.1	5.3	15.6	188.7
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273284	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		140000		"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	10.9	3.4	7.2	4.2	14.9	0.0	23.2	2.6	9.5	9.9	0.3	18.3	1.7	4.9	20.5	6.9	17.2	5.6	4.8	9.7	18.0	6.0	16.0	2.8	4.0	7.8	28.5	4.5	6.6	2.7	3.2	0.0	7.2	4.5	3.9	3.2	6.0	5.4	4.3	7.2	8.2	4.8	6.2	3.9	8.2	3.1	7.6	4.1	2.8	13.9	6.4	7.0	9.2	6.1	0.1	3.7	12.2	0.0	0.0	0.1	0.0	7.9	0.4	44.7	77.2	0.0	0.0	0.0	46.5	89.3	0.0	0.0	0.1	0.0	63.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	11.5	0.0	3.9	0.0	9.1	0.0	0.0	5.6	59.5	7.6	0.0	5.0	0.0	0.0	0.0	1.9	0.0	5.0	0.0	1.6	0.1	0.0	0.0	0.1	2.1	0.4	0.0	0.4	0.0	0.4	0.1	53.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	14.9	2.6	9.5	9.7	18.0	7.8	28.5	7.2	6.2	7.6	6.1	6.1	0.0	0.0	40.5	0.5	5.7	0.0	0.0	1.8	4.1	33.1	11.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	13.2	0.0	0.2	3.2	6.0	0.0	5.1	13.5	0.0	51.2	3.1	0.0	6.3	0.1	0.4	42.2	0.0	0.0	6.6	0.0	0.0	1.0	9.6	12.8	8.1	1.0	5.4	1.9	0.0	12.6	0.0	91.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	100.1	16.7	0.1	10.4	0.7	4.5	0.0	0.7	0.1	0.0	0.2
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161052	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 7.8;parathyroid gland: 4.0;placenta: 2.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 13.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.3;melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 7.7;HL-60: 6.6;U-266/84: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	7.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.1	0.0	1.0	0.0	0.2	0.0	4.4	0.2	0.0	3.7	0.1	1.1	0.0	0.5	3.5	0.6	0.7	0.4	7.7	0.0	0.1	1.3	1.2	0.1	2.5	2.1	0.5	0.2	1.9	1.8	0.0	0.0	0.0	6.6	0.0	0.2	1.2	0.1	0.3	0.0	0.0	2.8	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.1	1.5	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	3.7	0.1	0.8	1.4	0.0	0.0	0.0	1.5	0.2	1.7	4.7	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.2	0.0	0.0	0.0	13.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	2.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1
GNG4		ENSG00000168243	"G protein subunit gamma 4"	P50150	1	235547685-235650754	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.9;ovary: 32.1;pituitary gland: 32.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 24.4;Enteroendocrine cells: 43.0;Inhibitory neurons: 43.3;Intestinal goblet cells: 16.2;Oligodendrocyte precursor cells: 25.1;Prostatic glandular cells: 24.1;Proximal enterocytes: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 151.4;SCLC-21H: 158.4;SH-SY5Y: 222.8;U-2197: 67.2"	"Region enriched"	"Detected in all"	6	"olfactory bulb: 469.3"											NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.50e-3)"	"unprognostic (8.33e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.56e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.01e-3)"	1.4	11.3	20.0	1.7	25.6	0.1	0.6	7.9	21.0	4.7	3.1	3.6	2.5	9.5	0.1	14.4	3.3	0.5	0.1	15.4	40.9	1.9	0.3	0.1	5.7	21.3	28.2	32.1	5.1	0.0	32.0	1.7	25.4	22.6	3.0	2.4	2.0	0.7	0.1	0.5	5.3	6.6	18.9	0.1	3.1	1.7	33.6	4.9	0.3	0.0	3.4	1.0	2.4	7.3	37.2	2.0	26.4	0.0	0.0	1.3	2.4	0.1	0.4	3.3	4.5	0.1	1.5	0.0	0.3	11.2	9.0	3.3	28.4	1.2	6.7	19.4	10.2	0.1	0.7	14.4	0.4	0.2	12.1	2.4	0.2	0.4	0.9	0.0	0.0	2.0	0.3	0.1	2.1	0.1	7.6	1.2	151.4	0.1	0.1	0.0	13.8	0.7	0.0	1.1	158.4	222.8	0.9	0.3	3.2	1.7	0.2	5.3	0.0	1.7	5.0	67.2	5.2	3.5	0.2	0.0	4.9	0.1	44.5	1.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	20.0	25.6	7.9	21.0	15.4	40.9	21.3	28.2	25.4	18.9	33.6	7.3	0.1	0.0	0.0	2.9	0.2	0.5	2.6	0.3	0.0	2.3	0.2	0.9	0.5	0.0	1.0	0.0	0.0	7.7	2.7	1.6	0.0	0.0	1.1	1.5	24.4	1.4	43.0	0.0	2.3	9.0	10.0	1.7	0.0	0.8	0.0	3.8	0.0	0.0	0.9	1.7	43.3	16.2	4.1	0.0	3.6	1.0	0.3	1.1	0.0	4.7	1.0	0.4	0.0	25.1	0.8	1.6	1.3	0.4	0.1	24.1	24.5	4.9	0.2	1.3	0.0	0.2	1.6	1.8	4.4	0.0	0.0	6.3	1.1	0.3	4.6	1.5
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 46.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Excitatory neurons: 62.4;Hepatocytes: 66.8;Inhibitory neurons: 78.3;Oligodendrocyte precursor cells: 33.2"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;U-698: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3100000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	4.2	0.9	2.0	0.6	1.7	0.9	1.3	7.6	4.7	1.1	0.1	1.0	0.5	1.6	1.7	1.1	0.9	0.6	0.5	1.3	2.4	0.6	46.1	0.9	0.9	1.8	1.9	1.2	0.6	2.5	1.7	0.2	1.9	1.8	0.6	6.2	0.4	4.8	1.7	8.6	0.4	1.4	0.6	0.6	0.7	1.4	1.4	5.1	2.4	0.6	1.3	1.1	1.5	2.1	0.5	0.7	0.8	1.2	0.0	0.0	2.0	0.1	0.2	0.2	0.1	3.5	0.1	7.6	0.8	0.1	0.2	0.1	1.2	0.2	0.1	0.9	2.1	1.1	0.9	3.2	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.8	0.0	1.8	0.5	0.3	0.1	0.5	0.7	0.5	2.9	0.5	0.3	1.4	0.2	0.1	0.4	3.4	2.0	2.3	0.9	0.1	0.4	0.6	0.4	0.3	0.1	0.7	0.9	0.1	1.0	2.4	3.4	8.1	0.1	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	2.0	1.7	7.6	4.7	1.3	2.4	1.8	1.9	1.9	0.6	1.4	2.1	0.4	0.0	3.7	24.8	1.1	0.0	0.7	2.8	0.6	19.6	0.7	0.4	11.6	0.0	1.7	1.8	68.8	0.3	1.6	0.1	0.0	0.4	3.5	0.5	0.6	1.2	1.8	7.4	62.4	0.4	0.3	1.3	0.0	0.3	0.0	2.1	1.4	66.8	0.1	15.2	78.3	0.3	0.0	1.3	0.0	3.4	3.1	0.1	0.0	9.4	0.1	4.0	3.1	33.2	3.1	0.1	0.1	3.4	3.1	0.3	0.1	0.5	1.1	10.9	0.0	3.6	1.4	0.5	5.8	0.3	0.6	0.0	0.5	0.9	0.5	2.6
GREM1	"CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS"	ENSG00000166923	"Gremlin 1, DAN family BMP antagonist"	O60565	15	32718004-32745106	"Disease related genes, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 113.0;smooth muscle: 68.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 66.2;Granulosa cells: 121.1;Oligodendrocytes: 40.5;Skeletal myocytes: 181.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 24.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 294.7;BJ hTERT+: 468.5;BJ hTERT+ SV40 Large T+ RasG12V: 286.8;fHDF/TERT166: 957.0;hTEC/SVTERT24-B: 227.8"	"Group enriched"	"Detected in many"	5	"hippocampal formation: 3.2;olfactory bulb: 10.9"	"Low region specificity"	"Detected in many"			HPA007526	Uncertain				"Secreted to blood"	NA	NA	242000000			"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA007526: AB_1849971"	"unprognostic (4.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.13e-11)"	"unprognostic (1.77e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-3)"	32.7	0.5	1.4	6.5	3.6	0.2	5.5	1.1	2.4	44.7	0.0	36.1	2.6	9.6	0.0	13.6	1.1	113.0	1.3	1.5	1.3	1.2	1.1	2.2	1.1	3.1	3.0	0.3	2.2	0.0	0.2	0.3	1.8	8.2	26.7	0.1	0.6	3.8	0.6	7.6	52.3	68.2	1.1	0.8	36.8	0.5	3.8	0.0	2.3	0.0	1.7	21.7	50.4	6.1	0.0	3.5	0.0	0.0	11.1	12.5	0.0	294.7	468.5	112.5	286.8	0.3	0.0	0.0	0.0	957.0	0.0	0.0	0.0	0.0	109.7	0.0	0.1	0.0	0.1	0.0	3.3	0.0	0.0	3.1	0.0	227.8	0.1	70.6	0.0	0.0	0.0	0.0	143.4	0.1	0.0	0.0	1.2	0.0	0.9	0.0	20.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	57.7	0.0	0.1	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	3.6	1.1	2.4	1.5	1.3	3.1	3.0	1.8	1.1	3.8	6.1	0.7	0.0	0.0	0.3	0.4	6.6	6.5	0.0	0.6	2.1	1.7	0.9	3.4	0.0	0.0	66.2	2.1	0.2	0.7	0.4	0.0	0.4	0.2	0.6	2.3	1.9	0.0	0.0	2.5	0.0	0.1	17.7	0.0	0.7	0.0	121.1	0.7	1.2	1.0	1.7	0.5	0.6	0.0	0.3	12.8	0.0	0.0	2.3	3.6	0.0	2.7	0.3	0.0	1.5	40.5	0.3	0.0	0.4	0.2	9.9	0.1	0.3	0.0	1.3	0.0	181.4	16.1	0.1	1.4	0.3	4.5	0.3	2.1	0.1	0.1	6.5
GSC2	GSCL	ENSG00000063515	"Goosecoid homeobox 2"	O15499	22	19146993-19150292	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 1.2;retina: 1.1;testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"THP-1: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043011	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"				"HPA043011: AB_10959883"						"unprognostic (3.29e-1)"									"unprognostic (1.56e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 275.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032200, HPA065612, HPA068442"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		72000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	28.1	9.0	22.1	79.6	20.9	184.0	27.4	17.8	27.3	93.3	2.6	59.9	118.7	22.8	16.7	275.1	41.0	39.2	35.8	24.1	23.3	89.2	20.0	46.5	139.3	24.3	19.1	4.7	31.9	15.0	15.4	82.4	21.1	27.7	57.2	32.2	69.7	12.6	119.7	141.6	103.6	9.7	15.4	68.7	73.3	80.1	22.9	156.0	31.5	35.1	154.7	100.1	109.6	25.2	1418.7	547.0	274.2	192.9	124.8	916.6	1193.8	556.0	628.8	421.5	233.4	361.3	960.0	658.9	273.1	229.1	264.0	294.7	326.2	991.8	332.3	146.0	228.2	202.6	177.1	488.2	263.7	732.1	227.3	396.1	109.4	765.1	395.8	1083.8	1290.0	369.3	832.0	32.9	596.0	143.0	650.0	898.8	1340.9	697.5	950.3	947.6	6.2	728.0	286.6	128.4	477.0	202.5	59.3	278.3	533.3	430.2	112.2	775.8	1132.1	218.5	691.2	321.3	528.0	260.5	444.5	867.4	461.2	301.7	1115.0	18.7	26.6	35.5	24.4	26.8	32.2	63.5	45.0	39.0	79.6	39.5	52.0	42.9	6.7	20.1	26.5	86.6	55.8	30.7	22.1	20.9	17.8	27.3	24.1	23.3	24.3	19.1	21.1	15.4	22.9	25.2	11.0	28.9	21.7	2.3	117.8	432.3	947.5	181.3	109.8	29.0	88.8	47.4	30.8	28.6	106.1	40.5	4.2	894.3	70.3	173.5	46.9	755.3	7.2	50.5	14.6	113.9	117.0	268.3	5.4	277.5	799.8	72.0	79.5	115.3	66.7	8.3	18.2	12.3	377.2	11.8	5.7	226.4	97.6	74.0	149.9	24.5	5.6	94.3	90.7	1.0	74.3	44.1	33.0	4.5	2.7	1838.5	249.1	2.6	198.2	1483.3	174.5	15.8	21.7	41.9	0.0	18.6	77.7	40.2	417.6	224.7	361.4	822.8	66.6	0.9	364.3	1681.0
IGLON5	LOC402665	ENSG00000142549	"IgLON family member 5"	A6NGN9	19	51311848-51330354	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2;retina: 13.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Horizontal cells: 79.1;Inhibitory neurons: 17.6;Spermatogonia: 9.7"	"Group enriched"	"Detected in many"	5	"glioma: 9.2;ovarian cancer: 3.5;testis cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 35.0;NTERA-2: 16.0;SH-SY5Y: 23.0;SuSa: 9.9;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041994	Approved				"Secreted in brain"	NA	NA		15000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA041994: AB_10794641"	"unprognostic (2.09e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.47e-4)"	"unprognostic (6.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.62e-7)"	"unprognostic (1.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.86e-3)"	1.7	1.7	11.5	0.2	9.0	0.7	0.9	23.4	21.6	0.5	1.1	0.6	0.1	0.1	0.7	4.2	0.1	0.2	0.3	11.7	17.1	0.4	1.9	0.2	0.0	47.2	19.1	1.2	0.2	1.8	1.2	0.4	44.9	0.2	0.0	13.9	0.7	0.7	0.0	0.6	0.3	0.1	16.5	0.1	0.2	8.0	22.2	0.0	0.2	0.0	0.0	0.4	1.2	10.8	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	16.0	0.2	0.0	0.0	0.0	3.5	0.0	0.1	0.1	23.0	0.0	0.0	0.0	9.9	0.2	2.2	0.0	0.0	6.4	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	9.0	23.4	21.6	11.7	17.1	47.2	19.1	44.9	16.5	22.2	10.8	2.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.8	0.1	0.3	79.1	17.6	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.7	0.0	2.5	0.0	5.5	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.9	0.9	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
INSM1	"IA-1, IA1"	ENSG00000173404	"INSM transcriptional repressor 1"	Q01101	20	20368104-20370949	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.4;pituitary gland: 29.2"	"Cell type enriched"	"Detected in some"	42	"Enteroendocrine cells: 506.7"	"Cancer enhanced"	"Detected in many"		"glioma: 9.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 370.4"	"Low region specificity"	"Detected in many"													NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"				"unprognostic (1.86e-2)"	"unprognostic (5.25e-4)"	"unprognostic (7.59e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-3)"		"unprognostic (4.34e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.22e-1)"	0.2	7.1	2.4	0.6	5.9	0.0	0.0	13.4	3.1	0.0	0.0	1.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.6	0.0	0.0	0.0	0.5	0.9	2.5	0.0	2.9	0.0	29.2	0.0	1.5	0.2	1.8	0.1	0.0	0.2	0.0	0.1	2.1	0.0	0.4	0.2	5.1	0.4	3.3	2.8	0.0	0.0	0.3	0.1	0.0	2.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.1	3.2	19.4	0.0	0.0	370.4	0.3	0.0	0.3	0.0	1.1	0.9	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	5.9	13.4	3.1	2.5	4.6	0.9	2.5	1.5	0.4	3.3	2.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.2	0.1	0.1	506.7	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.4	10.8	0.0	0.0	0.7	0.0	0.0	0.2	3.6	0.0	11.9	0.0	0.0	0.5	3.1	1.5	2.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85899162-85922606	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.5;lymphoid tissue: 244.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 225.8;dendritic cells: 492.3;Kupffer cells: 105.1;Langerhans cells: 366.0;Macrophages: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 2477.4"	"Lineage enriched"	"Detected in all"	7	"dendritic cells: 2477.4"	"Group enriched"	"Detected in some"	4	"Daudi: 240.7;THP-1: 382.3;U-698: 928.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	25.9	7.6	4.7	81.4	5.6	85.5	9.3	7.0	6.2	5.6	5.4	27.1	47.1	8.0	3.1	6.7	6.5	19.7	3.8	6.3	5.4	6.1	36.9	27.4	244.1	9.5	8.5	2.5	3.4	1.7	1.7	10.1	10.0	7.7	33.5	0.8	7.1	8.9	2.0	5.0	56.2	13.5	11.3	137.3	22.9	4.8	12.6	61.5	4.1	1.7	224.9	21.8	1.6	14.0	0.9	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	26.0	0.0	240.7	1.5	0.0	0.0	0.1	1.4	0.0	0.2	0.2	2.7	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.5	0.0	0.0	0.6	21.3	0.2	20.6	0.0	7.5	1.1	27.2	0.0	0.0	0.1	0.1	1.0	0.0	0.2	1.4	0.0	382.3	0.6	0.0	10.9	0.2	0.9	0.3	0.3	928.2	0.0	128.4	0.0	9.1	137.1	3.4	3.3	134.3	4.5	347.0	1.8	2.1	291.2	361.3	3.5	2.8	8.4	111.5	97.3	2477.4	0.7	150.1	4.7	5.6	7.0	6.2	6.3	5.4	9.5	8.5	10.0	11.3	12.6	14.0	3.7	0.0	4.2	0.0	225.8	10.5	0.8	0.0	0.6	0.0	2.4	3.4	1.5	2.8	1.3	0.0	0.0	0.8	492.3	13.0	1.9	0.5	1.5	7.3	7.6	7.6	28.7	7.4	0.6	1.4	5.7	10.8	15.3	12.5	2.5	0.4	1.8	6.5	64.1	0.0	0.2	11.8	0.0	105.1	366.0	4.6	0.3	122.2	44.4	33.7	35.3	0.4	23.7	1.0	0.4	0.1	10.7	0.0	14.1	2.3	34.2	3.5	0.0	0.2	6.6	0.7	6.7	0.7	6.7	0.4	9.2	1.1	23.1	48.8	25.6	2.5
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751677	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 24.0;salivary gland: 30.6;skin 1: 28.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 109.0;Alveolar cells type 2: 74.2;Basal keratinocytes: 202.1;Breast glandular cells: 147.4;Breast myoepithelial cells: 159.8;Suprabasal keratinocytes: 131.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 14.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 93.2;BEWO: 56.4;HaCaT: 32.0;hTCEpi: 68.9;SK-BR-3: 39.1"	"Group enriched"	"Detected in many"	5	"midbrain: 26.5;pons and medulla: 20.9;thalamus: 11.2"	"Region enhanced"	"Detected in some"		"pons: 5.1"	"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	3.8	0.1	2.0	0.0	2.7	0.0	24.0	4.9	1.0	0.6	0.4	0.7	0.0	0.0	3.1	4.5	0.2	0.0	1.5	0.8	2.8	21.5	0.0	18.1	0.2	20.7	8.2	0.0	2.0	2.9	1.6	5.6	22.3	3.6	0.3	1.1	30.6	0.9	0.3	28.2	0.0	0.0	4.2	0.0	15.7	2.1	4.7	0.5	1.8	0.6	0.2	0.2	2.0	4.2	10.7	0.0	93.2	0.0	5.4	3.9	56.4	5.4	3.4	5.0	4.0	11.8	0.0	0.0	0.0	11.5	0.0	32.0	0.1	24.6	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	68.9	2.4	20.1	0.0	0.0	0.0	0.0	0.0	3.6	19.1	0.0	0.1	10.2	25.7	0.0	0.0	5.7	0.0	22.7	0.0	3.5	0.0	18.6	39.1	0.0	14.3	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.7	4.9	1.0	0.8	2.8	20.7	8.2	22.3	4.2	4.7	4.2	5.5	109.0	74.2	0.0	0.2	202.1	17.6	33.1	31.9	1.4	147.4	159.8	2.7	0.0	23.9	7.3	0.0	27.8	1.2	3.0	27.4	0.1	5.0	0.1	0.4	2.9	0.0	0.0	0.0	0.0	18.6	15.0	15.3	0.0	1.3	0.1	0.0	0.0	3.3	0.0	0.0	2.5	14.2	0.0	15.4	10.4	0.0	0.7	19.6	0.0	0.0	0.3	0.0	1.5	0.0	0.3	2.9	0.0	0.1	23.5	0.2	0.6	13.0	2.5	0.0	3.6	14.6	9.4	9.4	20.1	131.3	15.2	0.9	0.0	2.8	8.3
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321540	"Human disease related genes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 237.4;tongue: 106.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	0.3	0.2	2.9	0.5	7.5	0.0	0.7	7.6	5.3	0.7	13.2	3.3	0.7	3.2	0.8	2.8	0.3	0.3	8.4	5.9	1.5	0.8	0.4	3.7	0.1	3.0	1.5	0.1	6.5	0.8	0.5	1.4	2.4	2.8	5.0	0.4	2.8	0.5	237.4	0.6	1.0	1.9	1.9	0.1	0.9	1.0	1.9	3.2	1.4	106.0	1.1	2.3	1.4	3.6	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	1.1	1.1	0.5	0.2	4.4	0.0	1.5	0.0	1.0	6.4	5.6	4.3	1.4	0.0	8.3	0.0	5.2	0.0	0.7	2.9	0.3	0.8	3.7	0.0	4.0	0.0	0.0	10.9	0.8	0.0	0.4	4.1	15.1	0.0	9.7	17.7	2.9	7.6	5.4	0.0	0.2	12.7	7.3	1.0	0.1	34.4	1.8	1.6	24.2	0.2	0.0	1.6	2.3	0.6	1.4	0.0	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.5	7.6	5.3	5.9	1.5	3.0	1.5	2.4	1.9	1.9	3.6	1.1	38.5	12.9	3.9	0.2	2.8	32.8	3.0	6.2	0.4	2.4	1.5	35.7	0.0	10.8	1.8	6.2	0.0	0.1	7.1	0.0	0.3	2.4	2.9	8.9	1.7	12.6	0.0	82.2	1.4	0.0	2.6	7.7	3.7	0.0	0.0	0.0	0.0	0.1	0.0	50.3	9.9	2.0	0.0	0.4	0.5	0.9	0.4	1.8	3.7	0.0	0.4	0.0	14.1	4.6	3.4	6.2	0.0	0.0	32.8	0.0	1.0	6.2	0.1	0.0	25.0	1.4	0.1	4.3	7.4	2.0	0.0	0.2	0.1	6.7	25.6
JRK	"jerky, JH8"	ENSG00000234616	"Jrk helix-turn-helix protein"	O75564	8	142657460-142681968	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052675			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA052675: AB_2681910"	"unprognostic (3.65e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.58e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.69e-2)"	3.7	4.5	5.9	4.1	6.1	2.1	4.0	7.9	7.4	7.4	4.0	5.9	3.0	6.7	3.4	4.9	5.5	2.5	5.9	5.8	4.7	7.9	4.0	3.9	5.4	6.2	5.2	8.5	5.4	4.6	6.4	3.0	5.5	6.2	2.8	3.8	4.7	4.0	7.5	6.0	5.3	3.7	4.3	7.2	5.7	6.6	6.2	5.1	6.9	4.7	5.9	5.7	4.7	6.8	6.5	6.9	8.0	6.4	7.6	10.8	4.8	10.4	4.2	11.9	6.8	6.3	13.1	11.0	4.1	8.2	8.2	8.7	7.0	6.2	6.0	8.5	12.0	11.2	25.3	7.2	3.1	8.6	7.5	7.2	5.4	7.6	4.3	6.0	6.8	13.1	12.0	4.8	10.1	11.1	10.1	4.8	6.8	4.6	9.6	13.1	5.0	6.2	4.1	11.1	14.5	9.6	18.1	7.3	4.3	5.0	7.3	5.2	8.1	9.1	19.5	9.1	5.5	6.3	7.6	6.3	6.9	10.7	9.0	1.0	0.7	0.9	0.9	0.5	0.5	0.4	1.0	0.9	0.7	1.2	1.3	1.0	0.8	0.6	0.2	0.6	0.6	0.4	5.9	6.1	7.9	7.4	5.8	4.7	6.2	5.2	5.5	4.3	6.2	6.8	3.5	6.4	1.1	8.5	4.8	0.0	2.5	0.0	2.2	14.7	4.5	3.3	11.5	4.3	0.6	7.3	20.9	4.4	8.6	3.2	3.9	2.8	1.9	1.4	4.9	6.5	9.1	12.0	11.3	2.5	2.7	3.7	6.6	2.1	1.3	15.5	8.2	2.6	3.0	10.1	11.0	3.1	0.0	6.6	0.0	2.2	11.5	3.4	0.0	8.4	4.5	4.4	12.3	9.5	9.5	5.6	1.4	11.7	4.3	3.7	2.7	2.7	0.7	10.0	0.0	5.8	4.8	9.1	19.4	3.2	0.0	2.2	2.5	6.8	4.2	4.5
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 81.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 49.9;Excitatory neurons: 36.7;Inhibitory neurons: 37.1;Muller glia cells: 19.8;Oligodendrocyte precursor cells: 36.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2;testis cancer: 1.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 81.3"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.8;SCLC-21H: 1.4;U-2 OS: 1.2;U-266/70: 1.9;U-266/84: 3.1;WM-115: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	1.3	0.3	5.0	0.7	7.4	0.0	0.6	11.1	81.3	0.2	0.0	1.6	0.4	0.1	0.3	0.4	0.1	0.3	0.7	4.5	12.5	0.1	0.0	0.1	0.6	28.0	7.5	0.1	0.8	0.0	2.1	0.0	32.0	0.5	0.5	9.6	0.5	0.8	1.0	0.5	0.6	0.4	0.1	0.3	0.7	0.9	27.1	3.0	2.3	2.1	1.5	0.3	0.3	20.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	3.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	5.0	7.4	11.1	81.3	4.5	12.5	28.0	7.5	32.0	0.1	27.1	20.7	0.1	0.0	0.0	49.9	0.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	36.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	37.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	8.4	0.0	19.8	0.0	36.2	6.8	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	4.2	0.0	0.4	1.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium inwardly rectifying channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 196.1;parathyroid gland: 269.2;thyroid gland: 139.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 279.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.3	0.4	10.0	0.4	14.0	0.6	3.8	22.7	11.6	0.1	2.3	0.6	0.7	0.5	15.9	0.3	5.1	18.8	0.6	6.8	39.5	196.1	1.3	0.9	0.8	39.7	37.6	0.2	44.2	269.2	1.0	0.9	25.7	0.2	0.2	1.2	11.8	21.7	0.3	0.8	2.5	0.0	29.9	1.5	23.4	1.7	27.3	0.2	139.4	0.0	0.1	0.0	0.0	20.8	0.1	0.4	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.8	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	12.7	0.0	0.0	279.8	0.2	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.3	0.3	0.1	0.0	0.3	0.2	0.2	1.6	0.3	0.0	0.1	0.3	0.1	10.0	14.0	22.7	11.6	6.8	39.5	39.7	37.6	25.7	29.9	27.3	20.8	0.1	0.0	0.0	12.1	0.0	0.0	0.0	2.7	0.0	0.0	2.3	1.1	0.4	54.3	2.6	244.6	0.0	0.0	0.0	0.0	41.1	12.4	0.0	2.8	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.3	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	54.8	0.1	6.0	0.0	0.0	0.0	0.0	1.0	95.2	9.8	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614106-233672514	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 157.8;Horizontal cells: 200.2;Prostatic glandular cells: 222.9;Urothelial cells: 371.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	69	"plasmacytoid DC: 6.9"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 6.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 64.7;SCLC-21H: 62.5;U-266/70: 137.3;U-266/84: 134.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 117.0"	"HPA016049, CAB022588"	Approved		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (7.06e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.64e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.84e-4)"	"unprognostic (4.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (7.29e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	3.9	4.1	17.7	2.9	19.8	0.3	5.7	58.0	28.4	7.8	50.4	15.7	16.9	6.1	30.9	20.9	10.9	12.1	41.0	24.3	13.7	9.2	12.1	4.4	1.0	23.5	17.8	7.3	5.5	16.2	22.2	6.8	24.1	6.4	13.9	18.5	15.1	11.3	0.4	13.3	12.6	3.8	15.4	0.9	38.1	0.9	16.3	0.5	7.2	0.9	4.4	11.5	14.4	21.3	33.2	18.3	0.1	0.0	0.0	0.0	50.2	8.8	0.0	0.0	0.0	0.0	52.9	0.0	20.7	6.8	7.3	47.1	8.9	15.2	0.0	0.1	15.8	0.0	64.7	0.0	0.5	0.0	1.8	3.9	17.0	0.0	12.4	1.1	0.2	17.7	7.9	15.0	0.0	12.6	12.2	0.1	10.9	38.5	41.0	0.0	2.7	3.7	16.0	28.4	62.5	11.8	33.5	14.3	0.0	1.0	4.1	0.1	0.0	0.1	25.8	0.0	1.0	137.3	134.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	17.7	19.8	58.0	28.4	24.3	13.7	23.5	17.8	24.1	15.4	16.3	21.3	0.4	9.6	22.9	5.9	0.6	63.3	136.7	32.6	3.4	2.9	23.0	6.0	54.7	12.8	44.6	18.4	4.2	0.5	3.0	91.0	1.9	29.2	1.1	52.7	26.4	3.5	29.3	0.0	157.8	48.3	14.0	31.2	50.4	89.3	0.0	15.0	0.0	8.9	0.6	200.2	61.0	56.3	24.4	0.3	4.4	0.2	1.5	1.0	10.6	12.2	0.0	72.6	0.0	36.2	73.2	96.3	82.4	0.0	0.2	222.9	10.6	8.8	42.9	5.1	0.0	2.3	6.9	0.6	3.2	19.1	47.6	0.8	1.4	0.5	31.2	371.6
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114055926-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 27.8;brain: 20.8;liver: 31.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 36.2;Excitatory neurons: 149.9;Inhibitory neurons: 97.0;Oligodendrocyte precursor cells: 63.3"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.5;NTERA-2: 6.4;SK-MEL-30: 12.9;THP-1: 21.8;U-937: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.4	27.8	7.8	0.2	10.8	0.0	0.5	11.3	14.0	2.0	2.2	1.4	0.3	2.9	0.3	0.2	0.4	0.4	6.8	20.8	7.5	3.9	31.3	2.3	0.4	11.1	4.7	0.7	4.5	0.4	7.6	0.0	6.7	9.6	0.7	2.5	0.5	4.3	9.5	1.3	0.3	2.0	9.0	0.5	0.7	3.0	8.2	0.2	0.3	6.7	0.2	2.3	1.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	17.5	2.7	0.3	0.0	0.0	0.2	0.0	0.5	0.0	2.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.2	0.0	0.3	0.0	1.4	6.4	0.0	0.0	0.0	0.0	0.8	0.2	0.1	2.1	0.0	0.0	0.2	12.9	0.4	0.3	21.8	0.3	0.0	0.5	1.8	0.0	0.1	0.0	0.1	2.0	7.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.8	11.3	14.0	20.8	7.5	11.1	4.7	6.7	9.0	8.2	11.1	1.4	0.0	1.1	36.2	0.0	0.3	0.3	0.0	0.0	7.9	0.6	1.3	15.1	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.6	0.6	0.5	0.0	8.2	0.0	0.0	149.9	0.9	0.0	0.8	0.0	1.3	0.0	0.8	5.0	18.3	0.0	0.0	97.0	1.0	0.0	1.0	0.3	0.5	0.0	0.1	21.4	6.5	0.0	0.4	0.0	63.3	9.2	1.0	0.1	0.0	1.2	4.7	0.0	0.7	0.0	7.8	0.0	0.1	0.3	0.3	6.5	0.3	0.3	0.0	0.0	0.2	0.5	0.6
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45091214-45101127	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 22.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Cholangiocytes: 7.2;Collecting duct cells: 1.8;Excitatory neurons: 6.2"	"Cancer enriched"	"Detected in many"	5	"cervical cancer: 6.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 22.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.3;HHSteC: 2.1;hTEC/SVTERT24-B: 1.0;THP-1: 1.8;U-87 MG: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.46e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.11e-4)"	"unprognostic (8.91e-3)"	"unprognostic (6.01e-3)"	"unprognostic (7.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.65e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"	0.0	0.4	0.9	0.1	2.9	0.1	0.2	0.0	22.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.1	4.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	1.5	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.4	0.4	0.1	0.1	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.8	0.0	0.9	0.2	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	2.9	0.0	22.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	2.0	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.1	1.1	7.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223854	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 7.2;monocytes: 8.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	5.9	7.6	5.6	11.4	7.6	27.2	6.3	5.3	7.8	7.6	7.6	14.1	8.0	5.7	3.7	9.1	13.4	6.0	6.8	6.6	5.9	7.8	7.4	8.8	10.4	6.9	6.7	6.7	5.9	3.2	5.8	4.6	6.1	5.2	12.2	12.0	5.7	4.7	17.3	11.2	8.9	6.9	6.2	10.5	5.6	15.7	5.6	10.8	27.2	9.1	9.4	7.7	8.1	9.4	15.1	9.7	11.2	23.0	13.8	20.5	24.5	11.7	12.6	7.5	10.2	16.3	7.4	34.1	31.6	19.2	22.8	15.5	17.8	20.8	16.0	31.6	14.6	17.2	8.6	15.0	6.7	25.5	17.5	10.3	23.4	21.5	17.7	12.1	7.7	15.9	38.3	5.2	12.7	12.6	14.1	10.5	3.8	31.6	12.8	26.8	20.3	24.4	10.7	19.8	34.2	10.6	9.7	23.5	22.9	11.7	22.3	20.3	6.5	16.9	9.5	11.9	15.5	5.2	15.9	20.0	6.4	18.9	37.8	1.2	4.6	7.2	0.5	8.6	0.3	1.2	0.5	0.5	3.7	1.3	0.5	0.2	4.9	0.3	6.9	1.6	0.7	1.3	5.6	7.6	5.3	7.8	6.6	5.9	6.9	6.7	6.1	6.2	5.6	9.4	4.9	0.0	8.2	14.7	8.7	12.7	5.7	3.8	7.4	5.0	7.6	6.6	10.4	11.5	10.4	1.8	10.4	2.7	3.0	23.0	1.9	6.6	0.7	36.2	10.0	4.2	6.7	3.8	19.0	4.3	5.1	5.8	8.2	15.5	2.5	3.3	4.2	7.7	7.5	5.0	10.8	9.6	10.2	36.7	11.7	0.7	3.7	20.6	7.2	22.5	27.7	6.6	8.2	16.1	23.8	7.2	21.2	6.8	3.7	5.4	6.2	11.2	21.0	15.5	0.0	6.9	6.2	0.7	18.2	9.7	15.9	1.4	5.6	3.1	10.6	6.6
KIAA1549		ENSG00000122778	KIAA1549	Q9HCM3	7	138831381-138981389	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 92.2;Inhibitory neurons: 54.6;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 20.6;SH-SY5Y: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019560	Uncertain		Approved	"Nuclear membrane,Intermediate filaments"		NA	NA		14000		"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane"	"Intermediate filaments"	"HPA019560: AB_1852418"	"unprognostic (7.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.30e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.28e-2)"	0.6	1.7	2.7	0.3	3.0	0.3	1.5	0.0	4.4	1.4	0.0	0.8	0.7	1.7	1.8	0.5	2.2	1.0	1.2	4.3	0.8	3.9	0.4	1.8	0.2	1.6	2.5	1.2	6.3	2.4	1.8	1.3	0.0	1.5	0.7	5.7	2.4	5.5	0.5	0.8	0.7	1.3	1.4	0.3	1.3	1.2	2.5	2.4	0.7	0.8	0.2	1.1	0.6	2.4	4.9	9.2	9.1	14.9	0.1	0.0	4.2	5.2	4.6	2.6	3.4	8.4	2.6	0.0	2.9	8.2	8.6	1.0	5.7	1.4	3.6	2.5	3.8	2.6	11.5	2.2	1.3	3.8	3.2	1.2	2.8	0.9	1.4	3.5	4.8	3.4	1.7	0.1	3.6	4.5	2.9	4.7	7.8	4.1	20.6	6.8	4.5	0.0	1.7	3.3	11.8	21.5	2.6	5.2	2.2	5.1	3.7	2.4	3.3	2.9	2.8	0.1	5.1	0.9	0.0	0.1	4.0	1.4	7.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	3.0	0.0	4.4	4.3	0.8	1.6	2.5	0.0	1.4	2.5	2.4	2.0	0.0	2.2	11.8	0.1	0.5	2.1	1.6	0.6	18.5	6.3	4.6	2.5	0.0	2.9	7.3	56.3	2.5	0.2	0.3	0.0	2.3	0.5	8.5	8.1	4.8	10.8	1.3	92.2	3.2	2.2	3.0	3.6	8.0	16.5	13.8	2.2	0.8	0.5	3.3	54.6	2.5	6.1	0.8	1.2	0.2	1.5	0.5	1.8	26.2	0.0	7.2	0.0	69.9	2.2	5.0	1.4	2.6	1.0	3.1	0.5	8.1	12.2	29.2	6.6	2.2	2.9	0.3	7.2	0.1	0.9	1.5	1.1	2.4	2.9	1.6
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 114.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 83.1;granulocytes: 529.3;Inhibitory neurons: 111.2;Ionocytes: 101.7;Melanocytes: 211.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 28.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 20.3;eosinophil: 12.8;NK-cell: 13.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 20.3;NK-cells: 13.1"	"Group enriched"	"Detected in many"	13	"HEL: 247.2;HMC-1: 496.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		49000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 5: Breast - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	6.6	1.8	8.2	5.3	6.3	6.4	114.9	21.4	6.5	17.6	5.1	13.5	9.2	9.6	5.9	13.0	2.9	20.3	3.4	23.9	5.1	12.4	0.8	21.8	3.4	6.8	12.3	45.0	2.6	1.7	1.9	10.0	8.8	5.6	16.0	3.2	21.4	8.7	1.1	24.5	13.4	10.1	5.9	5.0	17.4	6.2	16.7	3.1	47.1	6.9	6.2	14.5	4.9	5.1	0.0	0.0	3.9	0.0	0.7	0.3	0.0	3.3	4.6	12.6	15.8	0.0	0.0	0.0	0.0	7.3	0.6	0.3	2.6	0.0	10.8	0.0	5.9	247.2	0.0	0.0	0.0	0.0	496.2	0.0	0.0	0.0	0.0	0.0	28.4	4.3	3.5	0.5	0.0	0.0	1.4	2.5	6.9	0.0	0.0	0.8	0.0	0.0	0.0	24.2	6.0	2.1	0.0	0.0	0.0	14.1	0.0	2.6	0.3	0.5	0.0	4.9	0.1	0.4	0.0	0.0	0.5	0.9	0.6	20.3	0.0	12.8	0.1	0.0	2.3	0.0	0.4	0.9	2.3	0.0	0.0	0.0	1.0	13.1	1.4	0.1	0.0	0.2	8.2	6.3	21.4	6.5	23.9	5.1	6.8	12.3	8.8	5.9	16.7	5.1	7.3	6.4	21.9	9.8	1.0	14.3	0.9	0.4	2.2	4.5	83.1	59.2	0.7	4.3	3.6	3.7	0.0	0.1	5.2	0.4	3.9	1.0	0.0	0.2	0.7	9.2	5.4	15.5	0.9	0.0	0.1	2.8	8.6	0.7	529.3	0.5	1.8	0.0	0.3	0.0	111.2	0.5	101.7	0.3	4.2	0.4	1.2	1.6	211.7	14.0	0.2	2.4	0.0	16.1	3.7	0.0	0.1	0.0	3.2	0.5	0.0	0.8	0.1	0.2	0.0	0.7	0.8	0.1	12.3	2.2	3.8	0.3	8.8	63.7	0.6	0.3
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Inhibitory neurons: 29.3;Microglial cells: 30.9;Oligodendrocyte precursor cells: 102.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.3;plasmacytoid DC: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;granulocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 33.8;HeLa: 57.3;RH-30: 37.2;RPTEC TERT1: 106.0;SH-SY5Y: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA046039: AB_2679514, HPA059901: AB_2684155"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.7	7.3	4.6	2.6	11.1	0.4	24.6	2.7	4.8	20.5	5.5	5.4	3.1	31.4	7.3	5.9	10.7	5.6	7.8	3.2	5.9	16.0	4.7	1.4	0.6	5.9	10.3	7.4	4.6	3.4	2.2	0.8	6.4	6.2	3.9	4.2	2.2	12.3	3.6	1.1	4.8	29.3	4.0	1.6	3.2	3.6	5.9	5.0	0.8	5.6	1.2	7.5	5.0	3.8	1.1	0.4	6.9	14.5	0.1	0.0	0.2	0.5	0.0	0.4	0.0	9.1	0.1	0.0	16.5	0.0	0.7	16.9	33.8	5.6	0.0	0.0	12.9	0.4	57.3	0.1	0.8	1.1	2.2	1.8	2.3	0.2	0.7	6.9	25.8	0.0	0.0	0.0	0.0	1.4	5.9	1.6	13.4	0.0	9.6	0.0	37.2	0.1	106.0	4.0	0.0	94.3	0.5	1.2	0.9	2.7	20.9	0.2	0.7	2.4	2.9	2.0	8.6	0.4	0.0	0.2	10.2	0.0	4.1	2.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.6	0.0	1.1	0.0	4.1	0.2	0.3	4.6	11.1	2.7	4.8	3.2	5.9	5.9	10.3	6.4	4.0	5.9	3.8	0.7	0.0	0.0	13.7	0.0	0.8	6.8	5.4	12.0	6.2	2.4	19.9	10.5	0.0	4.8	1.8	0.0	0.2	0.1	1.2	29.4	1.1	0.3	8.0	22.7	1.9	1.2	1.3	8.0	3.4	0.1	8.7	0.0	1.3	0.0	10.0	8.6	1.3	0.6	0.0	29.3	2.1	0.0	0.0	1.2	0.9	6.2	1.0	1.8	30.9	0.2	7.2	0.0	102.5	12.3	0.7	3.4	1.9	0.1	2.7	2.9	12.7	22.3	1.2	6.6	18.1	5.3	1.8	10.6	4.8	0.4	0.0	0.6	6.4	4.1	3.6
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 27.6;Horizontal cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 136.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	11.1	10.5	31.1	18.7	32.7	6.8	9.4	28.3	77.9	21.4	0.2	8.9	6.6	13.1	3.5	11.3	7.3	10.1	9.4	35.0	43.8	10.8	4.6	13.2	23.5	75.5	40.0	13.2	11.4	5.8	13.9	7.3	73.0	12.3	4.1	4.0	17.9	8.2	23.7	11.4	12.1	7.1	31.8	22.3	9.2	15.6	59.1	8.1	11.2	7.8	18.2	13.1	14.7	38.3	47.4	37.2	27.2	45.4	35.1	47.0	20.0	28.8	27.3	22.6	25.4	21.3	45.6	30.2	12.7	35.5	76.9	28.1	10.1	17.8	8.6	53.7	18.6	23.2	13.1	24.6	40.5	17.2	81.4	46.8	15.6	18.5	9.6	68.3	34.4	20.9	15.1	9.0	28.8	41.4	14.8	31.4	52.1	16.6	23.7	21.1	43.3	18.2	26.5	10.1	10.7	25.2	18.6	43.7	23.5	29.7	13.9	15.4	41.1	36.0	33.7	94.5	47.7	10.2	12.5	54.9	136.5	12.4	25.2	0.1	6.1	3.5	1.8	6.0	1.4	3.4	0.4	1.2	7.0	1.7	0.1	0.5	0.5	5.8	3.8	0.7	0.3	3.3	31.1	32.7	28.3	77.9	35.0	43.8	75.5	40.0	73.0	31.8	59.1	38.3	2.9	3.2	2.7	7.5	14.4	2.9	5.2	6.6	1.8	6.6	7.7	6.9	3.4	7.2	3.8	1.8	2.1	2.5	11.9	2.9	0.0	6.6	1.2	2.7	9.7	4.1	2.4	0.4	15.4	6.5	6.3	9.2	3.1	5.1	5.7	27.6	3.3	2.1	25.0	35.3	20.8	2.7	0.0	13.5	10.8	2.2	7.2	15.6	3.6	6.5	14.9	3.5	22.6	6.6	2.4	13.5	2.3	6.0	10.0	9.0	0.3	2.8	3.1	3.3	0.0	5.3	4.5	3.4	11.5	1.8	3.1	3.7	11.1	6.9	2.4	7.2
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126613928-126701032	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;salivary gland: 18.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 5.0"	"HPA073716, HPA075656"			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA073716: AB_2686630, HPA075656: "	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	0.6	0.0	0.1	0.0	0.1	0.1	4.1	0.1	5.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	1.0	3.6	0.0	0.1	0.0	3.8	9.2	0.0	0.2	1.1	0.2	0.0	3.3	0.0	0.0	0.0	18.5	0.0	0.1	2.1	0.1	0.0	6.8	0.0	0.1	1.4	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.2	0.6	0.3	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.3	0.0	2.5	0.6	3.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	10.4	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.2	0.1	8.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.6	1.0	1.0	3.8	9.2	3.3	6.8	2.6	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.6	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 144.4"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		78000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	31.0	1.8	33.1	17.0	29.2	4.0	27.2	15.1	21.0	29.9	0.0	38.6	16.8	21.9	3.0	13.5	26.7	20.9	37.0	21.4	26.7	3.6	11.2	17.6	7.9	29.4	39.2	17.1	144.4	5.2	6.5	4.7	17.2	24.8	14.7	5.0	19.2	7.2	37.2	11.7	13.4	30.5	14.3	3.9	36.5	12.5	51.0	3.5	16.2	32.9	9.6	5.9	5.2	17.7	1.4	1.3	27.6	0.5	7.6	4.8	2.8	4.9	26.6	4.6	14.0	23.6	0.3	79.7	13.1	2.2	6.1	0.0	5.5	10.0	10.1	0.0	16.8	0.0	4.1	2.0	1.8	0.7	16.7	6.0	5.4	55.2	9.0	18.8	24.3	0.3	0.3	0.0	1.0	3.6	0.0	0.1	22.8	2.3	0.0	14.1	8.7	3.7	5.1	0.0	3.9	1.0	4.6	4.1	0.2	4.6	25.6	6.7	8.2	13.9	6.3	27.9	12.9	6.2	3.2	59.5	24.3	0.0	5.0	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.4	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.1	33.1	29.2	15.1	21.0	21.4	26.7	29.4	39.2	17.2	14.3	51.0	17.7	12.5	38.5	50.2	331.1	4.3	11.3	7.8	8.0	14.2	2.1	51.9	35.8	32.0	11.5	25.0	0.0	8.4	0.2	5.8	9.6	1.9	5.6	1.6	29.1	9.7	9.2	26.5	0.0	10.6	17.1	0.1	17.1	19.9	58.8	1.3	14.9	6.4	20.7	2.0	8.4	15.6	26.2	12.2	1.9	7.7	2.1	11.5	2.4	10.6	57.1	1.7	39.8	0.0	37.7	58.3	6.0	10.2	17.3	8.7	15.6	5.7	1.2	33.7	6.8	0.0	65.5	19.9	1.6	20.0	8.9	11.5	0.1	15.2	2.1	22.8	5.0
LUZP4	"CT-8, CT28, HOM-TES-85"	ENSG00000102021	"Leucine zipper protein 4"	Q9P127	X	115289715-115307563	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	82	"testis: 8.2"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 35.2"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 13.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046436, HPA051999"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA046436: AB_10964168, HPA051999: AB_2681688"															"unprognostic (1.84e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA12	"CT1.12, MAGE12"	ENSG00000213401	"MAGE family member A12"	P43365	X	152733757-152737669	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.8"	"Group enriched"	"Detected in some"	16	"Spermatocytes: 9.4;Spermatogonia: 20.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 143.0;HMC-1: 57.8;K-562: 89.5;OE19: 112.7;SH-SY5Y: 48.2;U-2 OS: 87.2;U-266/70: 69.2"															NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"								"unprognostic (3.47e-2)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-1)"		"unprognostic (1.60e-3)"		"unprognostic (8.57e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.78e-1)"		"unprognostic (4.06e-2)"	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.4	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	5.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	112.7	41.6	0.1	0.0	1.1	0.0	0.1	3.3	48.2	0.0	24.3	13.3	0.0	0.7	0.2	0.4	0.1	87.2	12.7	6.5	69.2	0.1	0.1	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.7	0.4	0.4	0.4	0.4	0.4	0.3	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.4	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEA4	"CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336"	ENSG00000147381	"MAGE family member A4"	P43358	X	151912509-151925170	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 23.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 20.2;Spermatocytes: 48.7;Spermatogonia: 179.8;Syncytiotrophoblasts: 33.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 19.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 440.0;AN3-CA: 263.1;HMC-1: 496.1;U-266/84: 836.2"									"HPA021942, CAB040535"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB040535: , HPA021942: AB_1853490"						"unprognostic (7.90e-3)"		"unprognostic (6.66e-3)"	"unprognostic (5.39e-1)"	"unprognostic (1.36e-1)"				"unprognostic (5.81e-2)"	"unprognostic (2.94e-2)"		"unprognostic (4.10e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	440.0	0.0	0.0	263.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.1	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	496.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.1	0.2	4.1	0.0	0.5	132.0	0.0	2.4	105.9	836.2	0.7	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	48.7	179.8	0.0	0.0	33.0	0.0	0.0	0.0	0.0
MAGEA6	"CT1.6, MAGE-3b, MAGE3B, MAGE6"	ENSG00000197172	"MAGE family member A6"	P43360	X	152766136-152769747	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	22	"testis: 7.1"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 29.8;Spermatogonia: 49.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 210.0;HMC-1: 156.5;K-562: 136.8;OE19: 272.9;PC-3: 148.1;SK-BR-3: 138.3;U-266/70: 176.3;U-266/84: 119.7"															NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"					"unprognostic (3.09e-1)"			"unprognostic (5.94e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.74e-1)"					"unprognostic (5.33e-2)"	"unprognostic (8.33e-2)"		"unprognostic (6.00e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	17.6	0.0	0.3	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	210.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	50.8	1.1	0.0	0.0	156.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.8	75.4	0.0	0.2	0.4	0.0	0.2	272.9	148.1	0.1	0.0	8.5	0.0	0.0	7.8	58.3	0.0	138.3	20.2	0.1	2.2	10.1	0.7	64.2	100.7	3.7	19.9	176.3	119.7	0.2	1.2	0.0	77.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	29.8	49.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MAGEB16		ENSG00000189023	"MAGE family member B16"	A2A368	X	35798342-35803735	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	33	"testis: 3.3"	"Group enriched"	"Detected in some"	35	"Spermatocytes: 7.4;Spermatogonia: 13.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 59.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055743, HPA076456"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Centrosome	"HPA055743: AB_2682902, HPA076456: "															"unprognostic (2.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGEB2	"CT3.2, DAM6, MAGE-XP-2, MGC26438"	ENSG00000099399	"MAGE family member B2"	O15479	X	30215563-30220089	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	60	"testis: 29.1"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 24.7;Spermatogonia: 95.8"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 33.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 92.4;K-562: 66.9;Karpas-707: 77.0;U-2 OS: 89.9;U-266/70: 149.7;U-266/84: 168.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA065224, HPA074544, HPA075519"	Enhanced		Approved	Cytosol		NA	Yes				"Cluster 36: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294"					"unprognostic (4.52e-1)"	"unprognostic (2.55e-2)"		"unprognostic (6.39e-2)"	"unprognostic (5.02e-1)"					"unprognostic (6.57e-2)"	"unprognostic (1.79e-2)"		"unprognostic (1.00e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	92.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.9	77.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.5	0.0	14.8	0.2	0.0	89.9	0.3	0.3	149.7	168.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	24.7	95.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: AB_2685331"	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (1.56e-4)"	19.1	17.0	17.9	11.7	17.8	19.4	19.5	16.8	19.0	25.1	10.4	24.4	13.1	26.1	3.7	20.2	20.5	5.9	20.8	14.8	15.2	18.7	24.7	17.1	11.7	17.3	17.3	23.2	21.6	9.6	23.4	9.2	17.1	21.0	4.6	5.6	19.2	7.9	52.4	27.9	20.1	6.2	15.1	24.5	18.8	17.5	17.3	10.9	19.0	16.4	6.1	22.0	22.4	19.9	25.8	14.4	12.2	20.2	9.7	9.3	22.8	16.5	8.0	11.0	11.3	20.9	15.2	30.5	25.9	8.8	10.7	22.9	10.7	12.8	4.3	24.7	53.3	21.4	20.9	15.6	12.4	20.1	26.0	10.8	16.1	8.7	9.8	14.5	10.0	21.9	31.9	38.5	6.5	13.4	28.8	48.6	21.7	13.6	32.0	28.5	13.4	31.0	9.8	21.0	22.4	22.5	11.3	19.4	23.9	7.3	21.0	22.7	15.3	33.2	19.0	23.7	22.7	55.5	27.7	28.8	16.6	29.2	13.6	0.0	0.8	0.6	0.6	0.8	0.4	0.7	0.5	0.6	0.4	1.0	0.5	0.7	1.5	1.0	0.5	0.8	0.2	0.4	17.9	17.8	16.8	19.0	14.8	15.2	17.3	17.3	17.1	15.1	17.3	19.9	15.4	25.6	18.1	11.1	27.0	38.6	37.2	22.7	22.2	52.9	23.5	16.5	14.4	24.3	14.5	20.2	77.2	28.3	27.8	31.1	13.7	22.8	4.8	16.2	20.3	19.5	36.5	23.6	9.9	19.0	31.1	18.5	16.3	24.8	10.8	33.3	21.4	22.2	18.6	57.2	11.0	24.0	32.6	22.2	17.1	11.7	28.9	20.5	32.0	6.5	25.3	23.9	46.4	9.0	15.0	25.7	20.8	12.4	30.4	39.8	38.7	18.4	15.3	65.7	32.9	30.2	22.1	17.7	36.4	22.7	42.6	49.3	30.3	30.3	27.6	33.2
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 31.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	4.9	3.9	5.1	6.4	4.4	5.8	6.0	9.4	7.7	7.8	0.0	6.0	5.3	9.3	3.6	8.5	7.2	4.5	5.5	6.4	4.8	5.0	4.5	6.2	7.3	2.7	2.0	8.6	6.4	8.0	3.9	7.1	3.6	7.3	5.3	4.1	7.3	6.3	11.1	8.5	5.5	7.6	2.7	6.3	5.8	7.5	3.1	9.6	5.5	10.2	9.8	7.1	6.7	5.6	8.1	9.0	16.8	14.7	9.9	11.9	11.1	9.0	7.9	10.2	10.7	12.6	5.8	16.7	6.4	23.2	14.6	19.7	17.4	18.0	12.4	12.4	14.3	21.8	8.5	12.9	7.9	22.9	10.1	7.6	20.5	10.7	9.6	15.8	13.5	12.4	56.1	18.8	11.0	8.3	15.6	11.9	10.3	5.8	13.8	16.9	15.6	13.3	9.0	5.8	9.7	8.5	17.0	17.8	1.5	14.7	7.4	27.6	13.0	12.4	15.9	11.7	43.3	10.8	9.3	15.3	14.6	23.2	13.2	31.5	4.0	2.7	5.2	3.2	9.3	6.7	7.5	4.8	4.9	9.1	5.2	5.2	0.2	4.1	1.9	6.1	5.7	3.0	5.1	4.4	9.4	7.7	6.4	4.8	2.7	2.0	3.6	2.7	3.1	5.6	19.9	19.2	12.2	32.7	20.8	9.8	10.5	9.7	30.7	18.5	13.3	16.8	20.9	10.0	14.9	14.7	22.9	20.6	17.0	7.1	3.9	9.7	5.5	35.3	55.4	14.5	15.4	12.8	66.1	7.5	11.5	16.1	15.8	39.4	3.8	35.3	6.1	8.3	7.3	23.5	64.5	9.3	6.1	8.2	6.4	4.4	11.5	15.3	0.0	45.9	18.8	14.9	10.3	87.4	57.1	12.5	8.1	12.4	18.2	13.6	9.3	6.9	10.6	29.8	6.6	21.8	19.4	14.7	25.7	28.1	11.8	33.1	25.2	8.1	11.7	16.7
MFAP1	AMP	ENSG00000140259	"Microfibril associated protein 1"	P55081	15	43804492-43824690	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015583, HPA042370"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Centrosome	"HPA015583: , HPA042370: AB_10796904"	"unprognostic (1.05e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (1.04e-9)"	"unprognostic (1.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.54e-2)"	15.9	24.0	17.5	17.6	18.0	12.9	21.4	21.3	23.2	16.6	19.7	17.1	14.5	18.8	23.4	22.2	18.4	14.9	22.1	17.7	19.3	23.7	18.1	15.2	26.6	18.3	19.3	24.8	15.3	33.2	14.5	23.2	18.7	22.8	18.1	25.0	17.0	17.7	26.3	20.5	15.0	19.1	17.7	17.1	16.8	19.3	18.5	24.4	24.7	23.2	32.4	20.6	17.5	19.1	40.1	41.0	69.4	46.0	57.9	36.3	42.7	63.1	43.8	50.3	58.2	64.1	25.6	42.8	58.7	39.4	50.9	70.8	62.5	51.7	58.9	72.9	37.6	103.7	71.6	48.5	45.4	62.3	53.2	34.1	55.3	48.0	43.3	48.0	49.8	48.3	95.8	35.7	60.9	30.0	51.1	47.0	49.2	74.2	35.4	73.9	69.6	27.6	52.0	59.0	43.8	43.0	55.6	47.0	27.0	55.2	70.7	39.5	47.4	50.6	35.8	56.3	51.7	43.5	112.2	91.8	42.5	58.4	37.9	42.5	25.5	56.9	35.3	34.8	34.7	35.0	35.1	33.6	32.6	28.3	35.7	35.0	22.6	50.5	29.1	26.8	44.1	26.3	17.5	18.0	21.3	23.2	17.7	19.3	18.3	19.3	18.7	17.7	18.5	19.1	30.4	35.3	30.2	5.2	32.8	30.3	59.6	50.1	35.9	41.8	22.4	28.8	31.0	25.8	43.2	51.5	6.2	94.6	33.2	27.4	56.7	44.2	6.2	43.1	39.9	35.6	11.3	32.0	9.0	29.4	55.0	29.8	21.4	39.4	46.3	37.6	20.7	18.8	35.4	32.0	8.6	24.4	38.7	20.7	20.5	6.3	28.0	25.5	26.6	5.6	30.6	51.5	33.0	2.0	8.2	26.8	27.1	35.7	20.6	39.3	22.1	42.9	60.0	35.2	19.7	35.9	41.7	49.7	84.8	28.1	27.7	147.4	33.6	39.4	21.3	50.6
MFHAS1	"LRRC65, MASL1, ROCO4"	ENSG00000147324	"Malignant fibrous histiocytoma amplified sequence 1"	Q9Y4C4	8	8783354-8893630	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Signal transduction inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.4;Glandular and luminal cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 128.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051213, HPA054471"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA051213: AB_2681391, HPA054471: AB_2682498"	"unprognostic (1.33e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.23e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.01e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-1)"	5.8	2.0	7.3	7.9	6.9	11.9	3.6	7.5	8.7	6.3	4.1	12.8	6.1	5.1	3.3	5.3	6.6	5.5	6.6	8.3	6.4	13.5	6.0	9.9	10.4	6.1	7.4	3.4	4.6	5.7	2.0	8.8	6.5	5.3	11.4	5.4	3.4	4.4	2.4	6.1	7.0	8.2	6.5	11.1	6.3	6.0	9.0	9.0	5.4	2.7	8.6	9.2	3.5	6.2	19.5	14.4	8.6	6.6	8.0	10.1	28.3	7.9	17.0	5.6	7.6	23.3	3.7	28.5	9.5	7.6	16.2	6.5	9.1	7.3	4.9	37.0	8.1	2.1	5.3	15.1	9.5	8.2	2.9	5.5	15.0	7.6	7.5	6.0	12.5	34.8	13.4	0.0	4.7	7.0	128.0	7.2	16.8	25.8	6.1	17.4	13.1	4.4	39.3	20.0	13.6	11.0	4.6	7.2	12.7	14.6	4.9	11.1	5.3	6.8	10.1	27.3	15.4	1.5	6.9	21.7	12.6	10.8	4.2	0.0	0.1	0.0	0.9	0.0	0.7	0.4	1.3	0.8	0.2	0.3	0.6	0.5	0.0	0.1	0.0	0.0	1.2	0.3	7.3	6.9	7.5	8.7	8.3	6.4	6.1	7.4	6.5	6.5	9.0	6.2	10.7	54.5	43.9	105.4	6.5	37.5	24.5	6.0	2.8	19.0	6.2	3.2	17.2	20.0	16.5	31.3	4.2	3.7	6.5	30.9	13.7	12.0	2.5	50.8	20.3	19.2	18.8	71.4	46.9	15.4	3.2	17.8	8.2	119.2	22.2	5.4	25.4	17.8	31.8	3.3	56.8	29.3	10.2	27.5	21.0	3.4	11.5	13.0	10.6	61.8	8.0	24.3	14.4	38.2	6.2	28.5	20.7	8.2	2.1	47.5	6.7	16.5	5.4	8.1	0.0	4.5	24.1	1.9	21.7	2.4	50.0	2.3	24.0	1.7	36.3	16.9
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227060	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 18.5"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 9.0;SuSa: 1.9;U-698: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005662			Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.1	0.1	0.3	1.0	0.2	0.2	0.2	1.2	0.3	0.1	0.2	0.7	1.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	2.4	0.3	0.2	0.2	0.1	0.6	0.0	0.2	0.3	0.1	0.6	0.1	0.2	0.2	0.0	0.2	0.7	0.1	0.1	1.0	0.8	0.4	0.2	0.2	0.1	0.0	3.4	0.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.1	0.2	9.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	49.7	6.5	13.0	6.4	10.0	12.6	11.3	7.3	7.3	7.2	10.4	9.6	9.7	18.2	19.6	19.5	11.0	10.3	6.2	0.3	0.2	1.2	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.4	0.6	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.1	0.1	0.0	0.5	0.0	0.3	0.1	0.1	1.5	0.0	0.0	0.3	0.1	0.1	0.0	0.1
MYO1B	myr1	ENSG00000128641	"Myosin IB"	O43795	2	191245185-191425389	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 255.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 330.2;Hepatocytes: 414.2;Sertoli cells: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013607, HPA060144"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA013607: AB_1854251, HPA060144: AB_2684211"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.85e-2)"	"unprognostic (4.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	42.9	7.3	9.2	15.4	7.8	0.6	27.4	3.5	11.4	13.3	5.8	23.7	13.2	16.2	16.6	15.9	9.2	26.7	19.1	7.1	5.3	25.6	255.5	74.9	11.3	4.2	8.9	14.0	49.3	34.6	5.8	48.4	6.0	15.1	22.0	21.5	12.8	17.7	9.2	15.3	13.4	20.1	3.9	8.2	12.2	9.6	13.2	17.4	19.3	13.6	10.5	25.4	14.3	6.7	102.5	51.7	82.6	24.9	22.4	95.0	74.6	190.8	93.9	129.0	127.4	63.9	8.9	0.1	31.0	220.5	52.1	221.0	27.4	164.3	161.1	0.3	23.9	0.2	22.6	82.3	52.1	2.2	0.6	38.6	111.1	135.0	360.0	47.6	23.8	42.4	0.2	0.4	120.7	43.5	39.7	12.4	53.9	6.7	81.2	50.5	52.6	7.7	51.0	42.8	41.8	109.0	64.5	11.1	57.9	70.2	10.1	3.1	29.1	122.7	61.5	75.0	22.7	0.9	0.5	1.1	74.4	0.4	69.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	7.8	3.5	11.4	7.1	5.3	4.2	8.9	6.0	3.9	13.2	6.7	95.8	330.2	112.5	1.6	3.6	76.7	58.2	78.7	31.9	1.4	29.0	22.9	7.9	45.8	84.3	69.9	0.0	5.2	0.8	30.4	0.0	120.4	2.9	13.0	20.2	60.5	58.5	10.7	22.3	44.6	26.5	40.3	18.3	18.1	3.8	129.1	5.0	414.2	4.2	0.0	38.0	24.6	34.6	10.5	10.0	3.8	5.0	2.3	26.6	70.3	1.0	72.2	0.0	1.0	0.8	38.1	54.1	9.1	0.4	112.2	4.5	1.2	48.2	2.7	203.8	32.6	160.1	2.4	21.0	13.9	28.1	3.4	3.3	44.9	38.0	47.1
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"NEDD4 like E3 ubiquitin protein ligase"	Q96PU5	18	58044226-58401540	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 253.2;Excitatory neurons: 280.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 29.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 5.1"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 146.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	11.2	16.8	20.9	6.7	34.4	27.0	25.8	25.1	31.3	7.6	0.7	38.8	18.7	5.3	10.0	12.0	9.1	9.5	26.9	32.3	16.2	53.4	36.5	47.9	4.1	10.9	18.4	6.4	60.5	13.6	28.4	12.0	10.4	64.2	42.8	20.5	27.5	20.4	34.0	11.2	33.8	6.2	8.6	7.9	51.5	7.8	16.7	4.5	17.4	13.1	7.9	19.4	5.9	16.3	70.7	24.5	14.6	20.9	5.1	2.1	49.8	19.2	88.2	48.6	74.6	28.6	37.1	15.1	57.7	7.4	51.3	50.3	19.5	86.1	100.8	34.9	15.5	10.6	14.3	111.3	2.4	0.5	6.0	13.0	54.6	66.4	78.8	39.1	4.0	13.2	18.7	6.3	20.0	16.2	1.0	1.0	12.2	26.7	33.3	14.3	20.1	17.6	47.0	88.7	17.5	5.0	16.1	5.1	146.1	28.3	29.4	5.6	28.8	131.5	38.5	7.5	83.4	8.3	15.3	9.5	27.6	10.8	10.8	0.7	0.3	1.2	0.2	0.3	0.5	0.8	0.6	0.1	0.1	0.3	0.3	0.2	0.2	0.3	0.1	0.1	5.1	0.3	20.9	34.4	25.1	31.3	32.3	16.2	10.9	18.4	10.4	8.6	16.7	16.3	6.0	253.2	144.8	110.4	5.1	112.8	161.2	34.0	86.6	18.1	99.5	65.9	47.8	64.3	112.8	62.5	173.0	13.0	3.6	144.5	49.0	35.7	22.6	64.0	7.3	14.7	45.2	57.9	280.9	49.2	4.7	9.5	114.7	75.0	3.8	4.7	17.5	41.3	7.3	62.2	173.3	201.5	101.7	8.4	8.2	6.6	3.4	13.3	14.2	88.1	7.3	45.2	2.1	11.1	105.0	49.9	145.3	17.7	12.7	126.9	127.3	91.6	72.7	10.0	0.0	34.3	6.0	1.1	12.5	62.3	53.0	80.0	6.6	8.2	72.9	155.5
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787345	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 68.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA073029: AB_2732216, HPA073916: AB_2732245"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	9.5	27.8	29.2	5.9	28.8	2.3	9.5	27.7	27.9	13.1	23.8	8.6	2.8	9.5	12.5	6.9	15.0	5.7	14.6	29.6	35.6	12.8	16.3	7.4	7.1	32.0	34.3	11.1	11.2	9.0	17.9	6.4	36.8	11.3	4.8	13.4	10.0	8.1	24.5	15.8	6.8	8.5	31.9	12.4	6.9	26.1	36.1	4.7	11.8	13.7	6.9	9.8	8.8	28.3	8.2	22.9	14.1	27.7	6.6	12.2	6.3	13.0	10.6	12.2	8.4	7.1	8.8	3.2	4.9	15.7	26.3	7.1	13.5	14.1	16.7	9.7	6.7	11.3	5.7	13.9	5.3	5.0	8.2	10.8	20.7	10.7	9.9	11.8	11.6	3.7	16.1	10.8	15.0	8.6	0.9	5.2	12.6	33.9	12.1	14.4	18.1	8.8	14.4	12.3	21.5	17.0	10.2	5.3	19.1	11.2	8.4	0.7	14.3	13.9	19.8	3.8	18.4	10.0	22.3	5.7	36.6	16.7	28.8	0.7	2.2	0.2	12.7	3.9	17.5	21.9	12.9	15.3	4.6	16.9	18.7	16.8	1.3	15.1	2.0	8.3	9.3	7.0	29.2	28.8	27.7	27.9	29.6	35.6	32.0	34.3	36.8	31.9	36.1	28.3	7.2	0.0	5.8	6.2	14.0	8.5	17.1	8.0	13.6	32.3	13.1	7.7	19.6	14.3	7.0	7.3	16.7	18.6	5.6	1.5	33.2	21.1	1.1	6.9	8.4	8.9	10.1	10.3	6.3	23.3	15.8	10.3	3.1	3.8	2.5	14.9	7.9	23.6	15.1	8.4	6.9	6.1	14.2	6.9	6.6	2.1	14.0	6.8	14.2	0.0	6.6	38.9	11.3	6.0	3.7	15.1	1.0	24.5	3.8	15.3	0.8	32.2	6.8	17.1	6.6	11.8	10.2	19.0	68.1	8.3	12.8	5.3	9.7	8.9	6.2	12.0
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 105.5;choroid plexus: 59.5;fallopian tube: 60.1;retina: 85.2"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 652.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Group enriched"	"Detected in many"	15	"amygdala: 48.9;basal ganglia: 60.0;cerebral cortex: 105.5;hippocampal formation: 89.6;white matter: 42.0"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 70.4;naive CD8 T-cell: 111.1"	"Lineage enriched"	"Detected in many"	10	"T-cells: 111.1"	"Cell line enhanced"	"Detected in some"		"AF22: 104.6;HEK 293: 27.5;NTERA-2: 41.2;SCLC-21H: 75.6;U-266/70: 27.5;U-266/84: 29.5;U-698: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		6400000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	4.6	16.9	48.9	10.9	60.0	7.3	1.9	1.3	105.5	23.1	59.5	2.0	26.3	2.2	0.4	1.2	60.1	1.9	0.4	89.6	4.5	1.2	1.0	5.0	20.7	0.0	0.0	0.8	0.9	0.2	34.6	0.3	0.0	27.2	2.1	85.2	1.4	2.0	0.3	13.4	15.3	2.8	0.0	6.2	2.9	3.0	0.8	8.7	6.5	0.6	15.7	4.1	4.2	42.0	0.3	0.1	104.6	3.5	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	8.3	12.4	0.0	0.0	0.2	25.3	0.2	0.0	0.0	27.5	0.4	8.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	1.6	0.2	0.4	0.0	0.4	0.2	0.4	41.2	0.0	14.0	0.2	12.7	0.2	0.0	0.0	75.6	1.8	0.0	0.4	0.0	1.3	0.1	0.7	0.0	0.4	3.8	0.1	2.1	27.5	29.5	40.3	0.2	0.2	0.4	0.2	0.2	0.0	5.0	0.1	24.9	0.2	30.3	52.9	0.1	0.1	70.4	111.1	0.5	11.0	0.1	0.1	0.4	26.7	48.9	60.0	1.3	105.5	89.6	4.5	0.0	0.0	0.0	0.0	0.8	42.0	0.3	0.0	1.3	48.0	1.0	1.1	0.0	0.0	5.7	35.4	0.4	0.6	0.5	2.8	6.2	0.0	33.3	0.1	2.5	5.8	0.0	0.0	0.4	0.7	0.8	0.7	0.0	0.0	652.4	0.2	0.3	3.7	0.0	0.3	0.0	49.4	0.0	0.0	0.1	1.7	108.4	0.9	0.0	0.0	1.5	1.0	0.0	0.4	0.0	18.7	1.3	7.9	1.0	74.4	16.5	0.4	0.4	0.4	0.5	0.3	18.5	0.2	21.9	58.3	0.0	4.1	4.6	1.9	4.2	0.2	1.1	0.1	23.4	0.1	2.9	0.1
NETO1	"BCTL1, BTCL1"	ENSG00000166342	"Neuropilin and tolloid like 1"	Q8TDF5	18	72742314-72868146	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 21.9;retina: 34.6"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 206.4;Excitatory neurons: 307.1;Inhibitory neurons: 345.9;Oligodendrocyte precursor cells: 172.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Group enriched"	"Detected in many"	41	"amygdala: 6.6;basal ganglia: 12.4;cerebral cortex: 21.9;hippocampal formation: 17.5;white matter: 16.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 21.9;REH: 20.6;RPMI-8226: 32.7;RT4: 24.7;SCLC-21H: 26.9;U-2 OS: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064630			Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA064630: AB_2685305"	"unprognostic (4.02e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.35e-5)"	"unprognostic (4.05e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.13e-3)"	1.2	0.0	6.6	0.3	12.4	0.1	1.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	17.5	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	34.6	0.2	0.0	0.0	0.3	0.5	0.0	0.0	3.1	0.2	0.8	0.2	0.4	0.6	0.0	1.2	0.1	0.0	16.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	8.7	0.0	0.0	20.6	0.0	32.7	4.0	24.7	26.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	12.4	0.0	21.9	17.5	0.0	0.3	0.0	0.3	0.0	0.2	16.3	2.0	0.0	0.0	16.6	6.1	0.0	0.0	0.0	0.0	206.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	307.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	17.8	0.0	2.2	0.0	172.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NIPA1	"MGC35570, SLC57A1, SPG6"	ENSG00000170113	"NIPA magnesium transporter 1"	Q7RTP0	15	22773063-22829789	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 36.2;Inhibitory neurons: 33.8;Oligodendrocytes: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023269	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA023269: AB_1854485"	"unprognostic (1.64e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.32e-2)"	"unprognostic (6.95e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.66e-2)"	3.1	4.2	27.7	3.7	36.9	1.2	2.8	36.8	38.1	3.7	17.9	4.6	6.5	2.2	2.1	4.3	2.5	4.8	3.5	22.8	28.7	6.2	5.7	4.7	5.3	35.4	36.9	1.5	5.7	8.7	3.6	3.5	33.8	6.7	4.3	6.2	3.6	3.4	2.5	4.9	6.6	2.6	36.1	4.2	6.4	4.3	36.0	8.2	7.3	3.5	5.5	3.2	3.5	40.2	14.9	17.4	5.4	12.4	6.9	5.6	3.8	17.6	12.7	8.5	7.1	13.3	7.4	6.9	13.5	7.3	17.4	9.7	16.0	4.6	10.1	40.2	9.8	10.8	10.8	11.4	8.3	0.1	20.8	1.7	15.2	5.5	9.2	13.6	8.2	15.2	8.4	11.3	4.8	5.6	5.9	9.7	5.9	15.9	18.2	12.1	7.7	5.4	13.0	14.9	15.2	15.4	13.2	1.6	16.7	7.0	10.3	13.8	15.4	23.9	12.2	10.1	27.2	12.7	13.6	12.4	12.3	0.0	15.6	0.4	0.1	0.2	0.6	0.0	0.6	0.9	0.7	0.6	0.5	1.1	0.4	0.3	0.3	0.3	0.0	3.9	0.8	0.3	27.7	36.9	36.8	38.1	22.8	28.7	35.4	36.9	33.8	36.1	36.0	40.2	5.9	12.8	5.9	14.4	7.4	8.8	4.0	5.9	2.2	4.1	4.4	3.0	4.3	15.7	5.2	5.5	6.2	2.6	10.5	9.9	3.9	5.7	3.3	3.6	2.4	5.9	3.0	4.0	36.2	11.6	2.1	4.5	10.2	5.7	0.0	4.1	4.6	6.0	4.1	5.0	33.8	7.1	2.0	4.4	6.9	4.2	2.1	2.9	5.4	4.7	3.8	4.7	4.1	15.6	65.2	17.7	6.8	3.0	7.2	8.6	11.8	5.8	6.2	6.6	19.7	3.0	3.6	3.4	8.5	4.2	14.9	1.5	7.1	1.6	7.5	7.3
NLRP5	"CLR19.8, MATER, NALP5, PAN11, PYPAF8"	ENSG00000171487	"NLR family pyrin domain containing 5"	P59047	19	55999726-56061810	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	50	"parathyroid gland: 22.4"	"Cell type enhanced"	"Detected in some"		"Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"Karpas-707: 1.3;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047260, HPA056271"	Uncertain		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Vesicles	"HPA047260: , HPA056271: AB_2683083"	"unprognostic (9.67e-2)"			"unprognostic (2.22e-2)"								"unprognostic (5.03e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.72e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037726-48047221	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA038968: AB_10697402, HPA038969: AB_2676295"	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	12.2	13.0	7.1	10.1	7.2	18.0	16.4	8.6	8.3	12.9	6.9	20.2	20.8	9.7	13.8	16.3	11.6	9.0	11.0	6.9	8.5	17.2	14.1	9.2	7.5	7.2	7.7	8.6	9.4	8.2	9.4	12.6	7.8	15.1	22.1	10.3	12.1	10.0	11.9	8.7	16.3	10.5	6.8	5.5	13.0	10.7	7.6	10.7	13.4	18.7	10.3	12.9	10.3	7.8	47.5	28.4	52.4	23.1	21.2	30.3	37.8	37.7	35.8	41.3	39.7	42.1	45.2	34.6	20.7	30.3	36.7	54.3	51.3	56.1	63.4	18.3	41.8	34.1	28.0	46.2	19.8	52.0	31.2	20.9	35.3	33.3	46.7	18.4	45.3	34.5	30.7	13.5	67.2	23.2	40.5	48.4	83.0	72.8	32.2	27.6	33.8	22.7	46.2	35.8	31.4	33.1	25.6	43.8	30.3	44.7	22.5	38.7	23.0	28.5	34.7	36.2	53.3	6.9	12.5	43.6	14.8	40.1	47.4	1.6	4.8	3.5	2.9	6.9	2.9	3.1	4.6	3.6	4.9	2.6	5.3	5.8	1.0	2.8	4.8	3.7	3.4	2.7	7.1	7.2	8.6	8.3	6.9	8.5	7.2	7.7	7.8	6.8	7.6	7.8	12.0	12.8	15.7	0.7	14.7	16.6	34.6	18.1	19.9	9.2	14.0	11.6	12.5	12.8	20.7	7.3	2.1	36.2	12.6	30.4	49.0	17.3	16.7	45.7	20.4	15.1	8.4	10.5	3.9	17.6	79.4	12.8	18.3	39.5	9.5	8.7	7.5	17.4	16.8	38.7	3.1	23.5	26.4	7.8	10.5	9.3	16.8	11.4	10.6	1.9	10.3	10.8	6.2	0.5	3.0	16.4	18.3	12.4	16.8	41.9	18.9	40.8	13.6	9.0	0.0	9.5	17.1	8.9	34.4	34.9	20.5	38.0	13.2	15.3	31.9	42.0
OBI1	"C13orf7, FLJ13449, RNF219"	ENSG00000152193	"ORC ubiquitin ligase 1"	Q5W0B1	13	78614289-78659155	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034785, HPA034786"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034785: AB_10601496, HPA034786: AB_2674331"	"unprognostic (2.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (6.87e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-2)"	5.8	4.8	5.4	6.1	5.8	2.4	6.7	6.6	6.7	5.9	3.0	4.8	4.8	7.1	4.5	5.0	5.6	4.5	7.1	5.6	6.1	4.6	4.4	5.2	9.9	5.5	5.9	7.6	4.1	4.1	2.9	7.4	5.0	5.5	5.3	9.6	4.2	6.1	4.8	5.5	4.7	6.5	6.1	7.3	4.5	14.8	7.2	13.3	5.9	6.4	11.3	6.0	4.5	5.9	23.7	9.1	39.1	23.1	13.5	12.9	17.8	19.3	14.5	18.7	23.3	18.3	17.3	39.8	9.2	12.4	12.2	23.0	31.2	15.3	32.6	24.9	22.8	61.0	11.4	16.1	11.3	59.6	18.2	12.4	16.7	15.7	16.8	10.6	15.6	19.9	16.1	5.3	24.6	6.6	36.5	20.2	0.0	25.1	10.0	42.0	32.2	15.4	12.7	12.5	28.4	15.9	13.4	16.9	14.8	22.2	8.6	47.3	12.9	16.2	14.7	10.7	16.3	5.5	6.6	37.9	25.9	35.6	17.8	4.9	5.4	7.5	7.9	8.8	9.5	8.8	8.8	9.8	6.3	8.9	10.8	9.8	1.8	11.1	10.3	5.3	9.6	6.6	5.4	5.8	6.6	6.7	5.6	6.1	5.5	5.9	5.0	6.1	7.2	5.9	14.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	15.8	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	12.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.1	1.1	0.0	0.0	0.0
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563675-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	161	"testis: 16.1"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 19.3;Spermatogonia: 57.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 0.7;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 34.8;HMC-1: 55.3;U-266/84: 27.8"	"Not detected"	"Not detected"							"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	19.3	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301524	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.3;Microglial cells: 100.2;Oligodendrocyte precursor cells: 150.8;Oligodendrocytes: 77.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 33.3;JURKAT: 43.8;MOLT-4: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	11.6	3.0	8.1	4.3	7.8	18.6	7.7	27.9	5.9	6.7	5.4	7.0	11.0	6.7	2.5	4.4	6.3	10.0	2.9	5.6	6.6	9.2	2.8	6.7	4.0	8.8	10.9	15.0	28.6	1.9	2.7	3.1	9.3	4.7	3.9	15.1	7.7	3.5	2.4	5.9	9.2	3.3	8.0	6.8	14.4	10.0	10.4	19.1	4.1	3.8	2.0	10.6	5.7	9.2	0.1	3.1	8.8	0.0	4.8	7.2	0.2	1.2	4.2	0.9	0.1	0.2	0.7	0.2	4.2	2.5	0.0	0.9	6.9	0.0	0.4	2.3	2.4	7.9	13.0	0.0	4.1	1.1	33.3	4.5	0.4	0.0	0.0	4.8	1.6	43.8	6.0	0.1	0.9	0.0	39.5	0.4	14.5	0.1	1.2	19.2	0.5	1.8	3.6	15.4	17.5	0.0	0.8	0.1	10.2	5.5	0.0	6.3	0.5	2.6	4.4	0.8	4.4	0.7	0.1	1.0	4.6	5.4	2.6	0.9	1.9	2.4	0.3	1.0	0.5	0.1	0.3	0.2	1.3	0.4	0.2	0.1	5.6	0.3	0.8	0.3	0.0	0.7	8.1	7.8	27.9	5.9	5.6	6.6	8.8	10.9	9.3	8.0	10.4	9.2	13.9	0.0	10.0	114.3	7.7	14.3	10.4	1.7	9.6	30.7	7.1	7.7	2.7	8.6	6.7	12.9	29.2	0.1	11.8	15.0	3.9	5.9	3.7	23.7	14.5	18.0	7.2	5.5	13.5	14.1	0.1	13.5	34.1	21.2	5.7	5.7	17.5	1.0	1.2	21.9	22.1	7.9	2.0	19.7	14.0	5.7	17.1	20.3	17.8	100.2	22.9	9.7	10.3	150.8	77.5	9.1	6.0	18.0	5.6	7.8	12.4	10.1	8.8	19.7	13.1	5.4	22.0	2.0	24.0	4.7	18.3	0.1	6.2	5.6	3.1	12.6
PIWIL4	"FLJ36156, HIWI2, Miwi2"	ENSG00000134627	"Piwi like RNA-mediated gene silencing 4"	Q7Z3Z4	11	94543840-94621421	"Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.3"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 8.7;Spermatogonia: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"NB-4: 93.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036587, HPA036588, HPA057508"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Mitochondria"		"HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.80e-2)"	3.3	1.1	5.5	2.8	5.3	24.3	3.6	4.9	5.0	4.4	3.4	5.8	5.8	3.7	2.3	1.6	3.6	4.6	2.8	5.6	4.7	3.2	1.3	2.7	3.9	4.5	4.4	3.4	11.3	0.4	2.2	2.0	4.5	2.5	6.0	6.7	8.8	2.6	1.0	1.7	6.3	2.0	4.5	3.7	5.1	13.3	4.9	3.0	2.0	1.0	2.7	3.3	3.0	5.4	0.2	0.1	0.4	0.0	6.6	4.3	0.5	0.5	0.3	0.2	0.9	0.7	0.6	0.0	0.4	2.8	0.2	0.0	0.9	0.0	0.2	2.7	0.3	0.2	0.6	0.0	2.5	6.5	0.1	1.5	0.0	0.5	0.0	0.1	0.1	0.5	0.3	0.0	1.1	0.4	0.3	93.2	0.1	9.2	0.6	0.4	0.0	0.0	2.1	0.0	0.4	0.3	0.4	0.9	0.4	0.3	0.0	20.7	1.2	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	9.9	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	5.5	5.3	4.9	5.0	5.6	4.7	4.5	4.4	4.5	4.5	4.9	5.4	1.1	0.0	0.5	3.3	0.2	1.3	0.2	0.4	0.0	0.6	1.3	1.3	3.5	7.2	1.4	0.0	0.0	4.0	0.2	4.1	1.9	6.2	4.7	0.7	0.7	0.6	0.0	0.4	5.4	2.0	0.5	1.6	7.7	1.3	0.0	0.9	0.7	0.0	1.7	0.0	4.9	8.7	0.0	3.0	1.7	2.1	0.3	1.7	0.0	3.7	2.0	0.7	1.0	5.0	6.0	3.0	4.9	1.2	0.1	0.5	4.4	0.6	1.7	3.3	0.0	2.2	1.3	1.2	12.0	0.6	0.1	1.0	0.3	0.3	5.3	0.1
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291403	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"A549: 144.1;CAPAN-2: 154.6;OE19: 255.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055540, HPA058428"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA055540: AB_2682839, HPA058428: "	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	4.8	13.2	37.7	8.5	61.6	0.0	36.9	57.1	50.0	63.4	26.2	40.5	62.7	16.8	8.4	27.2	81.8	52.4	1.7	38.8	43.5	11.5	3.7	8.3	1.4	57.3	53.6	2.7	37.3	19.5	11.8	3.6	56.2	31.7	32.1	29.6	105.7	32.9	0.6	53.2	51.0	6.4	44.8	4.7	50.3	7.6	49.2	5.2	5.7	0.5	6.0	36.5	14.2	83.9	85.5	144.1	2.1	0.1	0.0	0.3	0.2	8.2	0.0	25.3	18.9	41.7	154.6	0.0	88.3	11.9	0.1	45.3	0.0	17.6	11.1	0.8	2.6	0.0	55.9	0.0	28.6	0.0	5.5	5.2	7.6	12.7	16.7	53.4	4.2	0.0	0.7	0.1	0.0	98.5	0.4	0.1	61.5	255.8	0.0	0.0	0.0	2.4	62.1	13.7	17.4	40.9	23.3	38.3	60.3	5.8	50.0	2.5	4.5	55.7	36.5	0.5	61.9	0.8	101.7	70.4	15.5	0.0	46.9	0.0	0.0	0.0	3.2	0.0	6.6	0.0	1.3	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	37.7	61.6	57.1	50.0	38.8	43.5	57.3	53.6	56.2	44.8	49.2	83.9	17.0	6.4	7.5	0.0	1.5	0.0	134.2	0.0	8.0	19.7	137.1	149.9	0.0	204.5	35.3	22.0	10.4	0.5	2.7	77.0	3.9	352.1	0.3	115.2	9.2	15.2	8.5	0.0	0.0	139.5	15.1	3.0	91.3	90.1	1.3	0.0	0.0	0.5	0.9	16.8	0.0	38.8	0.0	1.0	0.0	1.6	0.0	1.9	0.0	0.0	2.6	21.7	0.0	0.0	0.0	128.8	85.2	0.0	1.6	97.4	209.8	1.4	91.1	234.9	0.0	0.8	2.7	0.6	35.1	20.3	0.0	0.8	3.5	0.1	87.2	205.8
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;retina: 1.6;testis: 2.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 11.9;SH-SY5Y: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.0	0.4	5.2	0.0	5.8	0.0	0.0	0.1	6.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.5	0.0	0.0	0.0	0.0	1.3	3.9	0.0	0.4	0.0	0.2	0.0	2.8	0.0	0.1	1.6	0.0	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.0	7.1	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.9	0.0	0.0	0.0	0.5	0.1	0.4	21.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.8	0.1	6.6	6.1	4.5	1.3	3.9	2.8	2.0	7.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PMAIP1	"APR, NOXA"	ENSG00000141682	"Phorbol-12-myristate-13-acetate-induced protein 1"	Q13794	18	59899996-59904305	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 803.1;Endometrial ciliated cells: 463.6;Glandular and luminal cells: 529.8;Squamous epithelial cells: 474.5;Suprabasal keratinocytes: 691.2;Urothelial cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 169.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 169.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 207.5;U-138 MG: 202.1"									HPA051063	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA051063: AB_2681330"	"unprognostic (1.35e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.12e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.09e-1)"	2.0	0.7	2.8	8.0	2.7	88.1	3.9	2.6	5.1	6.5	3.0	2.5	3.7	5.4	0.2	13.7	2.9	8.0	0.9	2.6	2.8	2.3	2.1	3.8	14.7	2.8	2.7	0.7	1.2	14.8	16.7	13.4	3.0	3.6	3.4	2.0	3.6	1.3	1.5	24.1	3.9	1.9	2.7	4.6	2.5	3.1	3.7	12.1	2.1	1.5	14.2	17.3	7.9	2.4	26.6	17.4	5.2	1.6	8.8	69.0	19.8	125.4	84.1	71.5	70.7	1.7	32.5	104.6	17.0	23.5	207.5	38.4	21.0	11.8	70.4	33.7	154.5	19.4	26.0	4.6	87.6	67.1	28.2	28.7	30.8	93.8	48.5	26.1	24.0	46.7	26.7	17.5	24.1	2.6	53.8	20.1	151.7	2.7	32.7	54.1	28.8	39.1	41.9	24.2	39.7	32.7	6.1	3.2	71.5	56.1	5.3	54.6	90.6	202.1	54.0	10.3	141.4	2.8	0.3	92.1	16.8	37.6	48.5	169.8	16.7	103.6	10.9	26.2	9.6	33.8	5.0	6.8	12.1	25.0	4.1	5.9	53.5	6.3	32.1	10.2	25.2	15.1	2.8	2.7	2.6	5.1	2.6	2.8	2.8	2.7	3.0	2.7	3.7	2.4	29.2	32.1	25.7	0.7	175.3	803.1	316.2	236.4	415.4	0.2	111.8	82.0	4.7	12.8	129.6	3.7	2.1	120.3	125.3	141.1	0.0	54.7	0.8	463.6	48.8	48.5	133.4	5.5	0.0	67.0	14.7	32.9	168.2	529.8	31.8	11.8	7.9	0.5	89.5	0.0	0.0	146.8	181.0	37.2	363.3	1.1	0.9	140.6	74.7	7.5	142.4	0.3	34.0	0.0	0.2	100.1	123.6	1.2	63.1	265.7	94.7	0.5	101.5	0.7	0.0	10.8	32.0	0.3	19.8	474.5	691.2	315.2	117.0	19.8	122.2	569.2
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38043829-38046793	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.3;skin 1: 32.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 27.3;Breast myoepithelial cells: 39.1;Cone photoreceptor cells: 22.9;Suprabasal keratinocytes: 55.8"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1.8;head and neck cancer: 4.4;melanoma: 4.8;testis cancer: 1.3;urothelial cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 24.1;HDLM-2: 23.9;NTERA-2: 7.5;SCLC-21H: 5.7;SK-MEL-30: 28.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055980, HPA073824"			Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.2	1.5	2.3	0.2	7.0	0.0	0.3	0.9	10.3	0.2	0.1	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.1	9.7	1.9	0.0	0.0	0.0	1.0	1.4	2.6	0.1	0.1	0.2	0.0	0.0	1.3	0.2	0.0	0.3	0.3	0.1	0.9	32.6	0.0	0.0	0.6	0.1	0.1	0.8	2.0	0.3	0.0	0.5	1.0	0.8	0.3	2.5	0.0	0.0	24.1	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	23.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.7	0.0	0.1	0.0	28.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	7.0	0.9	10.3	9.7	1.9	1.4	2.6	1.3	0.6	2.0	2.5	12.2	0.0	0.0	2.3	8.3	27.3	2.9	1.4	20.5	7.8	9.9	39.1	5.2	0.0	0.2	0.0	22.9	0.2	13.4	13.8	0.0	0.0	0.2	0.5	2.3	1.9	1.8	2.7	6.4	0.0	0.1	5.2	7.1	1.4	0.0	0.5	0.0	0.0	0.3	1.7	1.1	11.0	0.0	0.0	1.3	0.0	0.3	4.3	7.2	1.0	0.0	14.0	0.0	0.5	0.2	0.0	0.1	0.0	2.7	0.7	0.3	0.1	0.0	21.1	0.0	8.5	7.2	0.2	4.1	20.2	55.8	0.1	5.2	8.3	5.7	3.2
PRDM14		ENSG00000147596	"PR/SET domain 14"	Q9GZV8	8	70051651-70071693	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	658	"testis cancer: 34.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	93	"NTERA-2: 49.4;SuSa: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019094, HPA057070"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"		"Cluster 5: NTERA-2 - Transcription"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA019094: AB_1855686, HPA057070: AB_2683327"					"unprognostic (5.86e-2)"					"unprognostic (9.32e-2)"			"unprognostic (6.14e-3)"	"unprognostic (1.37e-2)"	"unprognostic (8.62e-2)"			0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.6	0.4	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.4	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.6	0.4	0.1	0.0	0.3	0.1	0.3	0.0	0.2	0.8	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089241-123194266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.9;urinary bladder: 9.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Endometrial stromal cells: 6.5;Excitatory neurons: 7.9;Fibroblasts: 10.7;Late spermatids: 7.1;Oligodendrocytes: 11.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;HEK 293: 5.2;HEL: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	HPA030324	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	0.7	0.1	0.2	0.3	0.2	0.0	0.6	0.2	0.3	0.9	0.6	4.9	0.2	0.7	0.1	0.6	0.4	3.3	0.5	0.1	0.2	0.3	0.1	2.9	0.0	0.3	0.4	1.9	0.3	0.1	0.3	4.2	0.4	1.3	1.0	0.2	0.1	0.1	0.1	0.2	0.6	0.7	0.3	0.0	0.6	0.3	0.2	0.0	0.8	0.2	0.2	9.0	0.6	0.3	0.0	0.0	0.0	0.3	0.3	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.1	5.2	1.1	0.5	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.2	0.3	0.4	0.4	0.3	0.2	0.3	0.5	0.0	0.0	15.0	0.0	1.9	0.1	0.0	0.0	1.0	0.6	0.3	1.4	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.1	3.3	0.6	6.5	0.5	0.0	0.0	7.9	0.2	0.3	10.7	0.0	0.5	0.0	2.4	0.0	0.5	0.8	0.0	6.4	0.1	0.0	0.8	3.5	7.1	2.1	0.4	3.6	4.7	0.8	0.2	0.0	3.0	11.0	0.1	0.0	1.2	0.1	0.2	0.0	0.8	0.2	1.0	0.0	0.7	2.2	2.3	4.4	0.2	1.3	0.4	0.4	6.1	0.0	0.1
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827999	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.5;brain: 78.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.1;dendritic cells: 84.0;Kupffer cells: 104.7;Macrophages: 76.5;Microglial cells: 95.5;NK-cells: 90.6;Oligodendrocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 157.9;SK-BR-3: 162.2;T-47d: 145.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"		"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	14.8	10.6	32.8	37.4	56.4	52.5	15.0	43.2	47.2	12.3	1.2	7.0	6.3	4.0	1.4	6.4	4.7	13.0	6.7	32.1	42.0	4.8	5.2	26.8	36.6	52.1	52.0	2.5	5.3	6.9	7.6	11.7	53.8	4.8	6.0	3.9	5.3	3.4	6.6	3.5	12.7	7.7	43.5	42.9	8.8	6.0	45.3	9.8	9.4	8.6	21.8	12.3	3.2	78.1	2.3	6.1	78.4	0.0	1.3	5.7	27.2	2.7	3.5	11.2	2.8	0.4	0.3	16.4	49.5	7.2	21.4	1.0	4.1	0.2	7.5	3.7	2.0	2.4	8.8	0.0	4.6	9.0	51.1	6.3	0.0	25.7	0.0	7.6	68.4	7.2	0.2	0.6	14.8	157.9	0.2	24.7	3.1	8.1	6.4	24.1	22.8	9.8	0.5	0.0	16.5	2.4	14.7	162.2	17.8	4.4	145.0	67.4	77.2	4.5	15.6	0.2	4.6	0.9	3.5	20.1	72.4	17.8	24.3	4.5	1.9	2.2	3.7	2.2	2.2	1.5	2.0	3.2	1.6	1.4	0.3	1.1	9.2	1.8	2.0	1.3	7.3	2.0	32.8	56.4	43.2	47.2	32.1	42.0	52.1	52.0	53.8	43.5	45.3	78.1	43.2	3.2	6.6	87.1	35.4	2.5	0.3	0.4	1.2	0.3	40.0	21.5	3.7	2.8	2.6	1.8	8.4	0.7	84.0	0.9	0.0	0.2	3.5	3.5	4.7	24.5	1.2	14.1	13.3	1.2	4.4	10.3	4.1	6.2	1.3	0.7	20.7	1.9	32.1	0.0	4.6	1.8	0.0	104.7	28.2	2.9	0.9	76.5	8.8	95.5	47.1	19.4	90.6	49.3	190.2	0.1	1.0	0.4	23.3	0.7	0.3	0.2	4.5	0.7	0.0	18.1	3.3	2.2	11.6	0.4	2.4	9.3	63.9	41.2	4.5	0.7
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556124-151877125	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 143.0"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 208.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 178.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	27.1	7.7	21.7	12.8	20.3	8.1	18.4	16.7	22.8	16.2	11.1	25.8	24.4	19.8	14.3	16.2	17.9	12.8	143.0	23.7	21.1	22.5	36.1	14.2	11.6	19.3	17.4	10.9	10.9	9.2	9.5	16.1	19.7	25.3	18.9	2.9	15.0	19.5	15.0	13.5	26.2	16.5	15.8	17.6	26.7	12.8	18.5	7.9	16.6	21.7	9.8	47.9	17.5	19.6	46.6	13.6	9.1	10.6	36.4	28.6	14.4	21.5	19.5	22.7	22.3	8.6	52.5	0.0	34.0	28.9	178.2	13.9	5.7	22.4	30.0	15.8	6.2	11.5	1.8	0.9	60.8	8.5	11.4	16.5	49.7	21.8	21.0	34.1	40.2	14.9	4.1	5.6	66.2	17.2	3.5	6.7	9.7	18.8	37.5	5.6	6.9	9.7	39.2	10.9	38.5	6.7	10.7	19.9	10.0	22.9	4.0	13.6	52.8	5.0	4.3	2.8	13.1	3.5	5.1	0.0	63.5	29.8	45.9	26.2	9.3	10.9	5.3	7.0	4.1	9.6	4.9	4.8	6.5	4.0	4.8	7.3	11.1	4.4	6.4	6.0	2.9	5.3	21.7	20.3	16.7	22.8	23.7	21.1	19.3	17.4	19.7	15.8	18.5	19.6	19.2	6.4	19.8	37.5	24.8	10.6	39.9	25.0	19.9	22.3	20.6	14.5	122.3	8.6	22.9	46.0	8.4	3.9	43.8	29.5	64.6	14.1	49.3	75.1	16.9	20.4	13.1	3.8	208.5	22.7	31.2	24.9	21.9	98.1	22.2	4.6	18.9	76.8	17.7	3.3	85.2	34.5	105.8	57.2	48.2	35.8	7.5	50.9	16.0	73.1	62.9	14.7	37.0	39.2	4.4	27.5	21.9	7.9	23.4	45.7	77.7	19.7	14.2	6.1	13.1	6.9	27.3	4.0	32.3	12.8	10.9	50.6	27.3	5.0	28.0	45.2
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase receptor type J"	Q12913	11	47980558-48170841	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 167.5;Microglial cells: 189.3;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.5;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved				"Intracellular and membrane"	NA	NA		670000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA006026: AB_1078446"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.79e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.00e-1)"	6.0	3.2	10.2	20.5	13.8	29.5	6.1	6.9	14.9	6.2	18.5	10.2	9.4	2.4	7.8	1.9	4.1	7.1	2.7	10.0	12.7	13.9	11.9	10.0	15.5	9.7	11.7	1.6	6.1	15.8	10.1	7.6	12.4	7.9	8.7	8.1	10.1	7.0	2.4	4.2	14.5	5.9	6.0	23.3	14.6	2.3	18.5	7.0	19.6	2.7	11.0	6.9	2.1	14.7	7.6	28.3	12.1	7.0	1.9	4.1	4.2	7.5	5.5	12.9	9.2	2.0	40.8	6.9	51.8	19.1	19.6	6.0	19.0	2.0	14.9	46.6	5.4	1.9	34.9	2.8	12.1	2.7	41.5	3.2	0.6	3.8	1.0	31.7	7.8	0.5	2.6	4.4	4.7	17.0	0.1	17.3	9.7	25.7	4.4	1.6	1.6	4.0	52.6	11.1	7.9	2.5	20.2	12.0	19.4	8.9	13.0	20.3	25.7	9.9	10.8	20.5	23.4	1.1	1.7	11.4	11.7	8.0	37.3	0.7	1.1	2.8	1.6	2.0	1.0	0.8	0.9	1.2	0.8	0.5	0.7	0.9	9.5	1.0	4.7	1.5	1.0	0.8	10.2	13.8	6.9	14.9	10.0	12.7	9.7	11.7	12.4	6.0	18.5	14.7	1.5	9.6	16.7	43.1	11.3	0.3	9.8	0.8	0.6	13.6	8.3	4.1	3.7	17.2	13.0	38.6	6.2	1.9	32.7	35.5	0.0	7.4	5.5	13.5	2.2	4.5	12.6	3.2	81.0	5.0	0.6	4.0	22.4	22.9	13.9	2.5	5.0	15.6	30.0	10.1	167.5	10.1	2.0	74.2	5.7	8.2	0.3	40.2	1.8	189.3	36.0	10.3	21.6	239.8	167.7	11.8	28.0	0.4	12.9	25.3	37.6	13.5	4.9	1.3	0.0	3.3	4.9	0.2	4.8	0.5	0.3	1.9	22.0	2.3	7.6	8.2
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	1.6	1.6	66.0	1.2	64.2	0.0	4.0	57.2	88.4	1.8	21.5	4.4	0.6	0.1	0.8	7.9	0.3	0.7	1.3	64.0	64.1	0.1	0.1	1.2	0.0	60.9	62.9	0.7	2.7	0.0	2.3	0.2	62.4	1.0	1.1	19.0	3.4	0.7	0.1	31.9	1.0	1.3	63.7	1.0	13.8	0.3	58.6	0.2	0.1	0.3	2.6	0.9	2.3	72.4	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.0	64.2	57.2	88.4	64.0	64.1	60.9	62.9	62.4	63.7	58.6	72.4	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
RASEF	"FLJ31614, RAB45"	ENSG00000165105	"RAS and EF-hand domain containing"	Q8IZ41	9	82979590-83063177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 101.7;Gastric mucus-secreting cells: 356.8;Prostatic glandular cells: 106.4;Respiratory ciliated cells: 100.6;Urothelial cells: 107.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 53.2;RT4: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021431, HPA078596"	Approved		Uncertain	Microtubules		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Microtubules		"HPA021431: AB_1856087, HPA078596: "	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	1.1	1.6	16.2	2.8	15.4	3.6	17.6	21.2	21.9	2.9	18.0	15.2	6.3	2.7	10.2	7.1	6.3	12.6	1.1	13.9	9.2	5.3	2.4	8.2	1.5	10.0	6.3	1.5	23.1	5.3	3.9	3.4	9.8	15.2	15.2	5.1	15.3	3.8	1.9	3.8	8.6	1.1	1.0	1.5	41.0	4.0	9.8	3.4	25.9	0.0	3.5	13.8	2.3	24.7	14.0	15.5	1.8	1.5	0.3	0.5	5.6	1.0	0.2	1.6	3.9	8.7	16.9	2.3	13.7	0.4	11.0	16.3	0.3	0.4	1.9	1.4	17.3	1.9	11.9	2.2	0.2	1.7	1.6	0.3	6.7	7.6	0.2	2.1	0.1	2.4	2.5	16.8	0.2	27.2	2.3	1.8	10.5	53.2	6.1	2.5	4.8	6.0	18.0	38.5	5.6	8.3	2.8	26.8	1.1	6.7	22.9	2.0	2.6	2.6	14.6	2.1	1.7	11.3	10.1	1.4	5.8	1.0	3.0	6.5	2.0	1.9	3.7	1.4	3.5	3.9	3.5	2.9	1.1	5.3	3.8	3.3	9.8	3.6	1.6	3.8	2.9	0.7	16.2	15.4	21.2	21.9	13.9	9.2	10.0	6.3	9.8	1.0	9.8	24.7	0.7	76.9	101.7	0.3	1.1	0.8	5.4	7.9	4.0	1.1	61.3	21.1	0.6	42.9	59.7	9.2	4.2	5.5	0.5	61.8	7.9	35.4	0.6	39.7	7.9	4.5	3.6	0.8	1.0	37.4	10.3	5.7	356.8	88.2	22.1	0.4	0.7	1.7	0.8	0.0	0.6	85.7	48.8	0.0	0.4	2.1	0.3	4.2	1.8	4.7	1.6	0.1	0.0	0.0	0.2	46.2	40.0	0.0	1.5	106.4	10.4	8.3	100.6	1.3	0.0	0.7	2.8	0.5	4.8	28.2	0.9	7.5	3.1	1.2	35.7	107.7
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 124.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 124.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 145.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	33.1	22.9	13.8	43.3	9.3	17.3	14.9	7.1	9.5	19.4	33.0	106.6	21.1	23.9	15.1	36.8	13.2	29.3	44.3	7.6	9.2	6.9	10.9	32.5	37.0	11.4	20.5	19.6	13.1	3.3	4.6	39.6	13.6	33.0	42.0	1.5	35.6	48.7	45.0	6.8	26.3	60.1	11.4	47.6	34.5	13.5	22.1	15.4	6.5	13.1	33.2	50.3	14.1	13.4	28.1	30.9	9.6	18.6	10.2	14.7	58.3	11.9	61.8	15.8	18.6	22.3	28.9	43.6	24.8	8.6	19.0	12.1	29.6	12.5	19.0	35.5	11.3	28.6	13.0	25.5	27.9	30.5	19.3	10.0	10.7	36.2	26.7	46.1	68.0	20.7	15.4	21.0	18.7	26.5	20.2	19.9	21.4	65.8	18.8	32.5	30.9	18.4	20.8	33.6	21.7	22.7	20.0	3.8	145.5	23.0	17.3	19.0	98.7	12.8	15.6	13.5	13.1	19.5	22.0	28.0	15.4	26.2	37.8	19.6	16.6	12.5	13.2	17.7	11.1	14.1	19.4	14.9	9.1	10.1	19.1	20.3	124.1	12.0	17.7	8.4	22.1	2.8	13.8	9.3	7.1	9.5	7.6	9.2	11.4	20.5	13.6	11.4	22.1	13.4	30.7	3.2	15.4	4.2	32.7	16.3	15.0	5.5	2.8	0.0	12.4	13.7	56.5	30.0	8.9	5.5	0.0	35.5	39.0	67.4	0.0	12.4	0.3	14.4	4.1	31.2	26.4	16.4	8.7	21.2	19.1	14.5	20.9	28.3	6.3	4.7	20.7	4.6	24.1	0.0	16.2	15.8	2.0	69.9	149.3	0.8	2.5	55.7	48.0	49.6	72.7	2.8	32.0	3.5	4.8	24.0	14.5	14.3	9.8	25.5	13.3	1.7	3.9	0.2	13.1	9.2	27.0	0.6	19.3	5.9	11.9	19.7	30.7	1.6	20.7	21.1
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA049042: AB_2680610, HPA058085: AB_2683600"	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	6.3	8.2	4.7	7.2	5.3	9.5	7.9	6.4	6.4	7.8	2.7	7.0	7.1	8.1	7.5	7.0	7.5	6.1	6.4	5.7	5.3	12.4	11.0	6.6	11.3	3.4	3.8	9.5	8.2	9.4	6.1	6.5	3.8	6.9	8.0	9.8	7.6	6.9	8.7	8.5	6.7	7.1	4.3	9.3	6.7	6.1	4.5	13.2	9.8	9.9	12.8	7.5	5.2	6.4	16.3	16.9	16.0	19.0	21.8	12.5	17.3	15.2	12.9	19.0	18.8	17.9	19.1	25.3	11.3	11.1	15.5	18.2	26.9	10.1	22.4	21.6	14.5	21.2	16.4	14.6	14.1	26.9	16.6	10.1	12.9	17.6	15.0	12.7	15.4	17.9	41.6	25.2	16.0	15.0	26.1	11.3	26.1	14.2	27.9	22.9	33.9	31.6	13.2	11.7	25.0	20.1	21.3	22.3	19.2	19.0	24.2	14.9	11.8	15.6	16.6	23.1	20.2	12.2	18.3	30.6	13.9	16.5	24.5	22.0	4.9	7.9	8.0	6.4	8.5	7.8	7.4	8.1	5.4	6.2	7.1	8.7	11.6	8.2	8.3	6.0	8.1	3.5	4.7	5.3	6.4	6.4	5.7	5.3	3.4	3.8	3.8	4.3	4.5	6.4	14.7	19.2	12.2	11.4	31.0	26.9	9.7	5.9	15.9	14.5	18.9	14.6	7.1	8.6	13.4	22.0	29.2	9.1	25.2	15.8	9.8	12.1	7.3	13.1	14.0	13.2	12.1	23.1	19.9	11.6	10.7	13.5	9.7	21.0	13.9	25.6	17.2	21.8	10.9	16.8	15.7	14.0	10.2	15.6	25.9	3.2	12.8	17.9	19.6	8.4	15.6	12.6	15.5	14.6	21.2	13.6	9.8	16.1	25.9	13.5	14.7	28.8	13.2	18.3	19.7	21.9	14.1	10.2	20.4	14.6	33.8	10.8	27.9	12.6	15.8	13.4
RBFOX3	"FOX-3, HRNBP3, NeuN"	ENSG00000167281	"RNA binding fox-1 homolog 3"	A6NFN3	17	79089345-79516148	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.2;intestine: 97.4;urinary bladder: 80.5"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 320.4;Inhibitory neurons: 163.9;Skeletal myocytes: 124.4"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 217.2;cerebral cortex: 118.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 16.1;NTERA-2: 14.2;SCLC-21H: 22.4;U-2 OS: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030790, HPA075862, CAB078782"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB078782: , HPA030790: AB_10602305, HPA075862: "	"unprognostic (2.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-15)"	"unprognostic (8.92e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-1)"	0.5	0.9	11.8	0.4	29.7	0.6	0.3	217.2	118.3	3.0	0.0	97.4	1.5	39.9	3.1	9.6	3.6	0.0	0.3	23.6	0.0	0.3	0.2	0.6	0.1	12.3	1.1	1.3	0.5	0.9	7.5	0.0	13.4	22.3	2.4	3.4	0.2	24.4	0.5	0.5	9.1	9.5	0.0	0.5	4.2	7.5	0.0	0.0	0.3	0.0	0.0	80.5	8.2	40.2	0.0	16.1	0.2	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	14.2	0.0	0.2	0.3	0.7	0.1	0.0	0.0	22.4	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	11.1	0.6	0.0	0.9	0.0	0.4	0.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.8	29.7	217.2	118.3	23.6	0.0	12.3	1.1	13.4	0.0	0.0	40.2	0.5	0.0	0.0	5.9	0.2	2.0	8.1	0.0	0.0	11.5	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	5.7	0.3	0.4	7.5	0.0	0.0	320.4	0.0	0.1	11.8	0.0	0.7	0.0	0.1	0.0	0.2	0.1	5.0	163.9	0.0	0.0	0.6	5.5	10.1	0.3	7.6	5.4	10.3	0.0	1.2	2.1	11.1	4.8	0.0	0.0	10.5	0.0	15.2	0.0	0.1	0.0	3.1	0.0	124.4	7.5	2.4	26.4	0.0	1.4	0.1	2.3	0.1	0.0	2.8
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 142.1;skeletal muscle: 313.0;tongue: 105.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	5.4	0.5	3.7	1.7	4.1	0.1	3.7	0.1	5.7	13.9	2.5	9.7	1.6	31.2	16.8	7.4	24.0	2.6	142.1	4.5	4.9	0.9	1.1	1.3	0.5	1.6	1.9	2.1	0.2	2.1	5.5	0.6	0.7	9.9	7.4	0.4	4.1	5.8	313.0	1.4	3.6	29.3	0.6	1.2	2.1	4.2	3.0	0.8	2.1	105.7	0.3	8.8	3.6	2.2	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.1	0.1	5.7	4.5	4.9	1.6	1.9	0.7	0.6	3.0	2.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	20.8	1.0	1.3	0.9	0.4	1.1	5.1	5.6	1.0	0.2	3.4	1.4	0.6	0.3	0.4	0.5	0.6	2.2	0.3	5.5	0.9	3.0	0.4	0.6	14.4	27.3	0.4	1.3	31.8	5.3	0.5	12.0	1.8	1.4	4.7	5.1	2.0	5.9	0.9	1.4	1.0	4.8	0.2	2.2	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	5.8	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	1.0	0.9	5.1	5.6	0.3	5.5	14.4	27.3	12.0	4.8	7.6	5.8	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932161	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.5;intestine: 2.2;pancreas: 2.3;stomach 1: 6.5"	"Cell type enriched"	"Detected in some"	14	"Enteroendocrine cells: 68.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favorable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.0	4.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.4	0.0
RGMA	RGM	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3;skeletal muscle: 199.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		2000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	30.2	3.2	62.1	22.5	73.8	0.4	30.3	72.5	59.1	55.9	7.7	79.4	9.9	50.9	2.9	57.4	39.9	7.7	29.4	60.4	68.0	3.6	0.6	4.6	2.4	126.3	113.9	38.5	11.4	0.8	6.9	1.3	70.4	12.8	6.2	1.0	24.2	6.4	199.1	17.1	42.9	60.6	91.5	1.3	73.6	33.5	120.6	2.6	10.0	45.0	3.4	10.0	29.2	62.8	2.1	0.3	50.0	0.8	10.3	5.7	14.6	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.2	0.4	0.0	3.4	8.4	0.2	0.0	0.0	9.2	0.1	0.3	0.0	0.0	0.1	0.2	6.1	0.2	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.0	1.0	15.5	0.2	22.2	0.1	0.0	13.1	11.4	0.1	0.0	0.5	5.1	3.0	0.5	0.2	0.0	2.6	4.0	2.7	0.0	0.1	10.4	0.3	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.1	73.8	72.5	59.1	60.4	68.0	126.3	113.9	70.4	91.5	120.6	62.8	4.2	0.0	1.5	143.3	0.5	5.5	20.4	10.2	40.5	1.9	7.5	4.4	4.4	0.0	3.9	0.0	2.1	4.4	0.5	0.3	0.0	6.5	1.2	0.6	10.9	2.7	0.0	0.4	16.8	0.7	1.2	40.5	1.5	2.3	0.0	0.6	1.8	0.3	2.1	0.0	2.8	0.0	12.2	2.5	2.3	6.4	119.0	1.6	3.6	9.4	0.6	4.5	0.0	11.1	1.6	0.4	0.0	116.9	0.1	61.3	0.0	0.1	1.3	1.2	13.1	69.3	20.3	0.9	43.8	58.3	2.8	2.5	1.4	0.1	0.1	29.2
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109051-120115913	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 15.1"	"Cell type enriched"	"Detected in some"	14	"Spermatogonia: 123.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 4.9"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.9"	"Cell line enhanced"	"Detected in single"		"HEK 293: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	1.7	1.2	2.3	0.1	2.3	0.1	1.4	3.7	3.4	1.5	2.7	1.7	0.0	0.8	0.0	0.5	2.4	0.2	0.6	2.3	2.7	1.8	0.9	0.5	0.3	2.7	2.7	3.5	0.3	0.1	1.7	0.0	2.7	1.4	0.0	2.5	0.6	0.2	0.2	1.2	1.0	0.1	2.4	1.3	0.7	15.1	2.6	0.2	1.1	0.0	0.1	1.0	0.8	2.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.9	0.0	2.3	2.3	3.7	3.4	2.3	2.7	2.7	2.7	2.7	2.4	2.6	2.7	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.0	1.3	0.3	0.5	1.3	0.0	0.0	0.0	4.2	0.1	0.2	0.1	1.9	0.2	1.5	0.2	0.1	0.5	0.0	0.0	0.8	0.4	0.4	0.2	0.0	0.1	0.0	8.3	0.0	0.2	0.1	0.0	1.5	0.3	0.0	0.0	0.0	3.8	0.6	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.1	0.0	0.1	2.4	1.3	0.0	0.0	0.3	3.3	123.8	0.0	0.3	0.0	0.2	0.7	0.2	0.0
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767089	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 72.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 52.3;Endometrial ciliated cells: 76.5;Gastric mucus-secreting cells: 61.2;Glandular and luminal cells: 174.2;Squamous epithelial cells: 71.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.2;GAMG: 41.2;HaCaT: 47.5;hTCEpi: 31.4;RPTEC TERT1: 28.3;RT4: 30.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA030942	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA030942: AB_2732462"	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.22e-5)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.6	0.0	0.1	0.4	0.0	0.6	4.3	0.0	0.1	11.8	3.7	3.1	9.7	1.1	2.4	72.2	5.8	5.2	1.5	0.1	0.1	11.5	19.1	4.2	0.1	0.3	0.6	0.1	14.3	7.4	10.8	2.3	0.1	10.7	2.0	0.6	14.8	9.8	0.0	21.5	13.6	0.1	0.1	0.0	15.5	2.0	0.1	7.8	7.9	0.0	5.2	6.3	22.3	0.1	14.3	9.0	0.0	0.0	0.0	0.0	13.7	0.1	0.1	0.2	0.2	23.5	32.2	0.0	13.3	2.9	41.2	47.5	0.7	19.2	0.0	0.0	9.4	0.0	6.9	8.8	0.0	0.0	0.0	0.0	31.4	0.2	4.2	0.0	0.0	14.3	0.0	0.0	0.0	10.3	2.0	0.0	0.8	9.3	26.1	0.0	0.0	2.3	28.3	30.8	4.5	0.3	15.5	15.7	15.1	1.3	9.6	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	4.2	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.6	0.1	0.1	0.1	0.1	0.1	28.9	9.1	0.0	0.1	15.8	27.4	24.0	52.3	0.0	13.0	12.4	1.1	17.2	28.0	3.7	0.0	8.3	0.3	22.8	9.8	12.4	1.5	76.5	16.9	0.9	22.7	0.0	0.0	10.4	5.1	0.6	61.2	174.2	2.5	0.0	0.0	17.0	1.0	0.0	0.0	14.2	16.2	0.6	1.4	1.6	0.0	0.9	7.2	0.0	0.0	0.4	0.0	0.0	0.0	19.0	11.8	0.0	0.0	24.0	26.5	13.5	22.2	0.9	0.0	0.0	1.3	1.4	2.5	71.2	15.2	2.5	1.5	0.0	11.2	24.1
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128"	Q8TEB7	X	106693794-106797016	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.1;liver: 124.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Cholangiocytes: 50.1;Distal enterocytes: 49.3;Gastric mucus-secreting cells: 54.6;Hepatocytes: 76.9;Proximal enterocytes: 85.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.9;CAPAN-2: 35.0;Hep G2: 30.6;OE19: 96.2;RPTEC TERT1: 30.5;RT4: 88.8;WM-115: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	0.7	35.0	2.6	1.8	2.4	0.0	7.9	1.9	2.4	0.6	0.8	21.8	62.1	0.1	0.5	4.6	1.0	33.1	0.5	2.5	4.2	31.5	124.6	14.7	0.2	2.7	2.2	2.0	16.4	0.7	6.6	11.1	3.3	2.8	19.6	0.1	28.6	2.1	8.9	6.9	60.8	0.6	1.6	0.1	46.9	0.6	4.3	2.8	29.4	4.1	0.2	20.0	2.0	1.6	11.1	0.0	0.0	0.0	3.4	1.8	41.9	0.1	0.3	0.0	0.0	18.8	35.0	0.0	0.0	0.6	0.4	13.3	0.1	0.0	0.0	0.0	20.6	0.0	0.3	30.6	0.0	0.0	0.0	0.1	14.4	0.0	0.1	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.4	96.2	0.3	0.0	0.1	0.1	30.5	88.8	0.2	0.0	0.0	2.3	2.2	0.3	2.3	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	15.1	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	1.9	2.4	2.5	4.2	2.7	2.2	3.3	1.6	4.3	1.6	0.1	67.3	19.6	6.2	0.5	6.8	6.6	13.1	10.2	0.0	9.7	4.2	0.5	50.1	15.0	33.1	0.0	23.4	0.1	49.3	0.0	14.7	0.1	0.0	0.0	0.3	24.7	2.7	17.9	15.6	3.3	0.3	54.6	0.0	0.0	0.1	1.8	76.9	1.9	0.0	19.6	33.3	2.0	2.7	0.4	0.2	0.0	0.4	3.6	3.7	0.0	0.0	0.0	25.1	13.8	25.6	23.6	0.0	0.0	1.9	85.4	25.3	8.7	0.0	0.0	0.0	1.3	0.0	2.0	11.5	5.3	16.6	0.2	0.5	28.7	8.5
RSPO2	MGC35555	ENSG00000147655	"R-spondin 2"	Q6UXX9	8	107899316-108083642	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	"Developmental protein, Heparin-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;intestine: 13.9;placenta: 17.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 75.3;Inhibitory neurons: 86.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;U-266/70: 4.2"	"Group enriched"	"Detected in many"	7	"amygdala: 7.9;cerebral cortex: 17.9;hippocampal formation: 21.3;white matter: 13.2"	"Group enriched"	"Detected in many"	4	"amygdala: 8.3;cerebral cortex: 7.7;hippocampal formation: 8.5;midbrain: 12.9;spinal cord: 7.7"	"HPA024764, CAB025900, HPA053068"	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031"	"unprognostic (1.10e-2)"		"unprognostic (2.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.33e-3)"		"unprognostic (1.82e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (1.40e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	0.2	0.0	2.8	0.7	4.4	0.1	0.0	1.3	16.2	3.4	2.6	13.9	3.4	0.0	1.7	5.9	0.0	3.2	0.2	6.6	13.2	0.0	0.4	7.1	0.0	2.6	23.0	0.3	0.0	0.0	2.9	17.3	2.0	8.7	7.8	0.3	0.0	2.3	0.0	0.0	4.6	0.3	2.1	0.0	7.6	0.7	3.5	0.0	0.0	0.0	0.0	1.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.4	1.3	16.2	6.6	13.2	2.6	23.0	2.0	2.1	3.5	6.6	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	75.3	0.0	0.3	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	86.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	4.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.0	1.7	0.0	0.0	1.0	0.0	0.2	0.0	0.0
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;kidney: 36.4;liver: 36.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Cone photoreceptor cells: 25.0;Endometrial stromal cells: 17.5;Glandular and luminal cells: 14.3;Hepatocytes: 30.1;Microglial cells: 26.2;Oligodendrocytes: 47.6;Proximal tubular cells: 20.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 29.5;BJ hTERT+: 25.3;NTERA-2: 48.0;RPTEC TERT1: 40.4;U-87 MG: 46.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 52.6"	"Low region specificity"	"Detected in all"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: AB_2680902, HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favorable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.3	0.0	18.0	0.6	29.2	0.1	0.3	29.7	21.3	19.6	2.1	2.6	1.0	17.4	0.0	0.3	11.0	0.4	0.8	17.9	21.7	36.4	36.5	0.0	0.0	41.0	32.2	4.5	1.0	6.5	6.5	3.9	36.6	0.8	2.6	4.6	0.2	1.6	0.0	0.2	1.3	8.4	31.1	0.0	2.5	1.7	26.6	0.1	23.7	0.2	0.0	2.8	7.2	40.2	0.0	1.7	29.5	0.2	0.8	0.6	0.0	10.0	25.3	0.6	1.4	0.0	0.0	0.0	11.2	14.1	8.8	0.0	18.6	0.0	0.9	0.0	11.3	0.0	0.0	18.5	0.7	0.0	8.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.8	1.9	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	46.2	0.0	10.0	0.2	0.6	0.5	0.1	0.4	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.3	0.0	0.3	0.4	0.2	0.3	18.0	29.2	29.7	21.3	17.9	21.7	41.0	32.2	36.6	31.1	26.6	40.2	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	1.4	10.0	0.0	9.2	25.0	0.0	0.0	0.0	11.7	0.5	0.7	8.9	17.5	0.9	0.0	2.7	0.2	0.0	0.0	1.6	0.0	14.3	0.0	0.0	0.7	30.1	0.1	0.0	8.2	0.0	0.0	1.0	0.3	0.1	0.0	0.4	0.0	26.2	0.0	0.5	0.0	5.0	47.6	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	1.0	0.0	0.0	0.5	0.2	2.3	0.0	0.1	0.0	0.3	0.6	0.0	0.1
SALL3	ZNF796	ENSG00000256463	"Spalt like transcription factor 3"	Q9BXA9	18	78980275-79002677	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.4;prostate: 6.0;vagina: 8.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Bipolar cells: 14.7;Cone photoreceptor cells: 47.9;Horizontal cells: 25.2;Oligodendrocyte precursor cells: 21.1"	"Cancer enriched"	"Detected in some"	6	"glioma: 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;HEK 293: 2.7;NTERA-2: 9.5;SuSa: 1.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 12.5"	"Low region specificity"	"Detected in many"			HPA016656	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"			"HPA016656: AB_1856546"	"unprognostic (3.96e-2)"	"unprognostic (3.41e-3)"			"unprognostic (8.16e-2)"	"unprognostic (1.87e-2)"		"unprognostic (2.37e-1)"	"unprognostic (4.23e-1)"			"unprognostic (2.12e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.86e-3)"		0.0	0.0	5.7	0.0	6.2	0.0	0.0	5.8	5.7	1.0	3.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	5.2	8.2	3.3	0.0	0.0	0.0	9.0	6.5	0.0	0.0	0.0	1.2	0.0	7.2	6.0	0.0	1.8	0.7	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	1.3	6.3	0.0	0.0	0.0	0.0	0.4	8.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.2	5.8	5.7	5.2	8.2	9.0	6.5	7.2	9.4	6.3	7.5	0.2	0.0	0.0	25.5	0.0	0.0	7.4	0.0	0.0	14.7	0.0	0.1	1.8	0.0	0.0	1.8	47.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	25.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	4.8	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	1.8	6.6	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 491.6;liver: 484.7;skin 1: 447.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 267.4;Hepatocytes: 603.1;Squamous epithelial cells: 246.6;Syncytiotrophoblasts: 250.8;Urothelial cells: 492.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	7	"midbrain: 17.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 482.2;hTCEpi: 436.6;U-251 MG: 470.0;U-266/70: 467.4;U-266/84: 1069.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	3100000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 22: Epithelial cell types - Mixed function"	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	2.4	17.4	0.7	17.2	0.2	1.2	23.8	2.3	0.8	127.2	0.7	61.8	75.8	2.2	19.9	491.6	10.5	77.1	0.6	0.3	2.0	99.5	484.7	59.6	7.3	0.6	17.3	1.6	16.6	5.4	2.0	32.6	0.8	56.3	33.3	0.7	85.8	25.9	1.6	447.4	53.6	2.2	0.2	20.1	87.3	3.3	2.5	5.1	18.3	0.0	43.2	104.8	242.1	0.1	252.6	137.6	42.7	108.1	11.6	1.6	134.9	68.7	65.4	62.7	52.8	29.5	148.9	0.3	24.8	48.8	34.8	241.4	19.0	482.2	41.8	1.3	12.5	0.0	12.2	150.2	10.3	11.0	1.0	6.4	436.6	56.5	132.9	87.2	6.9	0.0	6.4	94.7	34.0	149.6	0.6	2.6	38.7	189.6	263.1	5.3	15.7	189.9	80.5	370.0	12.4	99.7	51.9	342.4	15.2	17.1	34.5	2.8	10.7	246.9	78.6	9.2	470.0	467.4	1069.8	1.0	74.5	0.6	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	2.3	0.8	0.3	2.0	0.6	17.3	0.8	0.2	2.5	0.1	0.4	93.0	99.0	0.0	33.0	113.9	189.1	162.8	81.4	0.6	29.9	26.7	0.9	267.4	161.8	42.3	0.0	3.8	0.7	147.2	31.3	61.3	0.1	16.6	5.0	3.5	10.8	13.5	0.3	21.8	46.3	5.0	55.0	22.9	6.3	7.5	7.5	603.1	2.3	21.9	0.2	73.1	50.8	10.6	11.9	0.3	0.6	2.5	21.4	0.0	0.6	0.3	0.0	1.0	0.0	111.4	78.0	1.2	165.1	78.0	106.5	88.5	43.4	0.4	0.0	0.1	15.0	1.0	14.0	246.6	229.0	250.8	4.0	0.1	85.1	492.8
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 260.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.5;NK-cells: 92.7;Oligodendrocytes: 310.5;T-cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 133.2;HMC-1: 97.2;JURKAT: 89.1;MOLT-4: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved					NA	NA		7500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (2.94e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (4.06e-5)"	7.2	12.8	73.5	35.1	149.7	28.7	6.1	129.0	122.7	9.1	34.2	10.4	10.6	6.5	12.2	27.3	11.0	12.3	12.1	72.0	88.4	32.0	4.1	14.2	62.4	165.2	145.6	6.5	8.0	6.0	13.8	5.5	147.8	11.9	9.7	5.0	12.0	6.6	88.0	17.4	28.9	5.5	119.1	51.3	16.7	10.6	127.0	43.4	11.8	27.5	49.8	11.4	16.2	260.2	12.7	9.2	8.4	12.4	0.4	0.8	19.0	1.1	0.5	2.6	1.7	6.1	13.8	47.3	5.1	0.2	9.7	6.4	7.5	3.6	1.1	133.2	7.5	20.1	3.3	0.7	1.5	26.4	97.2	0.3	2.8	0.6	0.3	0.3	4.9	89.1	4.8	31.5	0.0	20.9	120.9	33.9	20.6	25.0	0.5	38.2	2.8	13.4	16.5	13.0	19.7	13.1	3.4	8.9	0.3	11.7	10.1	14.4	3.2	0.1	7.6	1.0	6.1	34.9	16.3	6.6	6.0	32.1	7.6	17.2	7.5	38.2	22.0	7.0	13.3	4.3	17.5	18.6	2.6	2.5	19.9	23.2	37.0	9.4	8.1	8.0	17.7	14.5	73.5	149.7	129.0	122.7	72.0	88.4	165.2	145.6	147.8	119.1	127.0	260.2	3.4	6.4	15.7	33.6	35.4	4.6	3.3	2.1	3.4	12.4	9.5	5.5	18.7	5.7	6.9	11.0	2.1	9.0	76.5	1.5	3.9	5.4	2.2	10.9	6.4	5.2	1.8	23.1	44.5	3.3	2.1	6.7	7.7	15.4	42.5	8.0	5.3	1.6	21.6	33.7	17.2	6.3	4.1	28.2	6.1	3.8	7.5	37.4	1.8	49.6	43.7	8.9	92.7	12.1	310.5	3.7	0.7	15.1	53.7	6.5	0.5	14.2	5.7	5.1	0.0	11.4	2.6	0.9	26.1	7.1	5.4	3.7	89.7	2.3	3.3	7.7
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243665-44312951	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.2;endometrium 1: 33.6;smooth muscle: 29.3"	"Cell type enriched"	"Detected in single"	6	"Endometrial stromal cells: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SiHa: 36.2;U-2197: 80.8;U-87 MG: 46.3;WM-115: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Vesicles, Cytosol"		"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	1.0	1.8	18.6	1.2	17.2	0.0	0.2	0.0	21.4	16.6	0.0	18.7	1.9	33.6	0.4	1.6	4.5	3.1	0.9	18.0	15.3	0.5	0.1	0.3	0.4	10.8	17.8	1.0	0.8	0.1	2.6	0.5	2.4	3.7	2.0	5.6	0.3	11.0	0.0	0.7	2.4	29.3	0.3	0.1	1.6	1.1	43.2	2.6	0.4	0.1	0.7	11.9	5.2	2.8	0.0	0.3	3.5	1.2	0.0	0.0	0.0	1.0	2.3	2.4	1.4	0.0	0.0	0.0	0.0	2.3	14.5	0.0	5.0	0.3	0.3	0.0	2.3	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.8	11.2	0.5	0.0	0.0	0.1	0.1	0.0	0.4	0.0	3.3	0.0	0.8	0.0	0.0	0.1	0.0	0.0	12.9	0.0	36.2	0.1	0.2	0.4	0.0	0.3	0.1	13.1	2.0	80.8	0.5	0.0	0.0	0.0	46.3	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	17.2	0.0	21.4	18.0	15.3	10.8	17.8	2.4	0.3	43.2	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SHQ1	"FLJ10539, Shq1p"	ENSG00000144736	"SHQ1, H/ACA ribonucleoprotein assembly factor"	Q6PI26	3	72749277-72861914	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042792	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA042792: AB_10959736"	"unprognostic (1.10e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.83e-4)"	"prognostic favorable (6.49e-4)"	"unprognostic (2.05e-1)"	"unprognostic (4.54e-3)"	"unprognostic (9.21e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.30e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	5.9	7.0	7.3	8.1	10.1	9.2	8.1	7.1	7.6	6.7	6.1	8.8	6.7	7.1	11.4	6.4	10.7	5.6	10.1	5.1	6.6	7.4	8.0	6.2	8.9	7.1	7.0	7.6	7.0	8.5	4.6	5.3	7.4	5.7	8.7	5.5	5.7	6.0	9.1	7.5	6.1	8.0	5.2	7.0	6.4	10.0	8.0	15.3	8.2	8.6	10.0	8.4	5.1	10.4	13.5	18.1	12.0	20.3	15.7	19.2	12.1	21.8	15.8	22.4	24.6	14.5	10.7	22.4	10.2	15.2	18.2	10.9	24.9	20.5	27.5	20.1	19.6	23.3	14.1	17.3	15.9	39.7	18.8	19.2	15.4	33.1	13.6	10.4	21.2	35.8	19.0	13.5	18.5	20.2	113.4	14.1	33.9	41.5	22.7	27.1	18.8	17.3	19.7	17.6	7.6	30.4	20.3	14.3	10.6	16.0	14.7	14.9	15.1	18.0	17.5	30.1	19.5	24.9	53.8	32.7	16.1	32.0	18.3	0.9	11.9	4.3	14.2	13.5	19.1	13.7	15.8	15.4	12.3	13.3	17.7	15.4	0.5	24.2	12.3	17.6	14.4	14.5	7.3	10.1	7.1	7.6	5.1	6.6	7.1	7.0	7.4	5.2	8.0	10.4	5.9	12.8	6.9	8.8	8.3	13.3	4.3	6.9	5.7	7.5	7.2	5.3	9.5	4.3	6.5	5.5	0.0	6.1	9.9	4.3	7.9	8.6	6.9	11.5	9.6	9.1	4.2	10.3	12.1	6.1	7.9	7.1	5.6	8.0	15.2	6.6	11.4	7.6	6.9	3.3	13.5	6.8	4.1	6.6	6.2	1.9	5.9	5.7	5.4	20.6	4.1	3.2	2.1	16.1	33.9	6.5	4.3	5.7	6.1	5.1	4.7	5.7	16.2	5.4	0.0	8.0	5.9	9.1	19.5	10.8	10.2	5.7	7.6	14.8	9.3	3.9
SIPA1L3	"KIAA0545, SPAR3"	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907208-38208369	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 28.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 93.7;Inhibitory neurons: 87.3;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 59.6"	"Low region specificity"	"Detected in all"							"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	2.2	3.0	6.0	6.6	3.0	2.9	5.1	10.4	16.2	4.8	2.6	10.6	18.4	3.3	1.3	4.9	4.8	3.9	6.2	28.9	2.0	6.4	3.4	5.7	6.8	4.2	4.1	2.9	9.7	3.3	3.2	1.4	3.5	5.3	7.0	5.0	8.4	3.5	6.5	11.1	18.1	1.8	1.6	7.3	9.1	4.3	5.6	3.8	10.0	7.3	5.5	4.3	3.6	5.5	34.4	59.6	7.3	9.3	4.3	4.3	4.9	14.5	12.2	9.4	8.8	20.6	19.5	19.5	12.2	12.4	7.9	7.6	6.7	27.1	10.4	6.7	3.3	5.3	5.5	6.5	8.3	3.7	5.5	3.3	14.1	17.5	37.3	13.9	10.8	5.6	3.9	4.1	16.6	10.6	5.0	5.1	6.0	27.2	15.8	10.8	5.9	2.9	20.7	29.1	17.3	9.3	16.0	27.1	2.2	3.9	18.0	3.5	23.2	15.6	5.5	48.4	22.6	5.4	10.0	6.6	20.1	4.9	20.6	0.1	0.1	0.4	0.1	0.2	0.0	1.1	0.1	0.2	0.1	1.5	0.1	0.5	0.1	0.3	1.5	0.3	0.1	0.1	6.0	3.0	10.4	16.2	28.9	2.0	4.2	4.1	3.5	1.6	5.6	5.5	4.8	6.4	10.1	41.4	24.5	12.0	5.2	10.4	6.2	21.9	22.6	12.1	5.2	22.8	10.8	23.9	14.6	2.1	9.3	93.7	3.9	7.2	4.5	19.8	4.8	5.4	25.2	10.8	61.1	15.3	1.4	3.7	40.2	16.5	2.5	4.8	6.4	23.5	3.5	33.7	87.3	46.3	20.3	5.1	13.9	9.2	2.1	8.3	5.4	50.6	7.1	3.0	5.2	99.5	58.7	13.4	38.7	1.9	12.8	6.6	50.0	21.1	19.1	5.7	6.6	4.5	3.6	1.7	5.1	8.9	16.1	0.8	5.1	1.7	30.4	5.6
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643421-60658259	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	5.5	0.4	0.3	0.0	0.5	0.0	1.9	0.5	1.2	15.2	1.0	0.0	0.0	0.0	0.4	1.1	0.8	0.5	0.0	0.3	0.3	0.0	0.0	1.5	0.5	0.3	0.4	0.2	0.3	47.8	19.8	0.0	0.4	13.2	0.0	0.0	51.1	0.2	119.4	0.3	0.0	0.0	0.3	0.0	0.4	1.7	0.5	9.7	1.9	46.3	0.2	1.6	0.8	0.4	15.2	3.5	0.6	28.1	17.0	20.6	0.4	4.1	10.6	4.9	4.0	0.0	8.2	0.0	2.2	0.6	2.1	4.4	10.3	6.4	2.1	0.0	17.1	2.0	1.9	6.8	0.0	0.0	0.2	15.6	4.9	2.3	0.7	36.3	0.3	1.6	5.8	0.0	142.2	2.8	0.0	0.5	0.0	0.0	8.9	0.0	71.9	0.0	5.9	16.3	2.5	0.3	5.0	0.3	6.1	0.5	3.3	0.4	13.9	6.7	5.4	7.9	6.5	0.5	0.1	0.0	1.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.2	0.3	0.3	0.3	0.4	0.4	0.3	0.5	0.4	0.8	3.2	1.5	0.0	0.0	0.1	30.7	30.8	0.6	0.0	1.0	0.8	0.9	0.0	33.9	1.8	0.0	0.2	0.0	0.1	1.9	0.0	0.2	1.1	0.1	1.6	0.0	0.0	0.0	0.8	0.4	5.7	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.6	0.0	0.3	0.0	1.9	0.0	0.8	0.0	1.0	0.1	0.2	0.0	1.2	0.0	27.4	0.0	0.1	67.1	0.2	0.0	77.3	5.1	0.0	25.0	0.1	0.1	0.3	0.1	0.1	0.0	18.3
SOX1		ENSG00000182968	"SRY-box transcription factor 1"	O00570	13	112067149-112071706	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 14.8"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 4.0;Melanocytes: 3.6;Spermatogonia: 2.4"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 0.9;glioma: 2.3;melanoma: 2.0"	"Region enhanced"	"Detected in all"		"thalamus: 14.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 29.3"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"						"unprognostic (1.12e-1)"		"unprognostic (4.95e-2)"	"unprognostic (1.71e-3)"			"unprognostic (6.03e-2)"	"unprognostic (6.41e-2)"				"unprognostic (4.85e-1)"	"unprognostic (5.93e-2)"			0.0	0.0	2.1	0.0	3.7	0.0	0.0	1.3	2.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.3	0.0	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.8	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.7	1.3	2.7	1.6	5.3	1.8	4.1	2.1	1.2	14.8	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 255.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		7400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.8	0.7	0.9	16.4	1.5	1.4	34.7	5.0	1.3	42.8	6.4	108.7	159.9	13.2	78.9	255.5	33.6	38.0	1.3	0.9	2.0	79.9	3.5	47.6	6.4	2.8	3.2	2.4	69.2	132.9	31.4	144.9	2.2	52.3	89.2	0.4	162.7	31.4	0.6	148.9	138.2	4.3	1.7	6.9	88.3	1.8	3.2	9.9	34.7	0.4	45.5	57.1	90.1	2.3	124.8	1.0	0.0	0.9	0.1	0.0	323.2	2.3	3.0	4.0	2.4	195.3	202.4	0.3	141.2	0.4	3.6	377.6	30.8	181.9	2.4	1.0	10.6	5.6	3.3	10.8	2.2	21.9	93.9	0.3	264.0	3.9	16.5	3.4	14.7	12.1	2.7	1.1	0.2	96.5	0.9	16.6	37.4	207.6	17.7	12.6	0.0	24.9	179.3	308.2	79.8	3.9	9.3	558.8	15.7	56.9	267.7	16.1	0.0	0.2	2.0	1.2	0.5	1.2	24.5	0.8	0.8	16.3	1.1	0.0	19.7	14.3	0.4	15.9	0.8	8.4	3.0	1.4	32.4	6.0	1.1	0.3	25.9	5.5	18.1	4.0	0.5	7.6	0.9	1.5	5.0	1.3	0.9	2.0	2.8	3.2	2.2	1.7	3.2	2.3	0.8	57.7	14.7	0.0	7.6	76.0	96.7	220.0	55.8	0.1	96.2	63.5	0.5	105.8	207.3	134.3	0.0	1254.0	1.4	477.6	25.4	429.4	0.8	63.3	14.2	6.9	147.3	4.8	0.5	255.1	105.1	10.4	106.5	155.6	10.2	1.9	0.4	0.5	135.4	0.0	0.5	169.4	221.8	10.0	23.8	1.1	3.7	19.8	14.2	0.0	68.6	0.0	0.0	0.0	0.0	309.8	375.2	0.0	2.1	135.7	514.5	44.2	46.6	0.3	0.0	0.1	12.6	0.6	5.9	93.2	87.9	1673.8	6.6	0.1	182.7	222.3
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 9.7;urinary bladder: 9.5"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 13.2;Pancreatic endocrine cells: 30.9;Smooth muscle cells: 10.4;Spermatogonia: 13.1;Urothelial cells: 48.6"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.9;hTEC/SVTERT24-B: 51.5;RT4: 89.2;TIME: 46.2;U-87 MG: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008"	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.05e-5)"	3.0	0.4	1.1	3.1	1.8	0.1	1.6	1.1	4.0	3.0	2.5	0.4	0.9	2.2	0.3	0.3	1.1	0.9	0.2	1.2	1.8	0.5	0.1	7.3	0.1	7.6	2.9	0.3	0.0	0.0	1.5	0.3	4.2	1.6	0.5	0.0	0.3	0.1	0.1	0.3	0.9	1.4	1.6	1.9	0.9	9.7	11.8	0.2	0.3	0.0	0.0	9.5	0.9	3.1	29.8	0.8	0.1	0.1	0.5	4.0	1.4	37.7	49.9	35.8	23.7	0.5	1.7	0.5	5.0	42.7	14.7	3.9	0.0	0.7	11.2	0.1	0.1	0.0	5.8	0.2	1.7	0.0	0.6	17.7	0.6	51.5	1.7	28.9	24.4	2.0	0.7	0.6	21.5	0.1	0.2	0.0	0.7	0.4	0.8	0.0	3.8	0.0	0.1	89.2	0.0	0.0	0.9	0.2	2.6	1.2	21.6	0.0	46.2	37.4	3.9	24.6	14.3	0.2	0.3	0.1	84.6	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.1	1.1	1.8	1.1	4.0	1.2	1.8	7.6	2.9	4.2	1.6	11.8	3.1	0.2	0.0	3.7	0.3	0.0	0.1	6.5	4.5	0.0	0.0	0.3	0.1	0.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.3	1.7	0.6	2.3	1.8	0.0	0.4	9.8	0.6	1.0	0.0	5.9	1.3	0.2	0.4	0.0	13.2	0.0	0.1	0.0	0.0	0.6	0.2	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	1.6	30.9	0.0	0.4	0.1	2.5	0.0	0.1	0.3	0.0	0.0	5.1	10.4	0.0	13.1	0.0	0.0	0.3	0.4	0.1	0.0	48.6
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.5;skeletal muscle: 123.9;tongue: 69.8"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 81.0;Excitatory neurons: 16.0;Horizontal cells: 16.8;Inhibitory neurons: 32.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 39.2;K-562: 47.8;U-937: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		NA	NA		7800000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	2.2	1.5	5.3	0.2	11.2	62.5	0.3	28.3	11.4	0.3	27.7	0.2	0.1	0.2	5.2	2.0	0.5	0.4	22.7	10.8	4.0	1.0	0.1	0.4	0.0	28.5	5.3	0.2	2.6	11.1	5.3	6.7	28.2	1.5	0.1	1.6	2.2	1.1	123.9	0.2	0.2	0.8	8.5	0.8	0.2	0.7	9.3	0.4	0.1	69.8	0.0	0.2	0.2	4.4	0.3	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.3	2.3	6.3	0.2	0.0	0.4	3.7	39.2	0.3	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	47.8	0.0	0.0	0.3	0.0	0.3	0.0	0.5	2.1	0.0	0.0	0.2	0.0	0.2	6.1	2.6	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	6.7	0.0	0.6	1.5	7.7	0.0	0.1	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.3	11.2	28.3	11.4	10.8	4.0	28.5	5.3	28.2	8.5	9.3	4.4	0.1	0.0	0.0	0.7	0.0	0.8	0.7	0.6	0.0	10.3	0.5	0.1	6.3	1.5	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.4	0.9	0.4	3.0	81.0	16.0	0.2	0.3	0.8	0.0	0.9	2.5	0.2	0.0	0.0	0.2	16.8	32.1	0.3	0.0	0.0	0.4	0.4	0.3	0.3	1.8	1.9	0.0	5.0	1.0	11.1	2.1	0.3	0.0	1.2	0.1	0.7	0.0	0.2	0.0	2.6	6.6	11.6	3.8	0.1	1.1	0.5	0.4	0.1	0.6	0.4	0.1	0.6
SUSD5	KIAA0527	ENSG00000173705	"Sushi domain containing 5"	O60279	3	33150043-33218810	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052788	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA		17000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus, Vesicles"		"HPA052788: AB_2681948"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.45e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.89e-2)"	4.6	1.4	2.9	0.9	3.0	0.1	1.9	2.2	4.6	6.3	4.4	1.7	0.8	4.6	2.2	1.3	5.2	5.5	1.5	3.1	4.4	1.5	0.5	1.7	2.3	3.4	3.4	3.8	0.6	1.0	0.8	0.2	3.4	1.3	1.2	0.6	0.7	6.3	1.6	1.9	1.9	4.8	3.8	2.5	1.8	2.1	4.7	0.1	3.2	3.3	5.3	1.5	2.4	3.5	0.0	1.1	1.2	0.7	1.7	0.2	0.1	9.6	3.4	31.1	10.5	0.1	0.0	0.0	8.8	2.5	9.5	0.1	13.7	4.5	12.9	0.3	15.3	0.0	2.0	0.0	0.2	0.1	0.1	1.3	2.4	19.9	3.9	15.2	78.5	0.0	0.0	0.1	30.4	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.0	1.0	0.1	0.1	2.5	0.7	1.8	1.9	31.3	0.0	14.4	1.2	4.7	0.0	0.7	0.0	0.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.9	3.0	2.2	4.6	3.1	4.4	3.4	3.4	3.4	3.8	4.7	3.5	0.1	0.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	2.2	0.5	0.0	0.0	15.4	0.0	0.1	1.4	0.0	0.9	0.0	0.2	0.4	0.0	0.0	3.3	10.5	0.0	0.0	2.1	2.0	0.3	0.0	0.1	1.8	0.0	0.0	0.5	0.0	61.3	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	32.9	3.6	29.0	0.1	2.6	0.1	1.0	0.0	0.2	0.1	0.0	0.1
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.3"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	10.3	2.0	1.6	0.9	3.1	0.0	6.1	1.1	3.4	1.9	4.6	0.7	0.1	1.4	0.4	3.1	1.8	1.5	6.6	1.3	1.3	0.4	0.2	0.3	1.8	1.7	1.2	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.7	1.1	0.5	1.5	0.0	0.4	1.0	2.1	0.6	1.7	1.4	0.2	4.5	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.1	3.4	1.3	1.3	1.7	1.2	1.6	1.5	2.1	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 467.3;U-698: 597.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	23.8	17.9	20.7	49.2	20.0	72.8	26.1	18.1	22.7	33.4	21.9	32.3	35.5	29.6	16.2	28.2	25.5	19.8	22.8	19.1	17.8	27.2	18.9	25.9	86.6	22.0	19.3	35.1	28.4	10.2	26.2	17.9	20.4	27.3	18.7	11.0	26.4	12.0	19.5	32.9	48.0	14.4	18.3	62.5	27.3	74.8	20.3	68.4	31.6	12.5	61.0	27.4	27.4	21.8	83.6	48.6	146.4	139.8	18.6	49.6	50.4	51.9	48.0	67.8	60.6	89.8	68.7	421.7	53.5	50.1	12.7	98.4	87.9	69.2	42.8	253.7	52.4	43.2	71.2	115.2	44.8	105.7	56.8	34.0	75.1	52.4	39.2	64.0	82.5	176.1	163.8	146.6	46.0	158.2	301.1	107.8	187.1	65.1	49.2	467.3	61.7	104.3	46.5	78.5	119.3	175.7	50.1	55.9	70.8	53.0	63.8	191.7	103.2	87.1	90.5	116.0	94.1	353.5	173.5	597.2	63.1	140.3	80.1	3.3	1.2	1.0	3.6	1.5	3.6	10.0	2.1	3.1	2.8	10.6	2.8	4.3	0.4	2.8	3.2	12.9	2.2	1.7	20.7	20.0	18.1	22.7	19.1	17.8	22.0	19.3	20.4	18.3	20.3	21.8	17.3	6.4	9.1	14.7	33.9	13.9	5.3	10.0	4.6	12.3	16.6	16.1	10.7	4.3	10.8	1.8	27.1	4.3	26.5	14.7	1.9	11.4	8.6	9.9	20.4	13.5	16.2	32.2	3.9	6.9	8.9	12.3	14.8	16.6	7.0	27.8	9.7	4.8	7.7	5.0	5.6	16.5	16.2	8.9	12.3	5.2	13.7	9.4	10.6	6.5	8.1	9.2	10.3	3.0	7.3	17.6	13.3	10.1	31.1	13.0	16.4	6.3	2.9	13.8	19.7	8.2	16.9	5.5	46.2	9.0	13.2	2.9	12.5	10.4	20.1	8.5
TCF7	TCF-1	ENSG00000081059	"Transcription factor 7"	P36402	5	134114681-134151865	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"lymphoid tissue: 604.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 73.0;T-cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 28.8;memory CD4 T-cell: 49.7;memory CD8 T-cell: 29.0;naive CD4 T-cell: 97.2;naive CD8 T-cell: 62.3;NK-cell: 43.0"	"Group enriched"	"Detected in many"	20	"NK-cells: 43.0;T-cells: 97.2"	"Cell line enriched"	"Detected in many"	6	"MOLT-4: 1324.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019403, HPA058863, HPA070505"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275"	"unprognostic (3.63e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.10e-2)"	4.1	5.3	2.0	56.4	1.8	16.4	4.0	1.8	1.9	3.2	21.3	5.8	16.0	3.9	41.5	3.5	43.1	6.2	2.4	3.1	1.5	4.0	5.8	5.6	94.4	5.9	2.7	1.8	9.4	2.1	6.4	3.5	2.2	5.0	6.8	1.5	8.0	3.5	1.4	4.3	20.4	1.8	3.8	34.6	11.0	3.4	2.1	604.3	6.3	1.0	70.0	9.8	2.0	2.6	0.2	7.8	8.2	29.2	3.9	16.2	11.4	2.2	4.4	0.7	0.8	61.6	19.3	0.4	14.0	13.4	32.3	1.0	13.1	3.1	0.6	3.0	12.2	0.2	7.4	46.4	0.4	0.4	1.6	1.1	0.1	12.6	0.7	5.7	1.8	218.2	7.9	0.3	1.3	0.7	1324.2	1.4	9.0	19.2	10.4	1.6	0.0	1.4	3.0	1.4	3.4	25.1	6.0	1.8	1.6	6.4	1.6	7.3	1.9	81.2	0.5	37.0	2.8	1.3	0.1	0.4	42.7	0.5	4.1	2.2	0.3	3.2	12.3	0.2	28.8	3.5	49.7	29.0	0.2	1.4	97.2	62.3	1.9	43.0	0.2	0.5	6.5	21.8	2.0	1.8	1.8	1.9	3.1	1.5	5.9	2.7	2.2	3.8	2.1	2.6	6.0	3.2	1.9	4.6	27.3	15.7	27.9	6.9	2.8	28.6	14.5	14.9	3.1	10.0	2.9	3.7	73.0	21.6	47.4	18.4	0.0	6.1	3.8	57.6	30.4	9.6	12.6	5.3	2.4	9.9	30.5	11.7	6.6	35.8	20.3	12.1	6.8	3.0	7.1	10.1	2.0	17.0	6.1	9.7	20.0	2.3	6.2	8.7	10.6	1.0	17.1	12.4	41.2	3.5	4.1	23.6	18.5	4.5	9.3	24.6	50.8	1.4	2.5	58.4	0.0	61.4	16.1	4.0	11.0	3.3	11.4	30.0	108.3	8.6	24.1	14.9
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.1;salivary gland: 97.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 79.1;Distal enterocytes: 117.9;Glandular and luminal cells: 83.0;Ionocytes: 262.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 21.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.2;HEL: 15.7;hTCEpi: 17.3;RPTEC TERT1: 42.4;RT4: 31.8;SCLC-21H: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.9	0.3	0.9	1.7	1.6	0.2	28.7	1.7	1.1	18.1	19.0	19.0	0.6	0.5	8.3	13.3	3.5	2.9	0.2	1.7	0.9	49.1	0.2	5.6	0.2	1.6	2.1	0.1	6.4	2.6	0.8	7.4	1.1	13.6	22.6	0.0	97.5	2.0	2.6	31.9	3.2	0.6	0.7	1.8	16.3	1.1	1.9	0.2	37.6	0.1	1.2	1.8	10.9	0.7	0.0	1.6	0.0	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.7	0.0	0.7	0.4	4.4	4.5	0.0	0.0	3.2	15.7	0.0	0.0	0.0	0.0	0.6	0.0	17.3	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.9	0.1	0.0	0.5	2.1	42.4	31.8	13.3	0.1	1.7	0.1	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.7	1.1	1.7	0.9	1.6	2.1	1.1	0.7	1.9	0.7	0.1	6.4	28.8	3.9	0.3	1.7	38.0	10.3	28.5	0.0	22.1	11.6	2.6	17.2	35.4	79.1	0.0	32.2	0.9	117.9	31.3	2.7	0.1	43.5	5.8	1.0	10.2	0.0	0.2	1.5	2.3	0.8	58.6	83.0	0.0	1.2	0.0	0.4	4.9	0.0	0.3	31.2	262.4	4.6	0.8	0.5	0.3	5.5	7.2	9.4	0.2	0.5	0.0	0.0	0.1	7.4	28.0	0.0	2.1	36.3	0.3	27.7	11.9	0.0	0.0	1.9	1.1	0.1	1.5	41.0	3.3	20.2	1.1	9.5	44.3	40.7
TFDP3	"CT30, E2F-like, HCA661"	ENSG00000183434	"Transcription factor Dp family member 3"	Q5H9I0	X	133216662-133218354	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 4.2"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 23.5;Spermatogonia: 31.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077304			Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA077304: "	"unprognostic (1.57e-1)"								"unprognostic (2.17e-1)"					"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.5	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TIMELESS	"hTIM, TIM, TIM1"	ENSG00000111602	"Timeless circadian regulator"	Q9UNS1	12	56416363-56449426	"Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.5;Spermatogonia: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA060655	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA060655: AB_2684338"	"unprognostic (3.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.03e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (9.47e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.01e-2)"	3.4	3.4	1.6	11.0	2.1	22.0	4.5	2.1	2.1	4.1	2.7	6.7	6.0	4.4	2.5	6.8	3.1	3.3	1.8	1.5	2.1	3.8	9.8	4.1	15.3	2.4	2.4	1.9	5.0	5.9	5.4	8.7	2.5	3.2	8.5	13.7	3.9	3.4	3.4	5.5	6.2	5.6	2.1	6.8	5.5	6.2	2.6	19.8	4.7	1.6	17.9	4.7	3.9	2.5	39.4	89.1	111.4	51.9	9.9	9.9	62.8	41.9	25.3	58.3	46.0	45.6	56.5	113.3	41.5	24.5	29.4	32.8	82.0	32.7	53.5	54.2	45.7	86.9	47.6	33.6	5.1	66.2	62.2	6.9	10.3	41.9	25.2	16.0	31.5	67.3	82.7	99.5	49.8	77.2	94.7	51.2	79.2	49.5	36.8	93.5	56.7	55.5	22.7	49.5	85.4	58.9	78.2	43.9	12.2	45.6	77.4	51.8	18.9	45.3	45.1	41.8	35.0	37.3	50.9	62.8	21.1	39.9	55.5	0.1	0.6	0.4	1.8	1.5	0.3	3.3	1.1	1.2	1.0	4.9	0.8	0.3	0.2	1.5	1.1	1.2	1.5	1.1	1.6	2.1	2.1	2.1	1.5	2.1	2.4	2.4	2.5	2.1	2.6	2.5	2.6	0.0	5.0	2.3	8.2	3.3	3.0	3.0	6.8	57.5	3.1	3.4	2.1	2.8	6.8	7.3	2.1	15.9	1.8	2.7	0.0	4.8	6.9	2.5	3.9	5.0	1.8	16.6	0.9	5.7	20.9	3.7	6.6	4.8	5.7	15.5	4.6	10.6	8.5	6.7	1.3	5.2	4.1	2.6	3.7	2.9	1.2	4.6	0.0	1.9	4.2	4.8	4.1	0.5	3.2	3.7	0.6	1.2	18.2	4.2	1.1	2.0	3.4	17.8	0.0	2.7	7.0	1.6	24.5	12.1	1.4	9.2	6.1	3.2	8.5	3.0
TLE1	"ESG, ESG1, GRG1"	ENSG00000196781	"TLE family member 1, transcriptional corepressor"	Q04724	9	81583683-81689547	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011482, HPA071396"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB011482: AB_443210, HPA071396: AB_2686392"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.59e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (4.09e-1)"	44.9	40.1	36.1	11.8	31.8	40.0	39.0	23.1	35.5	57.4	11.7	39.3	7.7	50.1	27.1	20.3	43.0	27.3	19.3	41.2	22.1	21.4	80.7	23.5	12.7	20.7	32.3	42.0	59.9	6.3	19.1	19.3	20.2	31.0	21.6	11.1	47.5	17.4	90.7	31.8	30.2	33.3	20.1	44.7	38.2	25.8	27.6	6.6	24.9	22.5	13.5	30.2	35.5	23.3	69.9	50.6	49.7	0.2	50.3	28.3	99.6	3.9	12.4	8.6	11.3	8.8	26.2	0.0	43.1	27.6	69.0	40.9	1.0	22.3	8.3	0.2	40.0	0.0	12.0	74.8	24.5	0.0	1.3	12.4	47.2	26.2	57.1	22.6	35.1	20.0	0.3	22.4	25.8	74.2	9.8	0.4	88.6	48.0	26.1	66.9	35.2	4.9	46.1	38.2	25.2	31.0	4.8	39.6	22.2	53.3	27.9	31.4	27.6	21.7	22.5	10.5	30.8	0.5	0.3	1.6	28.0	0.2	41.0	8.4	0.0	4.6	2.1	0.0	2.9	6.6	0.2	0.9	0.6	5.8	0.0	0.2	0.0	4.3	0.1	1.7	0.0	0.6	36.1	31.8	23.1	35.5	41.2	22.1	20.7	32.3	20.2	20.1	27.6	23.3	66.6	0.0	6.5	121.5	52.4	54.6	22.3	9.8	18.8	36.6	33.5	18.4	5.7	41.5	15.8	14.7	16.7	67.2	63.5	49.5	15.6	40.8	1.7	85.9	76.2	38.2	28.8	13.9	36.5	23.8	71.9	27.5	23.9	205.8	0.0	30.1	27.1	65.3	7.8	16.8	23.5	24.0	36.7	6.4	20.5	3.6	22.7	9.6	46.2	46.9	8.1	39.5	68.0	22.6	14.5	54.8	41.0	34.3	35.1	40.5	12.2	3.0	17.1	6.0	118.3	12.8	47.4	2.2	102.4	29.3	43.8	50.8	18.6	71.4	48.6	69.4
TLE7		ENSG00000260734	"TLE family member 7"	A0A1W2PR48	16	71429980-71442054	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	26	"testis cancer: 1.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																								"unprognostic (2.29e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMCC2	"FLJ38497, HUCEP11"	ENSG00000133069	"Transmembrane and coiled-coil domain family 2"	O75069	1	205227946-205285632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 88.1;brain: 47.3"	"Cell type enriched"	"Detected in many"	8	"Erythroid cells: 622.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014254	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA014254: AB_1851326"	"unprognostic (2.59e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.18e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-5)"	"unprognostic (3.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.99e-3)"	"unprognostic (3.06e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.43e-3)"	1.4	2.6	15.2	0.4	24.2	88.1	0.9	18.7	47.3	1.8	0.0	2.5	0.3	1.6	0.0	0.7	2.0	0.3	3.6	25.2	16.1	1.4	0.7	3.1	0.3	38.5	26.1	3.1	0.5	3.1	5.0	5.3	41.0	1.0	0.1	8.5	0.9	0.3	3.5	1.7	0.9	0.5	17.3	16.0	0.9	2.0	25.5	0.7	1.3	1.5	0.2	1.2	1.6	33.6	1.9	0.9	1.7	3.8	0.7	0.2	0.9	2.4	1.0	2.3	1.8	0.3	0.2	1.8	0.4	0.6	6.3	3.2	1.1	0.5	0.7	5.7	4.2	7.5	0.5	0.1	0.3	0.3	3.5	0.4	0.1	1.2	0.0	2.0	0.3	1.7	4.0	2.4	0.9	0.1	0.0	0.9	4.1	0.0	5.2	2.8	4.3	9.1	0.4	0.1	32.0	4.3	0.2	0.0	8.0	1.5	0.7	0.4	0.8	1.5	2.5	3.9	2.7	4.9	2.1	1.2	1.3	0.6	9.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	15.2	24.2	18.7	47.3	25.2	16.1	38.5	26.1	41.0	17.3	25.5	33.6	1.9	0.0	0.0	6.2	0.4	1.0	0.4	1.2	0.0	34.4	0.2	0.0	4.6	0.0	0.3	1.8	10.4	0.1	0.3	0.0	0.0	1.6	1.5	3.7	0.8	2.5	3.5	622.1	7.9	0.0	0.2	1.0	0.0	1.9	0.0	7.4	3.9	0.0	0.9	40.4	10.1	0.1	0.0	0.6	6.1	0.8	1.2	13.1	3.6	2.8	7.8	17.7	0.0	2.5	73.0	0.2	0.0	0.4	0.8	0.1	0.0	0.2	0.9	43.2	0.0	1.8	2.8	1.1	4.8	0.4	0.9	0.0	0.7	0.8	0.1	0.1
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787594	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 4.6;Bipolar cells: 4.7;Cone photoreceptor cells: 6.2;Excitatory neurons: 5.1;Muller glia cells: 3.3;Rod photoreceptor cells: 8.3;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.7;JURKAT: 1.5;NTERA-2: 2.1;RH-30: 1.5;SCLC-21H: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015672, HPA076461"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA015672: AB_1858132, HPA076461: "	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	0.3	0.2	1.8	0.1	2.2	0.0	0.2	4.7	2.4	0.2	1.4	1.3	0.0	0.1	0.0	0.5	0.1	0.1	1.3	3.7	3.0	0.1	0.8	0.1	0.0	3.8	1.7	0.1	0.5	0.0	0.4	0.0	3.5	0.1	0.1	2.5	0.2	0.1	0.8	0.3	0.2	0.4	6.1	0.1	0.3	0.3	1.6	0.3	0.1	0.2	0.1	0.2	0.4	8.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	1.7	0.7	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	1.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.2	4.7	2.4	3.7	3.0	3.8	1.7	3.5	6.1	1.6	8.2	0.4	0.0	0.0	2.0	0.0	0.9	0.7	0.0	4.6	4.7	0.2	0.6	0.8	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	1.8	0.0	5.1	0.2	0.8	0.7	0.0	0.1	0.0	0.5	0.0	0.7	0.1	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	8.3	0.0	0.8	0.9	0.2	4.1	2.0	0.6	0.1	0.1	0.1	0.0	0.0
TMSB15A	"TMSL8, TMSNB"	ENSG00000158164	"Thymosin beta 15A"	P0CG34	X	102513682-102516739	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.0;prostate: 15.8"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 12.8;Granulosa cells: 25.9;Prostatic glandular cells: 13.8;Smooth muscle cells: 13.5;Spermatogonia: 19.8"	"Group enriched"	"Detected in many"	4	"glioma: 20.1;prostate cancer: 56.4;testis cancer: 14.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 571.5;HAP1: 110.2;MOLT-4: 113.4;NTERA-2: 148.0;RH-30: 259.9;SH-SY5Y: 148.1"					"Low region specificity"	"Detected in all"									NA	NA		130000	"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (5.33e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.96e-4)"	"unprognostic (2.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.07e-1)"	1.0	1.0	1.1	1.1	1.2	1.0	5.1	1.7	2.1	5.1	1.4	0.9	0.4	5.0	0.7	0.3	1.9	1.2	1.9	1.2	1.1	2.4	0.1	7.1	4.0	1.3	1.0	4.7	0.9	0.8	0.8	0.5	1.3	15.8	1.1	1.4	3.9	1.2	0.3	0.5	0.6	2.3	1.1	0.4	0.5	4.8	1.2	13.0	5.9	0.3	2.8	0.7	2.3	1.1	0.1	0.0	571.5	107.7	2.4	0.3	0.2	12.4	0.7	1.7	4.8	0.0	0.7	0.0	1.3	2.1	28.5	0.0	110.2	0.7	1.2	0.0	5.6	10.3	1.7	0.3	0.3	0.2	10.1	1.4	0.0	1.1	0.0	14.3	6.7	5.5	1.0	0.0	41.2	0.1	113.4	0.2	148.0	0.0	1.4	0.2	259.9	0.0	11.7	0.2	98.1	148.1	14.0	0.9	0.3	22.0	1.4	3.2	2.4	0.3	62.6	1.4	10.5	11.8	2.1	0.0	6.7	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	1.1	1.2	1.7	2.1	1.2	1.1	1.3	1.0	1.3	1.1	1.2	1.1	1.4	0.0	0.0	0.0	0.0	0.8	0.9	0.1	1.8	0.3	7.3	12.8	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.0	0.5	0.3	0.5	5.6	1.2	0.0	0.8	0.0	0.0	0.5	4.6	0.0	1.2	0.0	25.9	2.5	0.0	0.5	0.0	0.0	0.6	0.0	0.6	0.5	0.1	0.3	0.1	1.8	0.0	0.0	0.7	1.0	0.5	0.0	0.0	0.1	2.6	0.3	13.8	0.1	0.4	0.0	0.1	6.6	1.2	13.5	3.4	19.8	1.8	0.0	0.3	0.7	0.9	0.9	1.0
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391288	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.5;salivary gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 5.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 5.3"	"Cell line enriched"	"Detected in many"	6	"HDLM-2: 125.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		110000	"Cluster 48: NK-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	1.8	1.1	0.8	5.7	1.6	0.4	4.1	0.1	1.9	1.4	0.3	17.1	30.5	0.9	0.3	2.8	0.9	7.6	0.6	2.0	1.1	0.4	0.6	1.0	1.2	0.7	1.1	0.4	1.7	0.9	6.8	3.2	0.2	1.3	17.6	0.2	25.4	2.7	0.3	2.7	18.6	1.7	0.7	0.8	5.5	0.9	1.2	1.0	1.2	0.1	1.9	1.6	1.6	2.1	3.2	2.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.6	0.4	0.6	0.0	3.5	0.4	1.4	2.2	8.3	0.9	0.2	125.9	5.4	0.0	1.3	1.7	0.0	0.5	1.3	0.2	0.4	0.8	3.1	4.2	3.1	0.3	0.0	0.0	0.0	1.1	0.0	0.1	5.9	7.0	19.3	0.4	0.0	0.6	1.5	1.5	20.4	0.7	0.6	3.0	0.1	0.8	1.3	0.4	2.0	0.0	0.1	0.1	0.0	1.2	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.3	0.6	0.0	0.8	1.6	0.1	1.9	2.0	1.1	0.7	1.1	0.2	0.7	1.2	2.1	0.4	0.0	2.2	0.0	0.4	1.3	3.8	1.1	0.6	0.6	4.5	3.3	1.3	8.6	2.3	0.0	0.0	0.1	3.3	35.6	0.0	8.3	0.3	3.2	0.5	5.3	10.8	0.0	4.0	7.5	0.6	0.7	11.7	6.2	0.0	2.0	7.1	0.3	15.5	3.3	0.2	24.0	0.0	17.0	2.4	0.4	0.6	7.7	1.8	8.4	19.7	0.0	3.1	0.5	0.4	14.7	42.3	0.0	0.5	2.8	25.5	0.0	3.8	0.2	0.0	0.5	0.4	0.8	1.9	1.7	2.3	0.1	0.7	0.0	42.2	4.4
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.6;skin 1: 137.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.5	0.3	0.3	0.6	0.3	0.4	18.0	0.9	0.5	23.5	0.3	0.3	0.1	0.3	10.5	69.6	1.0	0.3	0.6	0.5	0.5	0.3	0.4	1.9	1.0	0.4	0.6	0.1	0.3	0.0	0.5	10.8	0.7	17.4	0.2	0.0	20.8	18.0	42.4	137.3	0.2	0.3	0.2	0.2	0.4	3.4	0.4	23.1	0.3	12.4	17.7	18.6	54.4	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.9	0.5	0.5	0.5	0.4	0.6	0.7	0.2	0.4	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32817997-32897824	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 4.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Extravillous trophoblasts: 15.6;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 4.5;Spermatogonia: 13.7"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 31.4;BEWO: 94.5;Hep G2: 63.8;NTERA-2: 84.3;SuSa: 76.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.0	0.0	1.0	0.0	1.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	31.4	0.0	0.0	0.0	94.5	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.6	0.0	63.8	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.0	0.0	0.6	6.9	84.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	76.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.8	0.9	0.8	0.1	0.1	0.1	0.0	0.8	0.2	0.0	9.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.7	0.0	1.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	3.1	0.0	15.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	3.6	0.7	0.5	0.0	0.0	0.1	0.3	13.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859479-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 83.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 13: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	4.4	4.4	5.8	4.9	6.9	3.9	7.0	9.2	7.4	7.5	5.0	7.5	3.8	5.5	9.1	10.6	6.5	4.6	6.0	5.9	6.3	6.2	5.9	5.1	6.7	6.7	6.9	9.0	7.8	5.9	6.9	4.2	7.0	7.8	4.7	5.6	7.0	6.2	6.5	6.8	4.8	4.3	6.3	5.8	6.4	5.5	6.2	8.2	7.3	7.7	8.3	6.4	8.3	8.9	11.7	15.8	12.2	12.8	6.8	4.9	9.7	9.1	5.3	11.7	9.5	17.0	7.5	10.5	15.0	2.1	7.9	9.7	17.4	5.4	11.1	6.1	21.2	12.6	12.4	20.4	3.6	7.6	6.4	2.7	8.3	10.1	3.5	4.0	9.4	10.3	27.5	7.1	4.0	83.1	15.6	8.5	10.8	13.0	6.9	16.1	17.9	16.2	5.0	4.8	11.3	6.8	6.4	4.9	6.5	14.5	11.8	7.2	3.0	8.4	18.3	5.9	9.8	8.3	13.7	16.2	4.0	8.3	7.5	6.5	8.4	16.3	11.4	5.8	13.2	11.7	14.0	12.1	5.9	8.9	18.1	14.8	8.8	10.1	6.5	9.9	16.7	7.1	5.8	6.9	9.2	7.4	5.9	6.3	6.7	6.9	7.0	6.3	6.2	8.9	8.3	12.8	36.1	10.7	16.9	15.7	14.4	9.1	10.8	7.6	10.9	11.3	5.3	5.7	17.6	3.7	6.2	6.3	9.4	3.2	11.7	5.7	1.7	9.2	8.5	9.4	10.3	13.9	9.2	4.8	7.4	9.6	4.1	16.3	11.4	9.9	8.9	3.8	4.0	3.3	9.5	5.5	8.2	4.7	7.1	0.8	5.6	6.9	7.2	9.4	6.0	10.3	13.4	8.5	18.4	3.7	7.5	8.2	10.9	12.5	3.6	3.6	9.4	8.6	6.6	13.3	9.6	14.7	24.2	10.6	16.9	4.0	16.2	2.6	4.9	6.8
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097597-109110992	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 64.9;Spermatogonia: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	19.8	56.7	32.4	14.7	32.4	16.0	23.1	30.1	34.8	16.6	27.7	28.0	17.1	14.5	12.7	29.7	15.6	10.4	21.1	29.2	34.9	27.5	32.2	9.6	18.0	32.2	31.4	15.7	12.4	33.2	10.9	17.8	34.1	13.6	29.3	6.8	17.7	17.6	43.0	32.7	18.8	14.5	31.6	16.1	17.7	24.3	33.5	22.8	22.2	33.5	27.0	13.5	20.1	30.8	77.1	77.5	72.8	66.6	118.6	33.8	69.5	44.4	30.1	68.6	52.3	61.7	51.6	100.3	65.1	40.2	35.9	47.6	81.4	46.0	66.4	85.6	150.9	98.1	41.1	105.5	17.7	147.6	58.2	30.7	41.6	33.0	18.3	54.6	50.4	117.8	80.9	32.5	47.0	96.2	136.8	173.6	130.0	124.2	117.7	123.9	109.8	85.9	43.4	95.6	103.3	57.4	79.6	67.8	39.5	94.2	126.2	68.2	26.0	59.1	52.7	39.3	62.5	62.6	145.0	190.5	44.8	97.7	73.8	12.9	2.7	5.0	22.4	5.3	31.6	16.0	25.5	25.6	6.8	17.2	16.4	18.4	0.0	16.5	5.5	4.9	25.5	14.4	32.4	32.4	30.1	34.8	29.2	34.9	32.2	31.4	34.1	31.6	33.5	30.8	26.6	0.0	4.8	16.0	9.2	18.0	11.0	13.2	25.0	2.6	21.7	14.1	12.4	7.2	5.0	42.3	4.2	64.9	12.5	14.7	19.6	14.4	3.4	7.6	15.0	17.7	8.4	32.4	7.0	6.2	38.1	12.6	14.3	9.9	7.6	24.8	20.3	20.8	18.3	5.0	6.2	21.4	10.2	3.8	5.4	4.2	14.0	5.5	14.2	6.5	3.8	15.8	7.2	6.6	4.0	5.0	10.3	14.7	16.7	6.8	9.3	20.2	3.2	3.5	6.6	10.2	11.5	21.9	74.6	37.8	20.9	20.4	15.3	25.7	40.4	9.7
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232866-47248328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 203.6;Horizontal cells: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	25.5	32.8	117.7	23.7	118.7	11.2	26.8	41.5	116.3	51.2	30.0	33.9	11.5	47.0	23.6	18.2	49.9	24.5	45.5	113.1	148.1	33.3	12.7	30.9	30.1	69.8	78.3	76.4	27.1	36.6	103.7	24.9	93.9	33.4	14.1	84.8	21.4	38.7	32.4	18.5	25.5	35.9	65.4	29.3	24.9	46.2	122.8	42.6	52.2	29.6	28.9	36.9	31.7	79.8	45.6	70.7	117.6	81.0	43.4	28.5	33.0	34.0	52.5	65.6	73.3	67.4	36.7	29.9	26.1	60.5	70.5	53.5	94.7	24.0	56.4	47.1	73.5	34.7	52.9	61.4	50.7	39.2	70.7	42.1	9.8	69.1	29.3	37.3	26.7	68.9	26.6	3.9	51.8	70.0	77.8	43.4	89.2	24.3	62.5	86.1	114.3	25.1	32.4	60.9	66.8	114.4	62.6	12.4	37.7	73.9	26.0	23.0	28.2	56.0	58.0	79.3	39.6	54.3	36.2	51.3	34.3	48.8	50.8	63.9	9.1	19.9	55.4	19.6	48.3	53.1	24.5	54.3	11.9	53.1	36.6	76.3	5.5	56.4	24.3	53.2	35.0	46.0	117.7	118.7	41.5	116.3	113.1	148.1	69.8	78.3	93.9	65.4	122.8	79.8	13.6	22.4	17.7	25.8	53.5	13.6	42.2	30.9	21.6	203.6	13.0	23.5	24.2	7.2	31.5	33.1	56.3	20.9	52.2	9.4	50.9	18.3	26.4	28.2	26.3	22.5	35.4	18.3	43.3	10.2	15.0	41.3	22.4	28.3	45.7	56.6	22.1	8.2	13.4	139.7	63.7	8.7	28.5	12.0	16.3	41.0	29.5	17.9	28.4	19.7	17.5	96.2	23.7	25.1	24.8	12.5	7.9	42.2	48.1	18.6	4.7	15.2	46.4	63.4	26.3	57.2	40.2	18.3	87.8	11.9	6.5	16.3	44.6	34.2	8.9	26.0
UXS1	"FLJ23591, SDR6E1, UGD"	ENSG00000115652	"UDP-glucuronate decarboxylase 1"	Q8NBZ7	2	106093308-106194301	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 323.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008825	Uncertain				"Intracellular and membrane"	NA	NA		24000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA008825: AB_1858708"	"unprognostic (4.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.45e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.20e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.32e-2)"	16.3	17.6	20.4	25.0	18.7	40.4	15.3	30.4	29.3	19.6	20.6	21.7	15.5	24.3	33.1	24.1	29.2	19.6	29.3	25.9	20.3	60.0	15.7	46.0	27.9	15.0	23.0	24.4	15.8	37.3	16.3	54.6	19.3	23.2	24.0	10.5	14.6	25.9	31.9	14.0	14.3	21.4	18.5	25.0	26.2	31.9	31.0	22.2	30.0	28.6	30.4	29.5	18.3	23.7	66.5	48.8	50.9	39.0	88.4	65.2	110.2	71.4	66.9	49.9	61.5	96.9	110.4	12.0	87.0	74.1	111.2	32.8	22.6	58.2	54.5	64.2	40.5	37.0	21.4	110.6	34.9	30.5	39.0	42.8	63.8	50.3	33.5	57.5	52.5	22.8	22.1	28.5	103.6	46.8	34.3	66.8	60.1	64.2	65.4	70.3	38.6	34.3	323.0	60.9	16.7	19.0	51.5	45.7	44.3	67.7	17.0	93.7	48.0	55.1	58.5	45.4	45.4	34.4	51.4	17.9	55.0	70.1	103.8	11.3	24.7	28.5	23.1	20.8	25.7	15.3	64.3	41.4	19.1	30.5	68.8	49.1	6.1	37.5	16.0	13.5	130.4	44.3	20.4	18.7	30.4	29.3	25.9	20.3	15.0	23.0	19.3	18.5	31.0	23.7	15.4	89.8	88.8	18.9	22.1	16.8	26.8	117.3	14.8	9.9	11.6	10.5	18.7	17.2	61.6	86.5	4.2	71.2	17.7	20.5	50.9	46.9	80.2	41.5	19.3	25.5	6.6	12.0	49.8	25.0	74.1	34.2	16.8	40.6	29.8	13.1	10.8	15.0	33.2	8.4	37.5	15.6	34.6	20.1	12.5	18.5	15.2	33.9	14.2	33.7	56.2	10.8	18.6	24.1	11.7	30.4	16.2	12.8	10.2	35.7	9.6	17.5	38.8	7.9	19.7	19.0	35.1	17.0	81.6	22.6	13.2	24.6	33.7	51.6	18.0	19.8
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788564-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adrenal gland: 70.1;brain: 186.9;choroid plexus: 232.4;retina: 188.7"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 297.8;Muller glia cells: 106.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.1;BJ hTERT+: 68.7;fHDF/TERT166: 38.1;NTERA-2: 79.9;U-87 MG: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.8	70.1	30.0	3.3	38.1	0.8	0.5	45.7	24.1	0.7	232.4	3.6	2.3	5.4	6.8	1.7	0.9	4.0	15.2	19.6	186.9	5.3	1.0	0.3	0.4	60.2	53.2	0.3	1.8	0.7	4.5	1.9	84.0	0.3	5.6	188.7	1.4	0.4	0.2	0.1	3.2	2.5	49.9	0.0	1.9	1.9	67.4	0.1	2.4	0.3	2.3	1.4	1.2	37.4	0.0	0.0	23.1	0.0	7.8	0.0	0.0	2.8	68.7	0.9	0.7	0.0	0.0	0.0	0.0	38.1	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.5	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	79.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.0	3.7	0.0	1.1	0.0	14.1	0.1	18.6	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	82.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	38.1	45.7	24.1	19.6	186.9	60.2	53.2	84.0	49.9	67.4	37.4	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.5	9.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	4.4	0.0	0.2	0.9	3.0	0.0	20.7	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.0	0.2	297.8	31.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.0	0.6	106.9	0.0	44.7	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0
WWC1	"KIAA0869, KIBRA, PPP1R168"	ENSG00000113645	"WW and C2 domain containing 1"	Q8IX03	5	168291645-168472303	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 142.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.2;Cone photoreceptor cells: 91.8;Endometrial ciliated cells: 81.8;Glandular and luminal cells: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 120.2;RPTEC TERT1: 260.4;SK-BR-3: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038016, HPA038017"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA038016: AB_10697091, HPA038017: AB_10669513"	"unprognostic (3.60e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.95e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-1)"	7.8	0.6	41.8	2.9	43.3	0.1	21.2	41.0	39.7	6.0	50.4	6.4	24.3	2.8	6.8	22.9	17.2	8.7	1.6	40.3	41.3	73.3	38.1	20.2	3.0	56.8	47.0	0.8	28.3	23.5	7.8	10.2	43.6	16.4	6.1	17.8	142.3	11.8	0.0	19.9	20.2	1.1	46.6	0.7	22.9	1.7	54.3	1.3	29.7	0.0	6.9	9.3	10.1	38.6	50.6	56.4	9.2	0.4	0.0	0.0	96.8	3.7	0.9	17.1	15.3	120.2	73.6	0.0	58.6	1.2	47.4	35.0	18.9	46.1	20.1	0.1	18.6	0.0	28.6	29.9	0.9	4.4	0.0	6.0	13.9	32.3	28.5	13.2	0.0	3.0	0.0	7.2	1.3	56.4	0.0	0.1	13.3	60.8	8.2	0.0	0.4	29.1	260.4	68.8	30.7	11.4	66.5	136.4	17.1	11.6	67.8	4.3	0.0	3.0	34.2	0.4	36.9	0.8	0.4	0.2	3.4	0.1	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.8	43.3	41.0	39.7	40.3	41.3	56.8	47.0	43.6	46.6	54.3	38.6	0.3	64.1	72.3	162.2	1.3	11.9	14.7	6.0	1.8	1.4	35.7	25.7	1.8	34.3	42.1	58.8	91.8	11.6	0.6	17.9	13.7	44.9	0.4	81.8	10.8	1.3	7.8	0.0	50.1	40.5	2.3	5.3	15.3	149.2	1.3	5.6	1.1	16.9	1.3	0.0	27.9	7.8	6.1	0.6	1.1	0.1	1.2	4.2	10.6	8.4	1.1	18.1	0.0	17.6	1.9	73.1	10.9	0.7	0.1	38.8	18.9	61.8	36.7	9.1	0.0	0.2	5.6	0.3	5.0	7.3	13.9	18.2	2.1	2.5	12.2	16.5
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629545	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Vesicles	"HPA048751: AB_2680512"	"unprognostic (1.13e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	29.4	23.6	17.7	15.1	19.9	44.5	30.6	19.6	24.8	37.0	16.9	28.3	17.5	33.8	6.9	25.4	32.0	11.8	24.3	17.8	17.9	27.7	27.8	27.2	20.7	19.9	18.0	45.8	35.9	13.4	27.1	15.4	20.2	32.7	5.4	9.0	31.1	17.5	35.6	39.0	27.6	9.3	18.6	34.5	30.9	37.7	18.3	21.1	34.7	13.3	10.6	29.1	29.6	25.5	39.8	35.7	21.2	27.9	21.9	16.3	41.2	22.8	26.5	39.6	40.0	46.4	25.4	26.7	44.1	21.3	28.9	34.2	30.2	33.2	10.0	47.1	39.0	35.5	30.2	41.3	28.3	47.5	30.8	28.8	27.0	28.0	20.2	21.3	24.2	56.4	32.4	69.0	12.4	44.0	44.9	73.8	48.3	24.8	69.6	49.3	26.8	47.0	15.8	30.7	30.2	34.4	25.9	25.1	23.2	13.8	32.0	41.6	24.1	18.1	29.5	41.3	39.0	117.7	75.0	39.0	31.0	40.1	27.4	8.8	10.0	9.3	11.8	10.2	11.3	10.1	11.0	9.1	8.0	12.2	13.1	10.0	6.4	8.3	13.9	6.9	14.2	12.1	17.7	19.9	19.6	24.8	17.8	17.9	19.9	18.0	20.2	18.6	18.3	25.5	18.3	0.0	1.8	3.9	22.9	19.6	16.2	28.1	14.2	14.1	89.4	54.4	1.4	25.8	20.1	47.8	12.5	46.0	24.8	28.3	35.2	19.8	39.9	24.7	13.3	16.4	18.6	14.1	2.3	34.4	26.4	16.7	33.6	32.3	19.7	27.7	17.5	46.4	19.8	3.3	2.5	21.2	24.4	19.2	11.0	19.1	28.3	18.3	26.6	3.7	26.5	13.9	23.7	1.0	3.7	15.1	12.4	21.8	19.4	12.2	28.9	159.5	13.4	14.2	39.5	15.9	21.6	36.1	57.3	14.6	17.8	65.9	20.6	17.8	23.9	14.3
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384293	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.4;intestine: 22.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 7.0;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 20.1;Proximal enterocytes: 21.5;Syncytiotrophoblasts: 36.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 46.9;HDLM-2: 70.1;RT4: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: AB_2674887"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.2	0.1	10.2	0.1	22.2	0.0	0.8	23.6	18.1	0.3	3.1	0.6	22.4	0.1	1.6	0.9	0.1	0.2	0.1	18.0	14.8	1.1	0.0	0.2	0.0	29.4	26.4	0.3	0.0	0.0	0.8	3.4	26.8	0.3	0.6	2.6	0.4	0.1	0.0	1.7	11.2	0.1	20.4	0.0	0.3	0.8	23.2	0.3	0.1	0.1	0.6	0.5	0.5	34.4	4.9	13.7	2.3	0.7	0.0	0.0	0.2	0.5	0.6	0.8	0.8	5.3	12.7	0.3	0.8	0.0	5.3	46.9	1.2	5.2	0.7	70.1	1.4	0.2	1.5	0.4	0.0	0.1	0.7	0.0	12.2	0.5	1.3	0.2	0.0	2.7	0.0	0.0	0.0	0.2	0.5	0.2	3.5	10.3	1.3	0.0	5.8	0.0	0.3	38.2	11.1	2.0	3.3	0.5	0.0	5.1	1.1	0.1	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	22.2	23.6	18.1	18.0	14.8	29.4	26.4	26.8	20.4	23.2	34.4	0.2	0.0	0.0	1.0	0.0	0.6	0.9	0.4	0.0	1.8	0.2	0.4	0.6	0.0	0.2	0.0	0.0	7.0	0.0	0.8	5.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	1.9	0.2	0.5	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	10.1	20.1	0.6	0.0	0.0	0.0	1.1	21.5	0.2	0.0	0.5	0.0	0.2	0.6	0.1	1.5	0.0	0.1	36.1	0.0	0.1	1.5	0.4